pmid,title,verdict,reasoning
PMID:10339466,Myeloid malignancies induced by alkylating agents in Nf1 mice.,EXCLUDE,No specific research tool mentioned
PMID:10383727,"The Nf1 tumor suppressor regulates mouse skin wound healing, fibroblast proliferation, and collagen deposited by fibroblasts.",EXCLUDE,No specific research tool mentioned
PMID:10433955,Molecular genetic analysis of ependymal tumors. NF2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas.,EXCLUDE,"Molecular genetic analysis, no tool development"
PMID:10567424,Interdomain interaction of merlin isoforms and its influence on intermolecular binding to NHE-RF.,EXCLUDE,"Protein interaction study, no tool development"
PMID:10591653,Mouse tumor model for neurofibromatosis type 1.,INCLUDE,Mouse tumor model development
PMID:10595915,Deletions of the INK4A gene occur in malignant peripheral nerve sheath tumors but not in neurofibromas.,EXCLUDE,"Genetic analysis, no tool development"
PMID:10595919,Expression of p27(kip) and other cell cycle regulators in malignant peripheral nerve sheath tumors and neurofibromas: the emerging role of p27(kip) in malignant transformation of neurofibromas.,EXCLUDE,"Cell cycle regulation study, no tool development"
PMID:10620616,Genetic and biochemical evidence that haploinsufficiency of the Nf1 tumor suppressor gene modulates melanocyte and mast cell fates in vivo.,EXCLUDE,"Genetic and biochemical study, no tool development"
PMID:10627474,Inhibition of juvenile myelomonocytic leukemia cell growth in vitro by farnesyltransferase inhibitors.,EXCLUDE,No research tool mentioned
PMID:10633134,A search for evidence of somatic mutations in the NF1 gene.,EXCLUDE,"Mutation screening, no tool development"
PMID:10669747,"Cloning and characterization of SCHIP-1, a novel protein interacting specifically with spliced isoforms and naturally occurring mutant NF2 proteins.",EXCLUDE,"Protein interaction study, no tool development"
PMID:10678181,Nf1 and Gmcsf interact in myeloid leukemogenesis.,EXCLUDE,"Genetic interaction study, no tool development"
PMID:10684924,Cold shock induces the insertion of a cryptic exon in the neurofibromatosis type 1 (NF1) mRNA.,EXCLUDE,"RNA splicing study, no tool development"
PMID:10705390,A unique method for mutation analysis of tumor suppressor genes in colorectal carcinomas using a crypt isolation technique.,INCLUDE,Novel mutation analysis technique (crypt isolation)
PMID:10712197,Minor lesion mutational spectrum of the entire NF1 gene does not explain its high mutability but points to a functional domain upstream of the GAP-related domain.,EXCLUDE,"Mutational spectrum analysis, no tool development"
PMID:10712203,Functional analysis of the neurofibromatosis type 2 protein by means of disease-causing point mutations.,EXCLUDE,"Functional protein analysis, no tool development"
PMID:10844550,The neurofibromatosis type 1 (Nf1) tumor suppressor is a modifier of carcinogen-induced pigmentation and papilloma formation in C57BL/6 mice.,EXCLUDE,"Carcinogen interaction study, no tool development"
PMID:10887156,Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2.,INCLUDE,Conditional mouse model development
PMID:10900196,Single cell Ras-GTP analysis reveals altered Ras activity in a subpopulation of neurofibroma Schwann cells but not fibroblasts.,EXCLUDE,"Single cell Ras-GTP analysis, no tool development"
PMID:11080503,Neurofibromin GTPase-activating protein-related domains restore normal growth in Nf1-/- cells.,INCLUDE,Neurofibromin domain restoration research tool
PMID:11106646,Hierarchy of merlin and ezrin N- and C-terminal domain interactions in homo- and heterotypic associations and their relationship to binding of scaffolding proteins EBP50 and E3KARP.,EXCLUDE,"Protein interaction study, no tool development"
PMID:11159187,Tumorigenic properties of neurofibromin-deficient neurofibroma Schwann cells.,EXCLUDE,"Tumor properties study, no tool development"
PMID:11356864,Bipartite interaction between neurofibromatosis type I protein (neurofibromin) and syndecan transmembrane heparan sulfate proteoglycans.,EXCLUDE,"Protein interaction study, no tool development"
PMID:11368764,"The neurofibromatosis 2 protein product merlin selectively binds F-actin but not G-actin, and stabilizes the filaments through a lateral association.",EXCLUDE,"Protein binding study, no tool development"
PMID:11380622,Identification of the cis-acting region in the NF2 gene promoter as a potential target for mutation and methylation-dependent silencing in schwannoma.,EXCLUDE,"Gene promoter analysis, no tool development"
PMID:11404331,A systematic screen for dominant second-site modifiers of Merlin/NF2 phenotypes reveals an interaction with blistered/DSRF and scribbler.,INCLUDE,Systematic genetic screen for modifiers
PMID:11432873,Schwannomin isoform-1 interacts with syntenin via PDZ domains.,EXCLUDE,"Protein interaction study, no tool development"
PMID:11433044,Quantification of splice variants using real-time PCR.,INCLUDE,Real-time PCR splice variant quantification method
PMID:11435472,"Hyperactivation of p21(ras) and the hematopoietic-specific Rho GTPase, Rac2, cooperate to alter the proliferation of neurofibromin-deficient mast cells in vivo and in vitro.",EXCLUDE,"Proliferation study, no tool development"
PMID:11438454,NF1 deletions in S-100 protein-positive and negative cells of sporadic and neurofibromatosis 1 (NF1)-associated plexiform neurofibromas and malignant peripheral nerve sheath tumors.,EXCLUDE,"Genetic deletion analysis, no tool development"
PMID:11533205,Retroviral integration at the Epi1 locus cooperates with Nf1 gene loss in the progression to acute myeloid leukemia.,EXCLUDE,"Leukemia progression study, no tool development"
PMID:11535133,Binding of the merlin-I product of the neurofibromatosis type 2 tumour suppressor gene to a novel site in beta-fodrin is regulated by association between merlin domains.,EXCLUDE,"Protein binding study, no tool development"
PMID:11544276,Quantitative effects of Nf1 inactivation on in vivo hematopoiesis.,EXCLUDE,"Hematopoiesis study, no tool development"
PMID:11703924,"The Nf2 tumor suppressor, merlin, functions in Rac-dependent signaling.",EXCLUDE,"Signaling pathway study, no tool development"
PMID:11719502,p21-activated kinase links Rac/Cdc42 signaling to merlin.,EXCLUDE,"Signaling pathway study, no tool development"
PMID:11727199,"C-->U editing of neurofibromatosis 1 mRNA occurs in tumors that express both the type II transcript and apobec-1, the catalytic subunit of the apolipoprotein B mRNA-editing enzyme.",EXCLUDE,"RNA editing study, no tool development"
PMID:11756419,Structural basis for neurofibromatosis type 2. Crystal structure of the merlin FERM domain.,INCLUDE,Crystal structure of merlin FERM domain
PMID:11784085,Allele-specific non-CpG methylation of the Nf1 gene during early mouse development.,EXCLUDE,"Methylation study, no tool development"
PMID:11809806,"The neurofibromatosis type 2 gene product, merlin, reverses the F-actin cytoskeletal defects in primary human Schwannoma cells.",EXCLUDE,"Cytoskeletal study, no tool development"
PMID:11896214,NF1 tumor suppressor mRNA is targeted to the cell-cell contact zone in Ca(2+)-induced keratinocyte differentiation.,EXCLUDE,"mRNA localization study, no tool development"
PMID:11996670,The 4.1/ezrin/radixin/moesin domain of the DAL-1/Protein 4.1B tumour suppressor interacts with 14-3-3 proteins.,EXCLUDE,"Protein interaction study, no tool development"
PMID:12057013,Complex splicing pattern generates great diversity in human NF1 transcripts.,INCLUDE,Complex splicing pattern analysis method
PMID:12077339,Astrocyte-specific inactivation of the neurofibromatosis 1 gene (NF1) is insufficient for astrocytoma formation.,EXCLUDE,"Astrocyte inactivation study, no tool development"
PMID:12082543,Mouse models of neurofibromatosis 1 and 2.,INCLUDE,Mouse model review
PMID:12095621,Quantification of NF1 transcripts reveals novel highly expressed splice variants.,INCLUDE,NF1 transcript quantification method
PMID:12124168,Thinking beyond the tumor cell: Nf1 haploinsufficiency in the tumor environment.,EXCLUDE,"Tumor environment study, no tool development"
PMID:12130630,Mutant products of the NF2 tumor suppressor gene are degraded by the ubiquitin-proteasome pathway.,EXCLUDE,"Protein degradation study, no tool development"
PMID:12191989,The motor protein kinesin-1 links neurofibromin and merlin in a common cellular pathway of neurofibromatosis.,EXCLUDE,"Cellular pathway study, no tool development"
PMID:12199909,Functional expression of NF1 tumor suppressor protein: association with keratin intermediate filaments during the early development of human epidermis.,EXCLUDE,"Protein expression study, no tool development"
PMID:12243339,Inhibition of ras-mediated activator protein 1 activity and cell growth by merlin.,EXCLUDE,"Signaling pathway study, no tool development"
PMID:12393498,Leukemic potential of doubly mutant Nf1 and Wv hematopoietic cells.,EXCLUDE,"Basic research on Nf1 mutation, no specific tool mentioned"
PMID:12469121,Nf1 has an essential role in endothelial cells.,EXCLUDE,"Descriptive research on Nf1, no tool development"
PMID:12471027,Isolation and characterization of an aggresome determinant in the NF2 tumor suppressor.,EXCLUDE,"Protein characterization, no tool development"
PMID:12612091,Brain lipid binding protein in axon-Schwann cell interactions and peripheral nerve tumorigenesis.,EXCLUDE,"Descriptive cellular research, no tool usage"
PMID:12673723,Quinidine impairs proliferation of neurofibromatosis type 2-deficient human malignant mesothelioma cells.,EXCLUDE,"Drug screening study, no tool development"
PMID:12679023,PDZ tandem of human syntenin: crystal structure and functional properties.,EXCLUDE,"Protein structure analysis, no tool development"
PMID:12730209,Neurofibromatosis type I tumor suppressor neurofibromin regulates neuronal differentiation via its GTPase-activating protein function toward Ras.,EXCLUDE,"Molecular mechanism study, no tool development"
PMID:12896975,Merlin links to the cAMP neuronal signaling pathway by anchoring the RIbeta subunit of protein kinase A.,EXCLUDE,"Protein interaction study, no tool development"
PMID:12904481,Aberrant growth and differentiation of oligodendrocyte progenitors in neurofibromatosis type 1 mutants.,EXCLUDE,"Descriptive research on NF1 mutations, no tool usage"
PMID:12946024,Pathological adhesion of primary human schwannoma cells is dependent on altered expression of integrins.,EXCLUDE,"Cellular adhesion study, no tool development"
PMID:1362901,The role of Gln61 and Glu63 of Ras GTPases in their activation by NF1 and Ras GAP.,EXCLUDE,"Molecular mechanism study, no tool development"
PMID:1427886,A radiation hybrid map of the region on human chromosome 22 containing the neurofibromatosis type 2 locus.,INCLUDE,Radiation hybrid map (computational/genetic tool)
PMID:14523097,The neurofibromatosis 1 gene product neurofibromin regulates pituitary adenylate cyclase-activating polypeptide-mediated signaling in astrocytes.,EXCLUDE,"Signaling pathway research, no tool development"
PMID:14580336,"Merlin, the product of the Nf2 tumor suppressor gene, is an inhibitor of the p21-activated kinase, Pak1.",EXCLUDE,"Protein interaction study, no tool development"
PMID:14627667,Identification of recurrent regions of chromosome loss and gain in vestibular schwannomas using comparative genomic hybridisation.,EXCLUDE,"Chromosomal analysis, no tool development"
PMID:14679174,It takes two to tango: mast cell and Schwann cell interactions in neurofibromas.,EXCLUDE,"Commentary on tumor interactions, no tool usage"
PMID:14679180,Neurofibromin-deficient Schwann cells secrete a potent migratory stimulus for Nf1+/- mast cells.,EXCLUDE,"Cellular migration study, no tool development"
PMID:14679203,Merlin neutralizes the inhibitory effect of Mdm2 on p53.,EXCLUDE,"Protein interaction study, no tool development"
PMID:14681409,The Unified Medical Language System (UMLS): integrating biomedical terminology.,INCLUDE,UMLS biomedical terminology integration tool
PMID:14724565,Role of TC21/R-Ras2 in enhanced migration of neurofibromin-deficient Schwann cells.,EXCLUDE,"Molecular mechanism study, no tool development"
PMID:14741381,"PKA phosphorylation and 14-3-3 interaction regulate the function of neurofibromatosis type I tumor suppressor, neurofibromin.",EXCLUDE,"Protein phosphorylation research, no tool development"
PMID:1496981,Analysis of chromosome 22 deletions in neurofibromatosis type 2-related tumors.,EXCLUDE,"Chromosome deletion analysis, no tool development"
PMID:14988005,Neurofibromin is actively transported to the nucleus.,EXCLUDE,"Protein localization study, no tool development"
PMID:14991710,Characterization of chicken Nf2/merlin indicates regulatory roles in cell proliferation and migration.,EXCLUDE,"Protein characterization, no tool development"
PMID:15039234,Loss of the nf1 tumor suppressor gene decreases fas antigen expression in myeloid cells.,EXCLUDE,"Cellular antigen expression study, no tool development"
PMID:15123692,"Merlin, a tumor suppressor, interacts with transactivation-responsive RNA-binding protein and inhibits its oncogenic activity.",EXCLUDE,"Protein interaction study, no tool development"
PMID:1519665,Nonradioactive in situ hybridization using digoxigenin-labeled oligonucleotides. Applications to musculoskeletal tissues.,INCLUDE,Nonradioactive in situ hybridization technique
PMID:15206577,Gene expression analysis of the lung following paraquat administration in rats using DNA microarray.,INCLUDE,DNA microarray gene expression tool
PMID:15240917,Survival of Human Neurofibroma in Immunodeficient Mice and Initial Results of Therapy With Pirfenidone.,INCLUDE,Patient-derived xenograft (PDX) model
PMID:15255999,"Molecular profiling of malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1, based on large-scale real-time RT-PCR.",INCLUDE,Real-time RT-PCR molecular profiling tool
PMID:15446585,Gene expression profiling reveals unique molecular subtypes of Neurofibromatosis Type I-associated and sporadic malignant peripheral nerve sheath tumors.,INCLUDE,Gene expression profiling tool
PMID:15570216,Targeted gene expression in the chicken eye by in ovo electroporation.,INCLUDE,In ovo electroporation gene transfer method
PMID:15598747,Neurofibromatosis 2 (NF2) tumor suppressor merlin inhibits phosphatidylinositol 3-kinase through binding to PIKE-L.,EXCLUDE,"Protein interaction study, no tool development"
PMID:15623944,DNA ploidy and chromosome (FISH) pattern analysis of peripheral nerve sheath tumors.,INCLUDE,DNA ploidy and FISH chromosome analysis tool
PMID:15647118,Patient-focused measures of functional health status and health-related quality of life in pediatric orthopedics: a case study in measurement selection.,EXCLUDE,"Clinical measurement review, no tool development"
PMID:15652750,Role for the epidermal growth factor receptor in neurofibromatosis-related peripheral nerve tumorigenesis.,EXCLUDE,"Molecular mechanism study, no tool development"
PMID:15659388,Erbin regulates mitogen-activated protein (MAP) kinase activation and MAP kinase-dependent interactions between Merlin and adherens junction protein complexes in Schwann cells.,EXCLUDE,"Protein interaction study, no tool development"
PMID:15681480,Sensitive detection of deletions of one or more exons in the neurofibromatosis type 2 (NF2) gene by multiplexed gene dosage polymerase chain reaction.,INCLUDE,Multiplexed gene dosage PCR detection method
PMID:15767669,TATA-binding protein (TBP)-like factor (TLF) is a functional regulator of transcription: reciprocal regulation of the neurofibromatosis type 1 and c-fos genes by TLF/TRF2 and TBP.,EXCLUDE,"Transcription regulation study, no tool development"
PMID:15831594,Methodological issues in longitudinal studies: vestibular schwannoma growth rates in neurofibromatosis 2.,EXCLUDE,Methodological study on longitudinal research
PMID:15832546,Psychological disturbance and sleep disorders in children with neurofibromatosis type 1.,EXCLUDE,"Clinical survey, no tool development"
PMID:15840687,NF1 gene loss of heterozygosity and expression analysis in sporadic colon cancer.,EXCLUDE,"Gene expression analysis, no tool development"
PMID:15849434,Identification of Rab GTPase-activating protein-like protein (RabGAPLP) as a novel Alix/AIP1-interacting protein.,EXCLUDE,"Protein interaction study, no tool development"
PMID:1587809,Expression of the GTPase activating domain of the neurofibromatosis type 1 (NF1) gene in Escherichia coli and role of the conserved lysine residue.,INCLUDE,Expression of NF1 gene domain in E. coli
PMID:15937108,The NF1 tumor suppressor critically regulates TSC2 and mTOR.,EXCLUDE,"Molecular mechanism study, no tool development"
PMID:15988004,Transcriptional repression of the Neurofibromatosis-1 tumor suppressor by the t(8;21) fusion protein.,EXCLUDE,"Transcriptional regulation study, no tool development"
PMID:16033085,Malignant peripheral nerve sheath tumors (MPNST) in neurofibromatosis type 1 (NF1): diagnostic findings on magnetic resonance images and mutation analysis of the NF1 gene.,EXCLUDE,Clinical imaging and mutation analysis study
PMID:16036108,Temporally regulated neural crest transcription factors distinguish neuroectodermal tumors of varying malignancy and differentiation.,EXCLUDE,"Tumor characterization study, no tool development"
PMID:1605307,Adrenal medullary tumors and iris proliferation in a transgenic mouse model of neurofibromatosis.,INCLUDE,Transgenic mouse model
PMID:16061561,Age related shift in the mutation spectra of germline and somatic NF2 mutations: hypothetical role of DNA repair mechanisms.,EXCLUDE,"Mutation spectrum analysis, no tool development"
PMID:16082189,Signal therapy of breast cancers by the HDAC inhibitor FK228 that blocks the activation of PAK1 and abrogates the tamoxifen-resistance.,EXCLUDE,No specific NF research tool mentioned
PMID:16093333,Sensory neurons from Nf1 haploinsufficient mice exhibit increased excitability.,INCLUDE,Animal model (Nf1 haploinsufficient mice)
PMID:16098465,Early inactivation of p53 tumor suppressor gene cooperating with NF1 loss induces malignant astrocytoma.,EXCLUDE,No specific research tool mentioned
PMID:16116616,Palindromic AT-rich repeat in the NF1 gene is hypervariable in humans and evolutionarily conserved in primates.,EXCLUDE,"Genetic polymorphism analysis, no tool development"
PMID:16117786,Gonosomal mosaicism for a nonsense mutation (R1947X) in the NF1 gene in segmental neurofibromatosis type 1.,EXCLUDE,"Genetic mutation analysis, no tool development"
PMID:16169856,The neurofibromatosis type 1 gene product neurofibromin enhances cell motility by regulating actin filament dynamics via the Rho-ROCK-LIMK2-cofilin pathway.,EXCLUDE,"Molecular mechanism study, no tool development"
PMID:16226702,A mouse model for studying therapy-induced cancers.,EXCLUDE,"Commentary on mouse models, no tool usage"
PMID:16226708,Therapy-induced malignant neoplasms in Nf1 mutant mice.,INCLUDE,Animal model (Nf1 mutant mice)
PMID:16267393,The Phosphorylation status of merlin is important for regulating the Ras-ERK pathway.,EXCLUDE,"Molecular mechanism study, no tool development"
PMID:16314489,Inactivation of NF1 in CNS causes increased glial progenitor proliferation and optic glioma formation.,INCLUDE,Animal model (NF1 CNS inactivation model)
PMID:16324214,"Evolution and origin of merlin, the product of the Neurofibromatosis type 2 (NF2) tumor-suppressor gene.",EXCLUDE,"Evolutionary protein analysis, no tool development"
PMID:16340004,New approaches to the analysis of palindromic sequences from the human genome: evolution and polymorphism of an intronic site at the NF1 locus.,EXCLUDE,"Genetic sequence analysis, no tool development"
PMID:16374483,Neurofibromatosis type 1 protein and amyloid precursor protein interact in normal human melanocytes and colocalize with melanosomes.,EXCLUDE,"Protein interaction study, no tool development"
PMID:1639394,A yeast artificial chromosome contig encompassing the type 1 neurofibromatosis gene.,INCLUDE,Genetic tool (Yeast artificial chromosome contig)
PMID:16397625,A novel bipartite phospholipid-binding module in the neurofibromatosis type 1 protein.,EXCLUDE,"Molecular mechanism study, no tool development"
PMID:16418572,Sichuan pepper extracts block the PAK1/cyclin D1 pathway and the growth of NF1-deficient cancer xenograft in mice.,EXCLUDE,"Molecular mechanism study, no tool development"
PMID:16513807,Effect of neurofibromatosis type I mutations on a novel pathway for adenylyl cyclase activation requiring neurofibromin and Ras.,EXCLUDE,"Molecular mechanism study, no tool development"
PMID:16524466,Cognitive dysfunction in NF1 knock-out mice may result from altered vesicular trafficking of APP/DRD3 complex.,INCLUDE,Animal model (NF1 knock-out mice)
PMID:16537381,Mixed-lineage kinase 3 regulates B-Raf through maintenance of the B-Raf/Raf-1 complex and inhibition by the NF2 tumor suppressor protein.,EXCLUDE,"Molecular mechanism study, no tool development"
PMID:16571745,Temporal control of Rac in Schwann cell-axon interaction is disrupted in NF2-mutant schwannoma cells.,EXCLUDE,"Molecular mechanism study, no tool development"
PMID:16581517,The tumor suppressors Merlin and Expanded function cooperatively to modulate receptor endocytosis and signaling.,EXCLUDE,"Molecular mechanism study, no tool development"
PMID:16619545,Expression of emmprin and matrix metalloproteinases (MMPs) in peripheral nerve sheath tumors: emmprin and membrane-type (MT)1-MMP expressions are associated with malignant potential.,EXCLUDE,"Tumor expression analysis, no tool development"
PMID:1672744,A polymorphic cDNA probe on chromosome 17q11.2 located within the NF1 gene [D17S376].,EXCLUDE,"Genetic polymorphism identification, no tool"
PMID:16793550,The kelch proteins Gpb1 and Gpb2 inhibit Ras activity via association with the yeast RasGAP neurofibromin homologs Ira1 and Ira2.,EXCLUDE,"Molecular mechanism study, no tool development"
PMID:1679535,A TaqI polymorphism in the human NF1 gene.,EXCLUDE,"Genetic polymorphism identification, no tool"
PMID:1679929,A BglII polymorphism in the human NF1 gene.,EXCLUDE,"Genetic polymorphism identification, no tool"
PMID:16835260,Nf1+/- mast cells induce neurofibroma like phenotypes through secreted TGF-beta signaling.,INCLUDE,Animal model (Nf1+/- mast cell model)
PMID:1684425,A BglII RFLP near the human neurofibromatosis type 1 (NF1) gene.,EXCLUDE,"Genetic polymorphism identification, no tool"
PMID:16870183,NF1 mRNA biogenesis: effect of the genomic milieu in splicing regulation of the NF1 exon 37 region.,EXCLUDE,"mRNA splicing analysis, no tool development"
PMID:16894610,Regulation of the neurofibromatosis 2 gene promoter expression during embryonic development.,EXCLUDE,"Gene promoter regulation study, no tool development"
PMID:16906226,The neurofibromin GAP-related domain rescues endothelial but not neural crest development in Nf1 mice.,INCLUDE,Animal model (Nf1 mice)
PMID:17053831,Hyperactivation of p21ras and PI3K cooperate to alter murine and human neurofibromatosis type 1-haploinsufficient osteoclast functions.,INCLUDE,Animal model (Nf1-haploinsufficient mice)
PMID:17075701,Electrophysiological validation of a human prototype auditory midbrain implant in a guinea pig model.,EXCLUDE,"Auditory implant validation, not NF-specific"
PMID:17090653,Beta common receptor inactivation attenuates myeloproliferative disease in Nf1 mutant mice.,INCLUDE,Animal model (Nf1 mutant mice)
PMID:1715669,The neurofibroma in von Recklinghausen neurofibromatosis has a unicellular origin.,EXCLUDE,"Tumor origin study, no tool development"
PMID:17210637,"Identification and characterization of putative tumor suppressor NGB, a GTP-binding protein that interacts with the neurofibromatosis 2 protein.",EXCLUDE,"Protein interaction study, no tool development"
PMID:17215387,Phosphatidylinositol 3-kinase and Akt nonautonomously promote perineurial glial growth in Drosophila peripheral nerves.,EXCLUDE,"Drosophila nerve development study, no NF tool"
PMID:17216419,Nf1 expression is dependent on strain background: implications for tumor suppressor haploinsufficiency studies.,INCLUDE,Animal model (Nf1 strain background analysis)
PMID:17295913,Functional analysis of splicing mutations in exon 7 of NF1 gene.,EXCLUDE,"Splicing mutation analysis, no tool development"
PMID:1729894,Multicolor in situ hybridization and linkage analysis order Charcot-Marie-Tooth type I (CMTIA) gene-region markers.,EXCLUDE,"Genetic mapping study, no tool development"
PMID:17548515,Contact-dependent inhibition of EGFR signaling by Nf2/Merlin.,EXCLUDE,"Molecular mechanism study, no tool development"
PMID:17558420,Imatinib mesylate inhibits cell invasion of malignant peripheral nerve sheath tumor induced by platelet-derived growth factor-BB.,EXCLUDE,"Tumor invasion study, no tool development"
PMID:17581973,Distinct functional domains of neurofibromatosis type 1 regulate immediate versus long-term memory formation.,INCLUDE,Functional domain analysis using animal model
PMID:17649826,Expression of insulin-like growth-factor-1 receptor (IGF-1R) in peripheral nerve sheath tumors in neurofibromatosis type 1.,EXCLUDE,"Tumor receptor expression study, no tool"
PMID:17786186,MMP-13 and p53 in the progression of malignant peripheral nerve sheath tumors.,EXCLUDE,"Tumor progression study, no tool development"
PMID:1783401,cDNA cloning of the type 1 neurofibromatosis gene: complete sequence of the NF1 gene product.,EXCLUDE,"Gene sequence analysis, no tool development"
PMID:17868749,Point mutation in the NF2 gene of HEI-193 human schwannoma cells results in the expression of a merlin isoform with attenuated growth suppressive activity.,EXCLUDE,"Molecular mechanism study, no tool development"
PMID:17924978,Natural history of meningioma development in mice reveals: a synergy of Nf2 and p16(Ink4a) mutations.,INCLUDE,Animal model (Nf2 and p16 mutation mice)
PMID:17962031,Modeling NF2 with human arachnoidal and meningioma cell culture systems: NF2 silencing reflects the benign character of tumor growth.,EXCLUDE,"Cell culture modeling, no tool development"
PMID:18055911,Deletions of NF1 gene and exons detected by multiplex ligation-dependent probe amplification.,INCLUDE,Genetic deletion detection tool (multiplex ligation-dependent probe amplification)
PMID:18188004,Real-time PCR analysis of candidate imprinted genes on mouse chromosome 11 shows balanced expression from the maternal and paternal chromosomes and strain-specific variation in expression levels.,INCLUDE,Parse error - defaulted to include
PMID:18218617,"Neurofibromatosis type 1 (NF1) tumor suppressor, neurofibromin, regulates the neuronal differentiation of PC12 cells via its associating protein, CRMP-2.",INCLUDE,Parse error - defaulted to include
PMID:18242512,Induction of abnormal proliferation by nonmyelinating schwann cells triggers neurofibroma formation.,INCLUDE,Parse error - defaulted to include
PMID:18242513,The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells.,INCLUDE,Parse error - defaulted to include
PMID:18272679,Neurofibromin is required for barrel formation in the mouse somatosensory cortex.,INCLUDE,Parse error - defaulted to include
PMID:18328429,A conditional mouse model for malignant mesothelioma.,INCLUDE,Parse error - defaulted to include
PMID:18367665,Induction of apoptosis in neurofibromatosis type 1 malignant peripheral nerve sheath tumor cell lines by a combination of novel farnesyl transferase inhibitors and lovastatin.,INCLUDE,Parse error - defaulted to include
PMID:18371380,Neurofibromatosis-1 regulates neuronal and glial cell differentiation from neuroglial progenitors in vivo by both cAMP- and Ras-dependent mechanisms.,INCLUDE,Parse error - defaulted to include
PMID:18413802,Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells.,INCLUDE,Parse error - defaulted to include
PMID:18442999,Nf1+/- mice have increased neointima formation via hyperactivation of a Gleevec sensitive molecular pathway.,INCLUDE,Parse error - defaulted to include
PMID:18445079,Altered adhesive structures and their relation to RhoGTPase activation in merlin-deficient Schwannoma.,INCLUDE,Parse error - defaulted to include
PMID:18451155,Pten haploinsufficiency accelerates formation of high-grade astrocytomas.,INCLUDE,Parse error - defaulted to include
PMID:18483311,Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors.,INCLUDE,Parse error - defaulted to include
PMID:18503770,The pathological splicing mutation c.6792C>G in NF1 exon 37 causes a change of tenancy between antagonistic splicing factors.,INCLUDE,Parse error - defaulted to include
PMID:18614544,Neurofibromin regulates somatic growth through the hypothalamic-pituitary axis.,INCLUDE,Parse error - defaulted to include
PMID:18632543,Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: a randomized controlled trial.,INCLUDE,Parse error - defaulted to include
PMID:18632626,Merlin is a potent inhibitor of glioma growth.,INCLUDE,Parse error - defaulted to include
PMID:18636037,The ErbB inhibitors trastuzumab and erlotinib inhibit growth of vestibular schwannoma xenografts in nude mice: a preliminary study.,INCLUDE,Parse error - defaulted to include
PMID:18670322,Vestibular schwannoma quantitative polymerase chain reaction expression of estrogen and progesterone receptors.,INCLUDE,Parse error - defaulted to include
PMID:18671844,Modelling neurofibromatosis type 1 tibial dysplasia and its treatment with lovastatin.,INCLUDE,Parse error - defaulted to include
PMID:18768391,Pak1 regulates multiple c-Kit mediated Ras-MAPK gain-in-function phenotypes in Nf1+/- mast cells.,INCLUDE,Parse error - defaulted to include
PMID:18769552,Frequent EGFR Positivity and Overexpression in High-Grade Areas of Human MPNSTs.,INCLUDE,Parse error - defaulted to include
PMID:18800150,Mechanisms of loss of heterozygosity in neurofibromatosis type 1-associated plexiform neurofibromas.,INCLUDE,Parse error - defaulted to include
PMID:18923024,Tumor suppressor schwannomin/merlin is critical for the organization of Schwann cell contacts in peripheral nerves.,INCLUDE,Parse error - defaulted to include
PMID:18927496,Suppression of proliferation of two independent NF1 malignant peripheral nerve sheath tumor cell lines by the pan-ErbB inhibitor CI-1033.,INCLUDE,Parse error - defaulted to include
PMID:18931645,Bioluminescent imaging of intracranial vestibular schwannoma xenografts in NOD/SCID mice.,INCLUDE,Parse error - defaulted to include
PMID:18953429,"The neurofibromatosis 2 tumor suppressor gene product, merlin, regulates human meningioma cell growth by signaling through YAP.",INCLUDE,Parse error - defaulted to include
PMID:18953430,Tissue-specific ablation of Prkar1a causes schwannomas by suppressing neurofibromatosis protein production.,INCLUDE,Parse error - defaulted to include
PMID:18974932,A role for the p53 pathway in the pathology of meningiomas with NF2 loss.,INCLUDE,Parse error - defaulted to include
PMID:18984156,Nf1-dependent tumors require a microenvironment containing Nf1+/-- and c-kit-dependent bone marrow.,INCLUDE,Parse error - defaulted to include
PMID:18984165,Neurofibromin regulation of ERK signaling modulates GABA release and learning.,INCLUDE,Parse error - defaulted to include
PMID:18988803,Ras signaling influences permissiveness of malignant peripheral nerve sheath tumor cells to oncolytic herpes.,INCLUDE,Parse error - defaulted to include
PMID:19016857,Polypyrimidine tract binding protein regulates alternative splicing of an aberrant pseudoexon in NF1.,INCLUDE,Parse error - defaulted to include
PMID:19041782,Nf1 mutation expands an EGFR-dependent peripheral nerve progenitor that confers neurofibroma tumorigenic potential.,INCLUDE,Parse error - defaulted to include
PMID:19103750,"The neurofibromatosis 2 protein, merlin, regulates glial cell growth in an ErbB2- and Src-dependent manner.",INCLUDE,Parse error - defaulted to include
PMID:19144871,Identification of erythrocyte p55/MPP1 as a binding partner of NF2 tumor suppressor protein/Merlin.,INCLUDE,Parse error - defaulted to include
PMID:1915269,The GTPase stimulatory activities of the neurofibromatosis type 1 and the yeast IRA2 proteins are inhibited by arachidonic acid.,INCLUDE,Parse error - defaulted to include
PMID:19191334,Microarray analyses reveal regional astrocyte heterogeneity with implications for neurofibromatosis type 1 (NF1)-regulated glial proliferation.,INCLUDE,Parse error - defaulted to include
PMID:19262146,Phosphorylation of merlin regulates its stability and tumor suppressive activity.,INCLUDE,Parse error - defaulted to include
PMID:19282654,"Tranilast, an anti-allergic drug, down-regulates the growth of cultured neurofibroma cells derived from neurofibromatosis type 1.",INCLUDE,Parse error - defaulted to include
PMID:19292874,Low U1 snRNP dependence at the NF1 exon 29 donor splice site.,INCLUDE,Parse error - defaulted to include
PMID:19306381,Neuregulin-1 beta and neuregulin-1 alpha differentially affect the migration and invasion of malignant peripheral nerve sheath tumor cells.,INCLUDE,Parse error - defaulted to include
PMID:19333415,Drosophila melanogaster as a model organism of brain diseases.,INCLUDE,Parse error - defaulted to include
PMID:19414599,Ral overactivation in malignant peripheral nerve sheath tumors.,INCLUDE,Parse error - defaulted to include
PMID:19427284,The neurofibroma cell of origin: SKPs expand the playing field.,INCLUDE,Parse error - defaulted to include
PMID:19427294,Cell of origin and microenvironment contribution for NF1-associated dermal neurofibromas.,INCLUDE,Parse error - defaulted to include
PMID:19430883,Suggested response criteria for phase II antitumor drug studies for neurofibromatosis type 2 related vestibular schwannoma.,INCLUDE,Parse error - defaulted to include
PMID:19434310,Preliminary study regarding the utility of certain immunohistochemical markers in diagnosing neurofibromas and schwannomas.,INCLUDE,Parse error - defaulted to include
PMID:19451225,"NF2/merlin is a novel negative regulator of mTOR complex 1, and activation of mTORC1 is associated with meningioma and schwannoma growth.",INCLUDE,Parse error - defaulted to include
PMID:1946460,Identification and characterization of the neurofibromatosis type 1 protein product.,INCLUDE,Parse error - defaulted to include
PMID:19470767,Abrogating drug resistance in malignant peripheral nerve sheath tumors by disrupting hyaluronan-CD44 interactions with small hyaluronan oligosaccharides.,EXCLUDE,No specific research tool mentioned
PMID:19479903,Neurofibromin physically interacts with the N-terminal domain of focal adhesion kinase.,EXCLUDE,"Protein interaction study, no tool development"
PMID:19487675,Aberrant epithelial morphology and persistent epidermal growth factor receptor signaling in a mouse model of renal carcinoma.,EXCLUDE,No specific research tool mentioned
PMID:19574548,Cardiomyocyte-specific loss of neurofibromin promotes cardiac hypertrophy and dysfunction.,EXCLUDE,No specific research tool mentioned
PMID:19610677,Transition state structures and the roles of catalytic residues in GAP-facilitated GTPase of Ras as elucidated by (18)O kinetic isotope effects.,EXCLUDE,No specific research tool mentioned
PMID:19621444,Health-related quality of life measures in genetic disorders: an outcome variable for consideration in clinical trials.,EXCLUDE,Review of quality of life measures
PMID:19703993,Downregulated microRNA-200a in meningiomas promotes tumor growth by reducing E-cadherin and activating the Wnt/beta-catenin signaling pathway.,EXCLUDE,No specific research tool mentioned
PMID:19710506,Nf1 deficiency cooperates with oncogenic K-RAS to induce acute myeloid leukemia in mice.,INCLUDE,Mouse model of NF1
PMID:19789989,Liquiritin potentiate neurite outgrowth induced by nerve growth factor in PC12 cells.,EXCLUDE,No specific research tool mentioned
PMID:19793348,Genomic abnormalities and signal transduction dysregulation in malignant mesothelioma cells.,EXCLUDE,No specific research tool mentioned
PMID:19794125,Alterations of BRAF and HIPK2 loci predominate in sporadic pilocytic astrocytoma.,EXCLUDE,No specific research tool mentioned
PMID:19846776,PTEN dosage is essential for neurofibroma development and malignant transformation.,INCLUDE,Mouse model development
PMID:19877719,Comparative protein profiling reveals minichromosome maintenance (MCM) proteins as novel potential tumor markers for meningiomas.,EXCLUDE,No specific research tool mentioned
PMID:19884346,Fluorescence resonance energy transfer analysis of merlin conformational changes.,EXCLUDE,Protein conformational analysis technique
PMID:19901965,Inhibition of Eyes Absent Homolog 4 expression induces malignant peripheral nerve sheath tumor necrosis.,EXCLUDE,No specific research tool mentioned
PMID:19966217,Cardiac and vascular functions of the zebrafish orthologues of the type I neurofibromatosis gene NFI.,INCLUDE,Zebrafish orthologous model
PMID:1999496,"Plasticity of integrin expression by nerve-derived connective tissue cells. Human Schwann cells, perineurial cells, and fibroblasts express markedly different patterns of beta 1 integrins during nerve development, neoplasia, and in vitro.",EXCLUDE,No specific research tool mentioned
PMID:20002172,Decreased expression of neurofibromin contributes to epithelial-mesenchymal transition in neurofibromatosis type 1.,EXCLUDE,No specific research tool mentioned
PMID:20049725,Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene.,INCLUDE,Integrative genomic analysis tool
PMID:20054405,"Evolution and origin of HRS, a protein interacting with Merlin, the Neurofibromatosis 2 gene product.",EXCLUDE,No specific research tool mentioned
PMID:20154721,NF2-deficient cells depend on the Rac1-canonical Wnt signaling pathway to promote the loss of contact inhibition of proliferation.,EXCLUDE,No specific research tool mentioned
PMID:20156804,Overexpression of ezrin inactivates NF2 tumor suppressor in glioblastoma.,EXCLUDE,No specific research tool mentioned
PMID:20159598,Kibra functions as a tumor suppressor protein that regulates Hippo signaling in conjunction with Merlin and Expanded.,EXCLUDE,No specific research tool mentioned
PMID:20160012,The RasGAP proteins Ira2 and neurofibromin are negatively regulated by Gpb1 in yeast and ETEA in humans.,EXCLUDE,No specific research tool mentioned
PMID:20160346,Genetic and cellular evidence of vascular inflammation in neurofibromin-deficient mice and humans.,EXCLUDE,No specific research tool mentioned
PMID:20176786,Bioluminescent approaches for measuring tumor growth in a mouse model of neurofibromatosis.,INCLUDE,Bioluminescent mouse tumor measurement approach
PMID:20181838,"The tumor suppressor merlin is required for cell cycle exit, terminal differentiation, and cell polarity in the developing murine lens.",EXCLUDE,No specific research tool mentioned
PMID:20187887,"Application of the International Classification of Functioning, Disability and Health in children with neurofibromatosis type 1: a review.",EXCLUDE,Review of classification framework
PMID:20195187,Merlin knockdown in human Schwann cells: clues to vestibular schwannoma tumorigenesis.,INCLUDE,Human Schwann cell knockdown model
PMID:20200958,Local low-dose lovastatin delivery improves the bone-healing defect caused by Nf1 loss of function in osteoblasts.,INCLUDE,Lovastatin delivery model
PMID:20209053,Growth of peripheral and central nervous system tumors is supported by cytoplasmic c-Fos in humans and mice.,EXCLUDE,No specific research tool mentioned
PMID:20212043,Mammalian Ste20-like kinase (Mst2) indirectly supports Raf-1/ERK pathway activity via maintenance of protein phosphatase-2A catalytic subunit levels and consequent suppression of inhibitory Raf-1 phosphorylation.,EXCLUDE,No specific research tool mentioned
PMID:20233966,Use of chromosome engineering to model a segmental deletion of chromosome band 7q22 found in myeloid malignancies.,EXCLUDE,No specific research tool mentioned
PMID:20233971,Mast cells and the neurofibroma microenvironment.,EXCLUDE,No specific research tool mentioned
PMID:20302846,"Development of small-molecule inhibitors of the group I p21-activated kinases, emerging therapeutic targets in cancer.",EXCLUDE,No specific research tool mentioned
PMID:20345245,Molecular and cellular mechanisms of learning disabilities: a focus on NF1.,EXCLUDE,Review of molecular mechanisms
PMID:20368450,Microtubule-mediated transport of the tumor-suppressor protein Merlin and its mutants.,EXCLUDE,No specific research tool mentioned
PMID:20388501,Genome-wide gene expression analysis identifies K-ras as a regulator of alcohol intake.,EXCLUDE,No specific research tool mentioned
PMID:20406973,Anti-vascular endothelial growth factor therapies as a novel therapeutic approach to treating neurofibromatosis-related tumors.,EXCLUDE,No specific research tool mentioned
PMID:20410111,Defective cAMP generation underlies the sensitivity of CNS neurons to neurofibromatosis-1 heterozygosity.,EXCLUDE,No specific research tool mentioned
PMID:20428190,NF-1Score: a prediction score for internal neurofibromas in neurofibromatosis-1.,INCLUDE,Clinical prediction score development
PMID:20431046,Ras and Rap signaling in synaptic plasticity and mental disorders.,EXCLUDE,No specific research tool mentioned
PMID:20491622,"Merlin, a ""magic"" linker between extracellular cues and intracellular signaling pathways that regulate cell motility, proliferation, and survival.",EXCLUDE,No specific research tool mentioned
PMID:20511180,ErbB/HER receptor activation and preclinical efficacy of lapatinib in vestibular schwannoma.,EXCLUDE,No specific research tool mentioned
PMID:20550523,MicroRNA-10b regulates tumorigenesis in neurofibromatosis type 1.,EXCLUDE,No specific research tool mentioned
PMID:20551058,Cyclic AMP suppression is sufficient to induce gliomagenesis in a mouse model of neurofibromatosis-1.,INCLUDE,Mouse model of gliomagenesis
PMID:20554030,CXCL12 alone is insufficient for gliomagenesis in Nf1 mutant mice.,INCLUDE,Mouse model of gliomagenesis
PMID:20571392,Plexiform neurofibroma genesis: questions of Nf1 gene dose and hyperactive mast cells.,EXCLUDE,No specific research tool mentioned
PMID:20600672,Ultrastructural characterization of the optic pathway in a mouse model of neurofibromatosis-1 optic glioma.,EXCLUDE,No specific research tool mentioned
PMID:20606732,CD44 and p53 immunoexpression patterns in NF1 neoplasms - indicators of malignancy and infiltration.,EXCLUDE,No specific research tool mentioned
PMID:20624961,Neurofibromin regulates corticostriatal inhibitory networks during working memory performance.,INCLUDE,Uses Nf1 mutant mouse model
PMID:20643348,The Merlin/NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals.,EXCLUDE,Molecular mechanism study
PMID:20668197,A distinct set of Drosophila brain neurons required for neurofibromatosis type 1-dependent learning and memory.,INCLUDE,Uses Drosophila genetic model
PMID:20668201,Merlin inhibits neurite outgrowth in the CNS.,EXCLUDE,Molecular mechanism study
PMID:20680410,The role of neurofibromin in N-Ras mediated AP-1 regulation in malignant peripheral nerve sheath tumors.,EXCLUDE,Molecular mechanism study
PMID:20686603,The 4q12 amplicon in malignant peripheral nerve sheath tumors: consequences on gene expression and implications for sunitinib treatment.,EXCLUDE,Tumor genomic analysis
PMID:20699653,Analysis of steroid hormone effects on xenografted human NF1 tumor schwann cells.,EXCLUDE,Xenograft experimental setup
PMID:20739432,Gene expression analysis identifies potential biomarkers of neurofibromatosis type 1 including adrenomedullin.,INCLUDE,Gene expression analysis tool
PMID:20818339,MicroRNA expression profiling in benign (sporadic and hereditary) and recurring adrenal pheochromocytomas.,EXCLUDE,MicroRNA expression profiling
PMID:20826448,Reduced striatal dopamine underlies the attention system dysfunction in neurofibromatosis-1 mutant mice.,INCLUDE,Nf1 mutant mouse model
PMID:20856158,MicroRNA-21 overexpression contributes to vestibular schwannoma cell proliferation and survival.,EXCLUDE,MicroRNA molecular mechanism
PMID:20858602,Oligodendrocyte progenitor cell numbers and migration are regulated by the zebrafish orthologs of the NF1 tumor suppressor gene.,INCLUDE,Zebrafish genetic model
PMID:20890305,Regulation of mixed lineage kinase 3 is required for Neurofibromatosis-2-mediated growth suppression in human cancer.,EXCLUDE,Molecular signaling study
PMID:20920304,"Scoring of senescence signalling in multiple human tumour gene expression datasets, identification of a correlation between senescence score and drug toxicity in the NCI60 panel and a pro-inflammatory signature correlating with survival advantage in peritoneal mesothelioma.",EXCLUDE,Gene expression analysis
PMID:20951236,"Experiences of families with a child, adolescent, or young adult with neurofibromatosis type 1 and plexiform neurofibroma evaluated for clinical trials participation at the National Cancer Institute.",EXCLUDE,Clinical trial experiences
PMID:21031597,Dissecting loss of heterozygosity (LOH) in neurofibromatosis type 1-associated neurofibromas: Importance of copy neutral LOH.,EXCLUDE,Genetic LOH analysis
PMID:2105641,Flanking markers bracket the neurofibromatosis type 2 (NF2) gene on chromosome 22.,EXCLUDE,Genetic mapping study
PMID:21072183,p21-Activated kinases are required for transformation in a cell-based model of neurofibromatosis type 2.,INCLUDE,Cell-based transformation model
PMID:21074722,"The NF2 tumor suppressor, Merlin, regulates epidermal development through the establishment of a junctional polarity complex.",EXCLUDE,Molecular mechanism study
PMID:21084862,Merlin's tumor suppression linked to inhibition of the E3 ubiquitin ligase CRL4 (DCAF1).,EXCLUDE,Molecular mechanism study
PMID:21111000,A novel imaging-compatible sciatic nerve schwannoma model.,INCLUDE,Novel imaging-compatible schwannoma model
PMID:21157378,Neurofibromatosis-1 heterozygosity increases microglia in a spatially and temporally restricted pattern relevant to mouse optic glioma formation and growth.,INCLUDE,Nf1 heterozygous mouse model
PMID:2117565,The human homolog of murine Evi-2 lies between two von Recklinghausen neurofibromatosis translocations.,EXCLUDE,Genetic mapping study
PMID:21182951,Schwannomin/merlin promotes Schwann cell elongation and influences myelin segment length.,EXCLUDE,Molecular mechanism study
PMID:2119504,Genetic and physical map of the von Recklinghausen neurofibromatosis (NF1) region on chromosome 17.,EXCLUDE,Genetic mapping study
PMID:21196210,Genetic basis of tumorigenesis in NF1 malignant peripheral nerve sheath tumors.,EXCLUDE,Genetic tumorigenesis study
PMID:21199799,Dose-dependent effects of focal fractionated irradiation on secondary malignant neoplasms in Nf1 mutant mice.,INCLUDE,Nf1 mutant mouse model
PMID:2121371,The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins.,EXCLUDE,Genetic sequence analysis
PMID:21216928,Interpreting mammalian target of rapamycin and cell growth inhibition in a genetically engineered mouse model of Nf1-deficient astrocytes.,INCLUDE,Genetically engineered Nf1-deficient astrocyte model
PMID:21224727,Autophagy blockade enhances HDAC inhibitors' pro-apoptotic effects: potential implications for the treatment of a therapeutic-resistant malignancy.,EXCLUDE,Therapeutic strategy review
PMID:21255467,SMARCB1/INI1 germline mutations contribute to 10% of sporadic schwannomatosis.,EXCLUDE,Genetic mutation analysis
PMID:21352477,Motor deficits in neurofibromatosis type 1 mice: the role of the cerebellum.,INCLUDE,Nf1 mouse model
PMID:21383154,Missense mutations in the NF2 gene result in the quantitative loss of merlin protein and minimally affect protein intrinsic function.,EXCLUDE,Molecular mutation study
PMID:21402777,FERM domain phosphoinositide binding targets merlin to the membrane and is essential for its growth-suppressive function.,EXCLUDE,Molecular protein function study
PMID:2142531,Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis.,EXCLUDE,Genetic mutation analysis
PMID:21439418,Primary osteopathy of vertebrae in a neurofibromatosis type 1 murine model.,INCLUDE,Nf1 murine model
PMID:21451418,Empirical development of improved diagnostic criteria for neurofibromatosis 2.,EXCLUDE,Diagnostic criteria development
PMID:21454924,"miRNA signature of schwannomas: possible role(s) of ""tumor suppressor"" miRNAs in benign tumors.",EXCLUDE,MicroRNA signature study
PMID:21460792,Orthotopic xenografting of human luciferase-tagged malignant peripheral nerve sheath tumor cells for in vivo testing of candidate therapeutic agents.,INCLUDE,Luciferase-tagged MPNST xenograft model
PMID:21465658,Multiple increased osteoclast functions in individuals with neurofibromatosis type 1.,EXCLUDE,Cellular function study
PMID:21478499,Neurofibromin (Nf1) is required for skeletal muscle development.,INCLUDE,Skeletal muscle developmental model
PMID:21479127,Succinate Dehydrogenase Subunit B (SDHB) Is Expressed in Neurofibromatosis 1-Associated Gastrointestinal Stromal Tumors (Gists): Implications for the SDHB Expression Based Classification of Gists.,EXCLUDE,Tumor expression study
PMID:21487440,Multiplex ligation-depending probe amplification is not suitable for detection of low-grade mosaicism.,EXCLUDE,Genetic mosaicism detection
PMID:21551250,Susceptible stages in Schwann cells for NF1-associated plexiform neurofibroma development.,INCLUDE,Schwann cell developmental model
PMID:21563229,Effects of splicing mutations on NF2-transcripts: transcript analysis and information theoretic predictions.,EXCLUDE,Genetic transcript analysis
PMID:21596366,Loss of BRCC3 deubiquitinating enzyme leads to abnormal angiogenesis and is associated with syndromic moyamoya.,EXCLUDE,Molecular mechanism study
PMID:21636709,Control of proliferation in astrocytoma cells by the receptor tyrosine kinase/PI3K/AKT signaling axis and the use of PI-103 and TCN as potential anti-astrocytoma therapies.,EXCLUDE,Signaling pathway study
PMID:21659924,"ErbB expression, activation, and inhibition with lapatinib and tyrphostin (AG825) in human vestibular schwannomas.",EXCLUDE,Molecular expression study
PMID:2167436,"Evi-2, a common integration site involved in murine myeloid leukemogenesis.",EXCLUDE,Genetic integration site study
PMID:21681782,Nf1 mutant mice with p19ARF gene loss develop accelerated hematopoietic disease resembling acute leukemia with a variable phenotype.,INCLUDE,Nf1 mutant mouse model with genetic modification
PMID:21686274,Inhibition of Cdc42-mediated activation of mixed lineage kinase 3 by the tumor suppressor protein merlin.,EXCLUDE,Molecular signaling mechanism study
PMID:21697395,Discovery of a small molecule targeting IRA2 deletion in budding yeast and neurofibromin loss in malignant peripheral nerve sheath tumor cells.,INCLUDE,Small molecule targeting NF research tool
PMID:21726432,MIA is a potential biomarker for tumour load in neurofibromatosis type 1.,INCLUDE,Potential biomarker development
PMID:21727212,Nilotinib alone or in combination with selumetinib is a drug candidate for neurofibromatosis type 2.,EXCLUDE,Drug candidate discussion
PMID:21748792,Hyperactivation of mTOR critically regulates abnormal osteoclastogenesis in neurofibromatosis Type 1.,EXCLUDE,Pathogenesis mechanism study
PMID:21750658,Multistep phosphorylation by oncogenic kinases enhances the degradation of the NF2 tumor suppressor merlin.,EXCLUDE,Molecular mechanism study
PMID:21778190,"AR42, a novel histone deacetylase inhibitor, as a potential therapy for vestibular schwannomas and meningiomas.",EXCLUDE,Potential therapy discussion
PMID:21855613,Genetically engineered mouse models shed new light on the pathogenesis of neurofibromatosis type I-related neoplasms of the peripheral nervous system.,INCLUDE,Genetically engineered mouse models
PMID:21876680,A comprehensive map of mobile element insertion polymorphisms in humans.,EXCLUDE,Genomic polymorphism mapping
PMID:21878642,KIBRA protein phosphorylation is regulated by mitotic kinase aurora and protein phosphatase 1.,EXCLUDE,Protein phosphorylation mechanism
PMID:21896734,Neurofibromatosis-1 regulates mTOR-mediated astrocyte growth and glioma formation in a TSC/Rheb-independent manner.,EXCLUDE,CNS dysfunction mechanism
PMID:21903164,Neurofibromatosis-1 heterozygosity impairs CNS neuronal morphology in a cAMP/PKA/ROCK-dependent manner.,EXCLUDE,Neuronal morphology mechanism
PMID:21931722,The probable cell of origin of NF1- and PDGF-driven glioblastomas.,EXCLUDE,Glioblastoma cell origin study
PMID:21949590,ALTERED CALCIUM CURRENTS AND AXONAL GROWTH IN Nf1 HAPLOINSUFFICIENT MICE.,INCLUDE,Nf1 haploinsufficient mouse model
PMID:21949657,The receptor tyrosine kinase Alk controls neurofibromin functions in Drosophila growth and learning.,EXCLUDE,Drosophila signaling mechanism
PMID:21961044,Erk1 positively regulates osteoclast differentiation and bone resorptive activity.,EXCLUDE,Osteoclast differentiation mechanism
PMID:21963267,Choroidal abnormalities detected by near-infrared reflectance imaging as a new diagnostic criterion for neurofibromatosis 1.,INCLUDE,Near-infrared imaging diagnostic tool
PMID:21963652,PET imaging for attention deficit preclinical drug testing in neurofibromatosis-1 mice.,INCLUDE,PET imaging preclinical tool
PMID:21980365,The haploinsufficient hematopoietic microenvironment is critical to the pathological fracture repair in murine models of neurofibromatosis type 1.,INCLUDE,Murine NF1 disease model
PMID:22012890,"Unfurling of the band 4.1, ezrin, radixin, moesin (FERM) domain of the merlin tumor suppressor.",EXCLUDE,Protein domain structural study
PMID:22077553,Pathogenesis of plexiform neurofibroma: tumor-stromal/hematopoietic interactions in tumor progression.,EXCLUDE,Tumor progression mechanism
PMID:22108604,Exploring the somatic NF1 mutational spectrum associated with NF1 cutaneous neurofibromas.,INCLUDE,NF1 mutational spectrum exploration
PMID:22125493,The NF1 gene contains hotspots for L1 endonuclease-dependent de novo insertion.,EXCLUDE,Genetic insertion mechanism
PMID:22384355,The SPRED1 Variants Repository for Legius Syndrome.,INCLUDE,SPRED1 genetic variants repository
PMID:22493273,Neurofibromatosis-like phenotype in Drosophila caused by lack of glucosylceramide extension.,EXCLUDE,Drosophila glycosphingolipid phenotype
PMID:22550514,Skin-derived precursor cells as an in vitro modelling tool for the study of type 1 neurofibromatosis.,INCLUDE,Skin-derived precursor cell model
PMID:22776759,Computer-based identification of a novel LIMK1/2 inhibitor that synergizes with salirasib to destabilize the actin cytoskeleton.,EXCLUDE,Computational drug identification
PMID:22811580,Ras-driven transcriptome analysis identifies aurora kinase A as a potential malignant peripheral nerve sheath tumor therapeutic target.,INCLUDE,Ras-driven transcriptome analysis tool
PMID:22821737,The Learning Disabilities Network (LeaDNet): using neurofibromatosis type 1 (NF1) as a paradigm for translational research.,INCLUDE,Genetically mediated mouse tumor model
PMID:22901811,ERK inhibition rescues defects in fate specification of Nf1-deficient neural progenitors and brain abnormalities.,INCLUDE,Neural progenitor ERK inhibition model
PMID:22916147,Applying microsatellite multiplex PCR analysis (MMPA) for determining allele copy-number status and percentage of normal cells within tumors.,INCLUDE,Microsatellite multiplex PCR analysis tool
PMID:22942771,Secretome survey of human plexiform neurofibroma derived Schwann Cells reveals a secreted form of the RARRES1 protein.,INCLUDE,Secretome survey tool
PMID:22961690,Phase I trial and pharmacokinetic study of sorafenib in children with neurofibromatosis type I and plexiform neurofibromas.,INCLUDE,Pediatric clinical trial tool
PMID:23045281,Rac1 is required for Prkar1a-mediated Nf2 suppression in Schwann cell tumors.,EXCLUDE,Schwann cell tumor mechanism
PMID:23055477,Neurofibromatosis type 1: modeling CNS dysfunction.,EXCLUDE,CNS dysfunction review
PMID:23056937,"Physical, cognitive, and psychosocial predictors of functional disability and health-related quality of life in adolescents with neurofibromatosis-1.",EXCLUDE,Clinical predictors study
PMID:23071067,Genetically mediated Nf1 loss in mice promotes diverse radiation-induced tumors modeling second malignant neoplasms.,INCLUDE,Radiation-induced tumor mouse model
PMID:23087000,Dedifferentiation of neurons and astrocytes by oncogenes can induce gliomas in mice.,EXCLUDE,Glioma induction mechanism
PMID:23124644,Anatomic MR imaging and functional diffusion tensor imaging of peripheral nerve tumors and tumorlike conditions.,INCLUDE,MR imaging and DTI peripheral nerve tumor tool
PMID:23140466,Regression of schwannomas induced by adeno-associated virus-mediated delivery of caspase-1.,INCLUDE,AAV-mediated caspase-1 delivery tool
PMID:23175151,MicroRNA profiling of peripheral nerve sheath tumours identifies miR-29c as a tumour suppressor gene involved in tumour progression.,INCLUDE,MicroRNA profiling tool
PMID:23221337,Sustained MEK inhibition abrogates myeloproliferative disease in Nf1 mutant mice.,INCLUDE,MEK inhibition mouse model
PMID:23225063,Dopamine deficiency underlies learning deficits in neurofibromatosis-1 mice.,INCLUDE,Dopamine deficiency NF1 mouse model
PMID:23239959,Partial Blindness to Submicron Topography in NF1 Haploinsufficient Cultured Fibroblasts Indicates a New Function of Neurofibromin in Regulation of Mechanosensoric.,INCLUDE,Mechanosensoric cell culture tool
PMID:23312374,Modeling cognitive dysfunction in neurofibromatosis-1.,EXCLUDE,Cognitive dysfunction modeling review
PMID:23318430,EGFR-STAT3 signaling promotes formation of malignant peripheral nerve sheath tumors.,EXCLUDE,EGFR-STAT3 signaling mechanism
PMID:23328114,Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition.,INCLUDE,Genomic imbalance analysis tool
PMID:23348505,"Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO.",EXCLUDE,Genomic mutation analysis
PMID:23356716,Miniaturized handheld confocal microscopy identifies focal brain invasion in a mouse model of aggressive meningioma.,INCLUDE,Handheld confocal microscopy tool
PMID:23358504,Integrated proteomics identified novel activation of dynein IC2-GR-COX-1 signaling in neurofibromatosis type I (NF1) disease model cells.,INCLUDE,Integrated proteomics analysis tool
PMID:23412344,Depletion of the novel p53-target gene carnitine palmitoyltransferase 1C delays tumor growth in the neurofibromatosis type I tumor model.,EXCLUDE,No specific research tool mentioned
PMID:23413263,Loss of SOX10 function contributes to the phenotype of human Merlin-null schwannoma cells.,EXCLUDE,No specific research tool mentioned
PMID:23423222,RAS/MEK-independent gene expression reveals BMP2-related malignant phenotypes in the Nf1-deficient MPNST.,EXCLUDE,No specific research tool mentioned
PMID:23424002,Reduced microglial CX3CR1 expression delays neurofibromatosis-1 glioma formation.,EXCLUDE,No specific research tool mentioned
PMID:23432799,"Development of the adult PedsQL neurofibromatosis type 1 module: initial feasibility, reliability and validity.",INCLUDE,Develops clinical assessment tool (PedsQL NF1 module)
PMID:23434321,CXCR4/CXCL12 mediate autocrine cell- cycle progression in NF1-associated malignant peripheral nerve sheath tumors.,EXCLUDE,No specific research tool mentioned
PMID:23446537,"[Quality of life in children with neurofibromatosis type 1, based on their mothers' reports].",EXCLUDE,Clinical observational study
PMID:23457304,Platelet-derived growth factor-BB activates calcium/calmodulin-dependent and -independent mechanisms that mediate Akt phosphorylation in the neurofibromin-deficient human Schwann cell line ST88-14.,INCLUDE,Uses neurofibromin-deficient cell line (ST88-14)
PMID:23475878,An unholy alliance: cooperation between BRAF and NF1 in melanoma development and BRAF inhibitor resistance.,EXCLUDE,No specific research tool mentioned
PMID:23487764,NMR-based functional profiling of RASopathies and oncogenic RAS mutations.,EXCLUDE,No specific research tool mentioned
PMID:23524941,"PAK1-deficiency/down-regulation reduces brood size, activates HSP16.2 gene and extends lifespan in Caenorhabditis elegans.",EXCLUDE,No specific research tool mentioned
PMID:23535903,"Canonical Wnt/-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance.",INCLUDE,Develops genetic mouse models
PMID:23555837,Genetic interactions between neurofibromin and endothelin receptor B in mice.,EXCLUDE,No specific research tool mentioned
PMID:23583712,Neurofibromin interacts with the cytoplasmic Dynein Heavy Chain 1 in melanosomes of human melanocytes.,EXCLUDE,No specific research tool mentioned
PMID:23685747,Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis.,INCLUDE,Forward genetic screen for identifying genes/pathways
PMID:23714726,Therapeutic potential of HSP90 inhibition for neurofibromatosis type 2.,EXCLUDE,No specific research tool mentioned
PMID:23723300,Genotype-specific abnormalities in mitochondrial function associate with distinct profiles of energy metabolism and catecholamine content in pheochromocytoma and paraganglioma.,EXCLUDE,No specific research tool mentioned
PMID:23749527,Extending the convergence of canonical WNT signaling and classic cancer pathways for treatment of malignant peripheral nerve sheath tumors.,EXCLUDE,No specific research tool mentioned
PMID:23762458,Motivational disturbances and effects of L-dopa administration in neurofibromatosis-1 model mice.,EXCLUDE,No specific research tool mentioned
PMID:23848554,MicroRNAome profiling in benign and malignant neurofibromatosis type 1-associated nerve sheath tumors: evidences of PTEN pathway alterations in early NF1 tumorigenesis.,EXCLUDE,No specific research tool mentioned
PMID:23858101,NF1 deletion generates multiple subtypes of soft-tissue sarcoma that respond to MEK inhibition.,EXCLUDE,No specific research tool mentioned
PMID:23863460,Hyperactive Ras/MAPK signaling is critical for tibial nonunion fracture in neurofibromin-deficient mice.,EXCLUDE,No specific research tool mentioned
PMID:23863479,Tumor suppressor Nf2 limits expansion of the neural progenitor pool by inhibiting Yap/Taz transcriptional coactivators.,EXCLUDE,No specific research tool mentioned
PMID:23907387,An integrative characterization of recurrent molecular aberrations in glioblastoma genomes.,EXCLUDE,No specific research tool mentioned
PMID:23928514,Natural compounds as potential treatments of NF2-deficient schwannoma and meningioma: cucurbitacin D and goyazensolide.,EXCLUDE,No specific research tool mentioned
PMID:23934191,LIM domain kinases as potential therapeutic targets for neurofibromatosis type 2.,EXCLUDE,No specific research tool mentioned
PMID:23960073,"FRAX597, a small molecule inhibitor of the p21-activated kinases, inhibits tumorigenesis of neurofibromatosis type 2 (NF2)-associated Schwannomas.",INCLUDE,Small molecule inhibitor (FRAX597) development
PMID:24012335,Spatial organization of Hippo signaling at the plasma membrane mediated by the tumor suppressor Merlin/NF2.,EXCLUDE,No specific research tool mentioned
PMID:24035394,Nf1 loss and Ras hyperactivation in oligodendrocytes induce NOS-driven defects in myelin and vasculature.,EXCLUDE,No specific research tool mentioned
PMID:24040940,Molecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumors.,INCLUDE,Molecular-guided therapy prediction tool
PMID:24065580,Prevalence of Sleep Disturbances in Children With Neurofibromatosis Type 1.,EXCLUDE,Clinical observational study
PMID:24101678,Autism traits in the RASopathies.,EXCLUDE,No specific research tool mentioned
PMID:24132643,EZH2-miR-30d-KPNB1 pathway regulates malignant peripheral nerve sheath tumour cell survival and tumourigenesis.,EXCLUDE,No specific research tool mentioned
PMID:24189137,Succinate-to-fumarate ratio as a new metabolic marker to detect the presence of SDHB/D-related paraganglioma: initial experimental and ex vivo findings.,EXCLUDE,No specific research tool mentioned
PMID:24197987,Vision specific quality of life in children with optic pathway gliomas.,EXCLUDE,No specific research tool mentioned
PMID:24211110,Ras-Mek-Erk signaling regulates Nf1 heterozygous neointima formation.,EXCLUDE,No specific research tool mentioned
PMID:24213576,PPAR/ promotes HRAS-induced senescence and tumor suppression by potentiating p-ERK and repressing p-AKT signaling.,EXCLUDE,No specific research tool mentioned
PMID:24232507,Neuregulin-1 overexpression and Trp53 haploinsufficiency cooperatively promote de novo malignant peripheral nerve sheath tumor pathogenesis.,EXCLUDE,No specific research tool mentioned
PMID:24249801,Achieving consensus for clinical trials: the REiNS International Collaboration.,INCLUDE,REiNS International Collaboration clinical trial framework
PMID:24249802,Functional outcome measures for NF1-associated optic pathway glioma clinical trials.,INCLUDE,Functional outcome measures for clinical trials
PMID:24249804,Recommendations for imaging tumor response in neurofibromatosis clinical trials.,INCLUDE,Imaging response recommendations for clinical trials
PMID:24249806,Patient-reported outcomes in neurofibromatosis and schwannomatosis clinical trials.,INCLUDE,Patient-reported outcome tools
PMID:24259290,Inhibition of SIRT2 in merlin/NF2-mutant Schwann cells triggers necrosis.,EXCLUDE,No specific research tool mentioned
PMID:24261697,High incidence of activating TERT promoter mutations in meningiomas undergoing malignant progression.,EXCLUDE,No specific research tool mentioned
PMID:24285727,Preclinical therapeutic efficacy of a novel pharmacologic inducer of apoptosis in malignant peripheral nerve sheath tumors.,EXCLUDE,No specific research tool mentioned
PMID:24295733,Rapamycin improves sociability in the BTBR T(+)Itpr3(tf)/J mouse model of autism spectrum disorders.,EXCLUDE,No specific research tool mentioned
PMID:24297905,Regulation of Son of sevenless by the membrane-actin linker protein ezrin.,EXCLUDE,No specific research tool mentioned
PMID:24309211,Neuronal merlin influences ERBB2 receptor expression on Schwann cells through neuregulin 1 type III signalling.,EXCLUDE,No specific research tool mentioned
PMID:24336571,Genome-scale CRISPR-Cas9 knockout screening in human cells.,INCLUDE,Genome-scale CRISPR-Cas9 knockout screening method
PMID:24346802,"Evaluation of Bcl-2, Bcl-x and cleaved caspase-3 in malignant peripheral nerve sheath tumors and neurofibromas.",EXCLUDE,No specific research tool mentioned
PMID:24371224,Tumor suppressor alterations cooperate to drive aggressive mesotheliomas with enriched cancer stem cells via a p53-miR-34a-c-Met axis.,INCLUDE,Parse error - defaulted to include
PMID:24375753,Sex Is a major determinant of neuronal dysfunction in neurofibromatosis type 1.,INCLUDE,Parse error - defaulted to include
PMID:24386979,"Modulation of Ras signaling alters the toxicity of hydroquinone, a benzene metabolite and component of cigarette smoke.",INCLUDE,Parse error - defaulted to include
PMID:24414536,mTORC1 inhibition delays growth of neurofibromatosis type 2 schwannoma.,INCLUDE,Parse error - defaulted to include
PMID:24431436,Neurofibromin is the major ras inactivator in dendritic spines.,INCLUDE,Parse error - defaulted to include
PMID:24465906,"Multiscale, converging defects of macro-porosity, microstructure and matrix mineralization impact long bone fragility in NF1.",INCLUDE,Parse error - defaulted to include
PMID:24470552,Treatment of orthotopic malignant peripheral nerve sheath tumors with oncolytic herpes simplex virus.,INCLUDE,Parse error - defaulted to include
PMID:24500418,"Phase 2 randomized, flexible crossover, double-blinded, placebo-controlled trial of the farnesyltransferase inhibitor tipifarnib in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas.",INCLUDE,Parse error - defaulted to include
PMID:24503545,Expression of WW domain-containing oxidoreductase WOX1 in human nervous system tumors.,INCLUDE,Parse error - defaulted to include
PMID:24506781,Exon-skipping antisense oligonucleotides to correct missplicing in neurogenetic diseases.,INCLUDE,Parse error - defaulted to include
PMID:24509877,MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1.,INCLUDE,Parse error - defaulted to include
PMID:24558021,Proteomic screening identifies a YAP-driven signaling network linked to tumor cell proliferation in human schwannomas.,INCLUDE,Parse error - defaulted to include
PMID:24559228,Abnormal late visual responses and alpha oscillations in neurofibromatosis type 1: a link to visual and attention deficits.,INCLUDE,Parse error - defaulted to include
PMID:2456020,Expression of nerve growth factor receptor in paraffin-embedded soft tissue tumors.,INCLUDE,Parse error - defaulted to include
PMID:24595234,In vivo functional analysis of the human NF2 tumor suppressor gene in Drosophila.,INCLUDE,Parse error - defaulted to include
PMID:24619350,Longitudinal evaluation of quality of life in 288 patients with neurofibromatosis 2.,INCLUDE,Parse error - defaulted to include
PMID:24676424,Neurofibromatosis type 1 gene mutation analysis using sequence capture and high-throughput sequencing.,INCLUDE,Parse error - defaulted to include
PMID:24681606,Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity.,INCLUDE,Parse error - defaulted to include
PMID:24686726,Activation of Sonic hedgehog signaling in neural progenitor cells promotes glioma development in the zebrafish optic pathway.,INCLUDE,Parse error - defaulted to include
PMID:24711647,ADAP2 in heart development: a candidate gene for the occurrence of cardiovascular malformations in NF1 microdeletion syndrome.,INCLUDE,Parse error - defaulted to include
PMID:24719295,Maximizing bone formation in posterior spine fusion using rhBMP-2 and zoledronic acid in wild type and NF1 deficient mice.,INCLUDE,Parse error - defaulted to include
PMID:24726726,Molecular insights into NF2/Merlin tumor suppressor function.,INCLUDE,Parse error - defaulted to include
PMID:24753394,Phase II trial of pirfenidone in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas.,INCLUDE,Parse error - defaulted to include
PMID:24786638,Analyses of merlin/NF2 connection to FAK inhibitor responsiveness in serous ovarian cancer.,INCLUDE,Parse error - defaulted to include
PMID:24815379,Application of COLD-PCR for improved detection of NF2 mosaic mutations.,INCLUDE,Parse error - defaulted to include
PMID:24817309,Nf2/Merlin controls spinal cord neural progenitor function in a Rac1/ErbB2-dependent manner.,INCLUDE,Parse error - defaulted to include
PMID:24824755,BNIP3 regulates AT101 [(-)-gossypol] induced death in malignant peripheral nerve sheath tumor cells.,INCLUDE,Parse error - defaulted to include
PMID:24832557,Trp53 haploinsufficiency modifies EGFR-driven peripheral nerve sheath tumorigenesis.,INCLUDE,Parse error - defaulted to include
PMID:24848258,Merlin deficiency predicts FAK inhibitor sensitivity: a synthetic lethal relationship.,INCLUDE,Parse error - defaulted to include
PMID:24882693,Molecular conformation of the full-length tumor suppressor NF2/Merlin--a small-angle neutron scattering study.,INCLUDE,Parse error - defaulted to include
PMID:24912773,Structural basis of DDB1-and-Cullin 4-associated Factor 1 (DCAF1) recognition by merlin/NF2 and its implication in tumorigenesis by CD44-mediated inhibition of merlin suppression of DCAF1 function.,INCLUDE,Parse error - defaulted to include
PMID:2491775,Genetic analysis of eight loci tightly linked to neurofibromatosis 1.,INCLUDE,Parse error - defaulted to include
PMID:2491777,Genetic linkage mapping of chromosome 17 markers and neurofibromatosis type I.,INCLUDE,Parse error - defaulted to include
PMID:2491778,Flanking markers for the gene causing von Recklinghausen neurofibromatosis (NF1).,INCLUDE,Parse error - defaulted to include
PMID:2491779,A refined genetic map of the region of chromosome 17 surrounding the von Recklinghausen neurofibromatosis (NF1) gene.,INCLUDE,Parse error - defaulted to include
PMID:2491781,Close flanking markers for neurofibromatosis type I (NF1).,INCLUDE,Parse error - defaulted to include
PMID:2491782,"Linkage analysis of neurofibromatosis type I, using chromosome 17 DNA markers.",INCLUDE,Parse error - defaulted to include
PMID:2491783,Physical mapping of the von Recklinghausen neurofibromatosis region on chromosome 17.,INCLUDE,Parse error - defaulted to include
PMID:2491784,Multipoint linkage analysis in neurofibromatosis type I: an international collaboration.,INCLUDE,Parse error - defaulted to include
PMID:2491785,"The order of loci in the pericentric region of chromosome 17, based on evidence from physical and genetic breakpoints.",INCLUDE,Parse error - defaulted to include
PMID:24925884,Correlation between in vivo 18F-FDG PET and immunohistochemical markers of glucose uptake and metabolism in pheochromocytoma and paraganglioma.,INCLUDE,Parse error - defaulted to include
PMID:24932921,Neurofibromin deficiency-associated transcriptional dysregulation suggests a novel therapy for tibial pseudoarthrosis in NF1.,INCLUDE,Parse error - defaulted to include
PMID:24958239,SVA retrotransposon insertion-associated deletion represents a novel mutational mechanism underlying large genomic copy number changes with non-recurrent breakpoints.,INCLUDE,Parse error - defaulted to include
PMID:24980480,Novel age-dependent targets in vestibular schwannomas.,INCLUDE,Parse error - defaulted to include
PMID:24997609,"Asfotase- improves bone growth, mineralization and strength in mouse models of neurofibromatosis type-1.",INCLUDE,Parse error - defaulted to include
PMID:25003081,An integrative analysis of meningioma tumors reveals the determinant genes and pathways of malignant transformation.,INCLUDE,Parse error - defaulted to include
PMID:2500456,"Type 1 neurofibromatosis: selective expression of extracellular matrix genes by Schwann cells, perineurial cells, and fibroblasts in mixed cultures.",INCLUDE,Parse error - defaulted to include
PMID:25012216,A neuronal function of the tumor suppressor protein merlin.,INCLUDE,Parse error - defaulted to include
PMID:25026211,Merlin/NF2 loss-driven tumorigenesis linked to CRL4(DCAF1)-mediated inhibition of the hippo pathway kinases Lats1 and 2 in the nucleus.,INCLUDE,Parse error - defaulted to include
PMID:25043298,Oncogenic role of Merlin/NF2 in glioblastoma.,INCLUDE,Parse error - defaulted to include
PMID:25043591,Combined MEK inhibition and BMP2 treatment promotes osteoblast differentiation and bone healing in Nf1Osx -/- mice.,INCLUDE,Mouse model (Nf1Osx -/- mice)
PMID:25070947,Neuronal NF1/RAS regulation of cyclic AMP requires atypical PKC activation.,EXCLUDE,Neurophysiology mechanism study
PMID:25074460,Neurofibromatosis type 1 molecular diagnosis: what can NGS do for you when you have a large gene with loss of function mutations?,INCLUDE,Next-generation sequencing diagnostic tool
PMID:25079666,Primary culture of human vestibular schwannomas.,INCLUDE,Primary cell culture tool
PMID:25083141,Insights into synaptic function from mouse models of human cognitive disorders.,EXCLUDE,General cognitive disorder review
PMID:25092287,Translationally controlled tumor protein is a novel biological target for neurofibromatosis type 1-associated tumors.,EXCLUDE,Molecular biology mechanism study
PMID:25109740,TAGLN expression is upregulated in NF1-associated malignant peripheral nerve sheath tumors by hypomethylation in its promoter and subpromoter regions.,EXCLUDE,Molecular genetics analysis
PMID:25113746,A murine model of neurofibromatosis type 2 that accurately phenocopies human schwannoma formation.,INCLUDE,Murine NF2 model development
PMID:25184332,Heat hyperalgesia and mechanical hypersensitivity induced by calcitonin gene-related peptide in a mouse model of neurofibromatosis.,EXCLUDE,Pain mechanism study
PMID:25204795,Regulation of cell proliferation and adhesion by means of a novel region of drosophila merlin interacting with Sip1.,EXCLUDE,Molecular interaction study
PMID:25217104,The p53/mouse double minute 2 homolog complex deregulation in merlin-deficient tumours.,EXCLUDE,Tumor mechanism study
PMID:25240281,PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors.,EXCLUDE,Tumor genetics analysis
PMID:25246427,The impact of coexisting genetic mutations on murine optic glioma biology.,INCLUDE,Mouse optic glioma model
PMID:25274808,Hippocampal dysregulation of neurofibromin-dependent pathways is associated with impaired spatial learning in engrailed 2 knock-out mice.,EXCLUDE,Neurological mechanism study
PMID:25289889,Combinatorial therapy with tamoxifen and trifluoperazine effectively inhibits malignant peripheral nerve sheath tumor growth by targeting complementary signaling cascades.,EXCLUDE,Drug combination study
PMID:25325900,The use of next-generation sequencing in molecular diagnosis of neurofibromatosis type 1: a validation study.,INCLUDE,Next-generation sequencing diagnostic tool
PMID:25329635,Genetic modifiers of neurofibromatosis type 1-associated caf-au-lait macule count identified using multi-platform analysis.,INCLUDE,Multi-platform genetic analysis tool
PMID:25335493,Expanding the mutational spectrum of LZTR1 in schwannomatosis.,EXCLUDE,Genetic mutation spectrum study
PMID:25336744,The tumor suppressor Nf2 regulates corpus callosum development by inhibiting the transcriptional coactivator Yap.,INCLUDE,Mouse developmental model
PMID:25340526,Nilotinib is more potent than imatinib for treating plexiform neurofibroma in vitro and in vivo.,INCLUDE,In vitro/in vivo drug testing tool
PMID:25360213,A chemical biology approach identified PI3K as a potential therapeutic target for neurofibromatosis type 2.,INCLUDE,Chemical biology screening approach
PMID:25377441,Development and validation of the English Pain Interference Index and Pain Interference Index-Parent report.,INCLUDE,Pain assessment tool development
PMID:25433207,Nf2-Yap signaling controls the expansion of DRG progenitors and glia during DRG development.,INCLUDE,Mouse developmental model
PMID:25437375,"Abnormal relationship between GABA, neurophysiology and impulsive behavior in neurofibromatosis type 1.",EXCLUDE,Neurophysiology mechanism study
PMID:25452392,Evidence of polyclonality in neurofibromatosis type 2-associated multilobulated vestibular schwannomas.,EXCLUDE,Tumor genetic analysis
PMID:25475340,Validity and interexaminer reliability of a new method to quantify skin neurofibromas of neurofibromatosis 1 using paper frames.,INCLUDE,Skin neurofibroma quantification method
PMID:25480913,Mutations in LZTR1 add to the complex heterogeneity of schwannomatosis.,EXCLUDE,Genetic mutation study
PMID:25483400,Nf1 regulates alcohol dependence-associated excessive drinking and gamma-aminobutyric acid release in the central amygdala in mice and is associated with alcohol dependence in humans.,EXCLUDE,Alcohol dependence mechanism study
PMID:2551169,Transplacental induction of peripheral nervous tumor in the Syrian golden hamster by N-nitroso-N-ethylurea. A new animal model for von Recklinghausen's neurofibromatosis.,INCLUDE,Animal model development
PMID:25534182,Depression among adults with neurofibromatosis type 1: prevalence and impact on quality of life.,EXCLUDE,Clinical prevalence study
PMID:25534823,Akt- or MEK-mediated mTOR inhibition suppresses Nf1 optic glioma growth.,INCLUDE,Mouse optic glioma model
PMID:25535838,Transient inhibition of the ERK pathway prevents cerebellar developmental defects and improves long-term motor functions in murine models of neurofibromatosis type 1.,INCLUDE,Mouse developmental model
PMID:25549701,Exome sequencing on malignant meningiomas identified mutations in neurofibromatosis type 2 (NF2) and meningioma 1 (MN1) genes.,INCLUDE,Exome sequencing tool
PMID:25551830,Soluble AXL: a possible circulating biomarker for neurofibromatosis type 1 related tumor burden.,EXCLUDE,Biomarker identification study
PMID:25557241,Outcomes of preimplantation genetic diagnosis in neurofibromatosis type 1.,INCLUDE,Preimplantation genetic diagnosis tool
PMID:25596744,Group I Paks as therapeutic targets in NF2-deficient meningioma.,EXCLUDE,Therapeutic target study
PMID:25616962,FGFR1 signaling in hypertrophic chondrocytes is attenuated by the Ras-GAP neurofibromin during endochondral bone formation.,EXCLUDE,Molecular signaling mechanism study
PMID:2562822,Fine structure DNA mapping studies of the chromosomal region harboring the genetic defect in neurofibromatosis type I.,EXCLUDE,Genetic mapping study
PMID:25639352,Neural Crest-Specific TSC1 Deletion in Mice Leads to Sclerotic Craniofacial Bone Lesion.,INCLUDE,Mouse model development
PMID:25692621,Interplay between VEGF-A and cMET signaling in human vestibular schwannomas and schwann cells.,EXCLUDE,Signaling pathway study
PMID:25710373,Spatial and temporal heterogeneity in high-grade serous ovarian cancer: a phylogenetic analysis.,EXCLUDE,Cancer heterogeneity analysis
PMID:2573276,Refined physical and genetic mapping of the NF1 region on chromosome 17.,EXCLUDE,Genetic mapping study
PMID:25750037,Role of Yes-associated protein 1 in gliomas: pathologic and therapeutic aspects.,EXCLUDE,Molecular mechanism review
PMID:25772366,Mouse low-grade gliomas contain cancer stem cells with unique molecular and functional properties.,INCLUDE,Mouse low-grade glioma model
PMID:25788518,Elucidating the impact of neurofibromatosis-1 germline mutations on neurofibromin function and dopamine-based learning.,EXCLUDE,Mutation mechanism study
PMID:25823924,NF2 blocks Snail-mediated p53 suppression in mesothelioma.,EXCLUDE,Molecular mechanism study
PMID:25833823,STAT3 and HIF1 Signaling Drives Oncogenic Cellular Phenotypes in Malignant Peripheral Nerve Sheath Tumors.,EXCLUDE,Oncogenic signaling study
PMID:25851896,Preclinical assessment of the anticancer drug response of plexiform neurofibroma tissue using primary cultures.,INCLUDE,Primary cell culture tool
PMID:25877069,Establishment of immortalized murine mesothelial cells and a novel mesothelioma cell line.,INCLUDE,Cell line establishment
PMID:25877329,A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor.,EXCLUDE,Genetic mechanism review
PMID:25884485,Evaluation of copy number variation and gene expression in neurofibromatosis type-1-associated malignant peripheral nerve sheath tumours.,EXCLUDE,No specific research tool mentioned
PMID:25887585,NMF-mGPU: non-negative matrix factorization on multi-GPU systems.,EXCLUDE,"Computational method, but not NF-specific"
PMID:25893273,High spatial resolution imaging mass spectrometry of human optic nerve lipids and proteins.,EXCLUDE,No research tool usage
PMID:25893302,Role of Merlin/NF2 inactivation in tumor biology.,EXCLUDE,Theoretical review of NF2 protein
PMID:25902174,Hippo pathway gene mutations in malignant mesothelioma: revealed by RNA and targeted exon sequencing.,EXCLUDE,No research tool usage
PMID:25909290,Expression alterations define unique molecular characteristics of spinal ependymomas.,EXCLUDE,No research tool usage
PMID:25917016,"Nf1 Haploinsufficiency Alters Myeloid Lineage Commitment and Function, Leading to Deranged Skeletal Homeostasis.",EXCLUDE,No research tool usage
PMID:25917366,HCN channels are a novel therapeutic target for cognitive dysfunction in Neurofibromatosis type 1.,INCLUDE,Uses HCN channel as potential therapeutic tool
PMID:25946318,Classic Ras Proteins Promote Proliferation and Survival via Distinct Phosphoproteome Alterations in Neurofibromin-Null Malignant Peripheral Nerve Sheath Tumor Cells.,EXCLUDE,No research tool usage
PMID:25962619,"ADHD-associated dopamine transporter, latrophilin and neurofibromin share a dopamine-related locomotor signature in Drosophila.",EXCLUDE,No research tool usage
PMID:26000738,Monoallelic loss of the imprinted gene Grb10 promotes tumor formation in irradiated Nf1+/- mice.,EXCLUDE,No research tool usage
PMID:26039236,Hyperactive RAS/PI3-K/MAPK Signaling Cascade in Migration and Adhesion of Nf1 Haploinsufficient Mesenchymal Stem/Progenitor Cells.,EXCLUDE,No research tool usage
PMID:26045165,Angiomotin binding-induced activation of Merlin/NF2 in the Hippo pathway.,EXCLUDE,No research tool usage
PMID:26057084,Merlin status regulates p75(NTR) expression and apoptotic signaling in Schwann cells following nerve injury.,EXCLUDE,No research tool usage
PMID:26066488,A Systematic Assessment of Accuracy in Detecting Somatic Mosaic Variants by Deep Amplicon Sequencing: Application to NF2 Gene.,INCLUDE,Deep amplicon sequencing tool for detecting mosaic variants
PMID:26073082,Runx1 contributes to neurofibromatosis type 1 neurofibroma formation.,EXCLUDE,No research tool usage
PMID:26073604,The SWI/SNF Subunit INI1 Contains an N-Terminal Winged Helix DNA Binding Domain that Is a Target for Mutations in Schwannomatosis.,EXCLUDE,No research tool usage
PMID:26076063,NF1 Mutations Are Common in Desmoplastic Melanoma.,EXCLUDE,No research tool usage
PMID:26150484,In vitro modeling of hyperpigmentation associated to neurofibromatosis type 1 using melanocytes derived from human embryonic stem cells.,INCLUDE,Human embryonic stem cell-derived melanocyte model
PMID:26190969,"In vivo synaptic transmission and morphology in mouse models of Tuberous sclerosis, Fragile X syndrome, Neurofibromatosis type 1, and Costello syndrome.",INCLUDE,Mouse models for synaptic transmission
PMID:26219339,A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas.,INCLUDE,High-throughput kinome screening tool
PMID:26258444,Merlin Isoforms 1 and 2 Both Act as Tumour Suppressors and Are Required for Optimal Sperm Maturation.,EXCLUDE,No research tool usage
PMID:26344136,NF2/Merlin is required for the axial pattern formation in the Xenopus laevis embryo.,EXCLUDE,No research tool usage
PMID:26344771,Mutational Analysis of Ionizing Radiation Induced Neoplasms.,EXCLUDE,No research tool usage
PMID:26423696,How to Target Activated Ras Proteins: Direct Inhibition vs. Induced Mislocalization.,EXCLUDE,No research tool usage
PMID:26445504,Mediator Subunit Med28 Is Essential for Mouse Peri-Implantation Development and Pluripotency.,EXCLUDE,No research tool usage
PMID:26461061,"Targeted NF1 cancer therapeutics with multiple modes of action: small molecule hormone-like agents resembling the natural anticancer metabolite, 2-methoxyoestradiol.",EXCLUDE,No research tool usage
PMID:26468183,Dysregulation of Mammalian Target of Rapamycin Signaling in Mouse Models of Autism.,EXCLUDE,No research tool usage
PMID:26478990,A novel diagnostic method to detect truncated neurofibromin in neurofibromatosis 1.,INCLUDE,Novel diagnostic method for detecting neurofibromin
PMID:26483553,NF2/Merlin mediates contact-dependent inhibition of EGFR mobility and internalization via cortical actomyosin.,EXCLUDE,No research tool usage
PMID:26490262,Nuclear import mechanism of neurofibromin for localization on the spindle and function in chromosome congression.,EXCLUDE,No research tool usage
PMID:26509978,Functional Analysis of Mutations in Exon 9 of NF1 Reveals the Presence of Several Elements Regulating Splicing.,EXCLUDE,No research tool usage
PMID:26530423,Chemically Induced Oncogenesis in the Peripheral Nervous System Is Suppressed in Congenic BDIX.BDIV-Mss1 and -Mss7 Rats.,EXCLUDE,No research tool usage
PMID:26536237,Anaplastic Lymphoma Kinase Acts in the Drosophila Mushroom Body to Negatively Regulate Sleep.,EXCLUDE,No research tool usage
PMID:26549023,"The scaffold protein KSR1, a novel therapeutic target for the treatment of Merlin-deficient tumors.",INCLUDE,KSR1 scaffold protein as potential therapeutic target
PMID:26554010,Anti-VEGF treatment improves neurological function and augments radiation response in NF2 schwannoma model.,EXCLUDE,No research tool usage
PMID:26558359,A novel genetic- and cell-based tool for assessing the efficacy and toxicity of anticancer drugs in vitro.,INCLUDE,Novel genetic and cell-based tool for drug testing
PMID:26585554,Loss of H3K27 trimethylation distinguishes malignant peripheral nerve sheath tumors from histologic mimics.,EXCLUDE,No research tool usage
PMID:26635368,"Interaction between a Domain of the Negative Regulator of the Ras-ERK Pathway, SPRED1 Protein, and the GTPase-activating Protein-related Domain of Neurofibromin Is Implicated in Legius Syndrome and Neurofibromatosis Type 1.",EXCLUDE,No research tool usage
PMID:26645727,Loss of H3K27me3 Expression Is a Highly Sensitive Marker for Sporadic and Radiation-induced MPNST.,EXCLUDE,No research tool usage
PMID:26657314,Immortalized Human Schwann Cell Lines Derived From Tumors of Schwannomatosis Patients.,INCLUDE,Immortalized Schwann cell lines from schwannomatosis patients
PMID:26658687,RNAi-nanoparticulate manipulation of gene expression as a new functional genomics tool in the liver.,EXCLUDE,No NF-specific tool usage
PMID:26740486,The Challenge of Cancer Genomics in Rare Nervous System Neoplasms: Malignant Peripheral Nerve Sheath Tumors as a Paradigm for Cross-Species Comparative Oncogenomics.,EXCLUDE,No research tool usage
PMID:26740548,Nf1+/- monocytes/macrophages induce neointima formation via CCR2 activation.,EXCLUDE,No research tool usage
PMID:26753962,ANRIL: a pivotal tumor suppressor long non-coding RNA in human cancers.,EXCLUDE,No research tool usage
PMID:26822862,Capturing the wide variety of impaired fracture healing phenotypes in Neurofibromatosis Type 1 with eight key factors: a computational study.,INCLUDE,Computational study of fracture healing phenotypes
PMID:26840085,Dual mTORC1/2 inhibition induces anti-proliferative effect in NF1-associated plexiform neurofibroma and malignant peripheral nerve sheath tumor cells.,EXCLUDE,No research tool usage
PMID:26861207,Feedback activation of neurofibromin terminates growth factor-induced Ras activation.,EXCLUDE,No research tool usage
PMID:26883872,3-D imaging mass spectrometry of protein distributions in mouse Neurofibromatosis 1 (NF1)-associated optic glioma.,INCLUDE,3D imaging mass spectrometry tool
PMID:26896440,Neurofibromin Loss of Function Drives Excessive Grooming in Drosophila.,EXCLUDE,No research tool usage
PMID:26904939,Insertional Mutagenesis Identifies a STAT3/Arid1b/-catenin Pathway Driving Neurofibroma Initiation.,INCLUDE,Insertional mutagenesis as a research tool
PMID:26908603,NF1 germline mutation differentially dictates optic glioma formation and growth in neurofibromatosis-1.,EXCLUDE,Genetic mutation analysis without specific tool development
PMID:27021207,Acceptance and commitment therapy in youth with neurofibromatosis type 1 (NF1) and chronic pain and their parents: A pilot study of feasibility and preliminary efficacy.,INCLUDE,Clinical assessment tool (therapy feasibility study)
PMID:27078850,Whole exome sequencing of urachal adenocarcinoma reveals recurrent NF1 mutations.,EXCLUDE,Genetic mutation sequencing without tool development
PMID:27081657,A randomized placebo-controlled lovastatin trial for neurobehavioral function in neurofibromatosis I.,INCLUDE,Clinical assessment tool (randomized trial)
PMID:27103823,Triterpenoid saponin flaccidoside II from Anemone flaccida triggers apoptosis of NF1-associated malignant peripheral nerve sheath tumors via the MAPK-HO-1 pathway.,EXCLUDE,Molecular pathway investigation
PMID:27159396,Cotargeting MNK and MEK kinases induces the regression of NF1-mutant cancers.,EXCLUDE,Molecular pathway investigation
PMID:27216189,YAP Mediates Tumorigenesis in Neurofibromatosis Type 2 by Promoting Cell Survival and Proliferation through a COX-2-EGFR Signaling Axis.,EXCLUDE,Signaling pathway mechanism study
PMID:27285107,Merlin inhibits Wnt/-catenin signaling by blocking LRP6 phosphorylation.,EXCLUDE,Molecular signaling mechanism study
PMID:27313208,The neurofibromin recruitment factor Spred1 binds to the GAP related domain without affecting Ras inactivation.,EXCLUDE,Protein interaction study
PMID:27345717,"Merlin, a regulator of Hippo signaling, regulates Wnt/-catenin signaling.",EXCLUDE,Molecular signaling mechanism study
PMID:27363027,Crizotinib inhibits NF2-associated schwannoma through inhibition of focal adhesion kinase 1.,EXCLUDE,Drug inhibition mechanism study
PMID:27385209,"Co-expression modules of NF1, PTEN and sprouty enable distinction of adult diffuse gliomas according to pathway activities of receptor tyrosine kinases.",EXCLUDE,Gene co-expression analysis
PMID:27418650,Stat5 is critical for the development and maintenance of myeloproliferative neoplasm initiated by Nf1 deficiency.,EXCLUDE,Molecular mechanism study
PMID:27458360,COMT Val(158)Met Polymorphism Is Associated with Verbal Working Memory in Neurofibromatosis Type 1.,INCLUDE,Genetic polymorphism assessment tool
PMID:27467574,Neuron-Specific Deletion of the Nf2 Tumor Suppressor Impairs Functional Nerve Regeneration.,EXCLUDE,Neurological mechanism study
PMID:27527646,Neurocognitive outcomes in neurofibromatosis clinical trials: Recommendations for the domain of attention.,INCLUDE,Neurocognitive assessment tool development
PMID:27527648,Patient-reported outcomes of pain and physical functioning in neurofibromatosis clinical trials.,INCLUDE,Patient-reported outcome measurement tool
PMID:27551454,Tumor suppressor Nf2/merlin drives Schwann cell changes following electromagnetic field exposure through Hippo-dependent mechanisms.,EXCLUDE,Cellular mechanism study
PMID:27588404,Characterizing the immune microenvironment of malignant peripheral nerve sheath tumor by PD-L1 expression and presence of CD8+ tumor infiltrating lymphocytes.,EXCLUDE,Tumor microenvironment characterization
PMID:27655679,Comprehensive adipocytic and neurogenic tissue microarray analysis of NY-ESO-1 expression - a promising immunotherapy target in malignant peripheral nerve sheath tumor and liposarcoma.,EXCLUDE,Tissue microarray analysis
PMID:27706810,"Antitumor effects of 4-methylumbelliferone, a hyaluronan synthesis inhibitor, on malignant peripheral nerve sheath tumor.",EXCLUDE,Drug effect study
PMID:27741517,"Ral A, via activating the mitotic checkpoint, sensitizes cells lacking a functional Nf1 to apoptosis in the absence of protein kinase C.",EXCLUDE,Molecular mechanism study
PMID:27748759,EGFR-Stat3 signalling in nerve glial cells modifies neurofibroma initiation.,EXCLUDE,Signaling mechanism study
PMID:27755359,Inhibiting p21-Activated Kinase Induces Cell Death in Vestibular Schwannoma and Meningioma via Mitotic Catastrophe.,EXCLUDE,Cell death mechanism study
PMID:27760236,Disease Burden and Symptom Structure of Autism in Neurofibromatosis Type 1: A Study of the International NF1-ASD Consortium Team (INFACT).,INCLUDE,Autism symptom assessment tool
PMID:27773571,NF1 Is a Direct G Protein Effector Essential for Opioid Signaling to Ras in the Striatum.,EXCLUDE,Molecular signaling mechanism study
PMID:27791021,Physical interaction between neurofibromin and serotonin 5-HT6 receptor promotes receptor constitutive activity.,EXCLUDE,Protein interaction study
PMID:27815398,Optic pathway glioma volume predicts retinal axon degeneration in neurofibromatosis type 1.,INCLUDE,Imaging tool for optic pathway volume measurement
PMID:27817916,Orbital/Periorbital Plexiform Neurofibromas in Children with Neurofibromatosis Type 1: Multidisciplinary Recommendations for Care.,INCLUDE,Multidisciplinary care recommendation tool
PMID:27833160,Photothermal therapy improves the efficacy of a MEK inhibitor in neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors.,EXCLUDE,Therapy efficacy study
PMID:27856782,Revisiting neurofibromatosis type 2 diagnostic criteria to exclude LZTR1-related schwannomatosis.,INCLUDE,Diagnostic criteria revision tool
PMID:27913619,The Caenorhabditis elegans NF2/Merlin Molecule NFM-1 Nonautonomously Regulates Neuroblast Migration and Interacts Genetically with the Guidance Cue SLT-1/Slit.,EXCLUDE,Molecular mechanism study
PMID:27920939,Epigenetic mechanisms drive the progression of neurofibromas to malignant peripheral nerve sheath tumors.,EXCLUDE,Epigenetic mechanism study
PMID:27921248,"The molecular pathogenesis of schwannomatosis, a paradigm for the co-involvement of multiple tumour suppressor genes in tumorigenesis.",EXCLUDE,Molecular pathogenesis study
PMID:27923908,Estrogen activation of microglia underlies the sexually dimorphic differences in Nf1 optic glioma-induced retinal pathology.,EXCLUDE,Cellular mechanism study
PMID:27927008,MicroRNA-296-5p Promotes Invasiveness through Downregulation of Nerve Growth Factor Receptor and Caspase-8.,EXCLUDE,Molecular mechanism study
PMID:27956228,Genome-Wide CRISPR Screen Identifies Regulators of Mitogen-Activated Protein Kinase as Suppressors of Liver Tumors in Mice.,INCLUDE,CRISPR screening tool
PMID:27956565,Randomized placebo-controlled study of lovastatin in children with neurofibromatosis type 1.,INCLUDE,Randomized clinical trial assessment tool
PMID:27999334,Hybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene.,INCLUDE,Next-generation sequencing tool
PMID:28029918,Activity of Selumetinib in Neurofibromatosis Type 1-Related Plexiform Neurofibromas.,INCLUDE,Drug activity assessment tool
PMID:28039362,Defining the temporal course of murine neurofibromatosis-1 optic gliomagenesis reveals a therapeutic window to attenuate retinal dysfunction.,EXCLUDE,Temporal progression study
PMID:28051113,"A comprehensive custom panel design for routine hereditary cancer testing: preserving control, improving diagnostics and revealing a complex variation landscape.",INCLUDE,Custom genetic panel design tool
PMID:28065690,Medium throughput biochemical compound screening identifies novel agents for pharmacotherapy of neurofibromatosis type 1.,INCLUDE,Biochemical compound screening tool
PMID:28066715,Challenges in Drug Discovery for Neurofibromatosis Type 1-Associated Low-Grade Glioma.,EXCLUDE,Drug discovery review
PMID:28067315,KANK1 inhibits cell growth by inducing apoptosis through regulating CXXC5 in human malignant peripheral nerve sheath tumors.,EXCLUDE,Molecular mechanism study
PMID:28068329,The primacy of NF1 loss as the driver of tumorigenesis in neurofibromatosis type 1-associated plexiform neurofibromas.,EXCLUDE,Genetic tumorigenesis study
PMID:28099845,Absence of Neurofibromin Induces an Oncogenic Metabolic Switch via Mitochondrial ERK-Mediated Phosphorylation of the Chaperone TRAP1.,EXCLUDE,Metabolic mechanism study
PMID:28125156,Application of the laser diode with central wavelength 975nm for the therapy of neurofibroma and hemangiomas.,EXCLUDE,Laser therapy technique
PMID:28126595,Global Proteome and Phospho-proteome Analysis of Merlin-deficient Meningioma and Schwannoma Identifies PDLIM2 as a Novel Therapeutic Target.,INCLUDE,Proteome analysis tool
PMID:28166733,A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma.,INCLUDE,Machine learning computational tool
PMID:28191549,Rationally combining anti-VEGF therapy with radiation in NF2 schwannoma.,EXCLUDE,Therapeutic strategy review
PMID:28193237,Evaluation of quality of life in adults with neurofibromatosis 1 (NF1) using the Impact of NF1 on Quality Of Life (INF1-QOL) questionnaire.,INCLUDE,Quality of life assessment tool (clinical questionnaire)
PMID:28195122,Integrated genomic analyses of de novo pathways underlying atypical meningiomas.,EXCLUDE,Genomic analysis without specific tool
PMID:28256556,An inflammatory gene signature distinguishes neurofibroma Schwann cells and macrophages from cells in the normal peripheral nervous system.,INCLUDE,Inflammatory gene signature analysis
PMID:28392281,Human stem cell modeling in neurofibromatosis type 1 (NF1).,INCLUDE,Human stem cell modeling tool
PMID:28398289,A high-throughput molecular data resource for cutaneous neurofibromas.,INCLUDE,High-throughput molecular data resource
PMID:28423318,Oligodendrocyte Nf1 Controls Aberrant Notch Activation and Regulates Myelin Structure and Behavior.,EXCLUDE,Biological mechanism study
PMID:28425622,Targeted Disruption of NF1 in Osteocytes Increases FGF23 and Osteoid With Osteomalacia-like Bone Phenotype.,EXCLUDE,Targeted gene disruption experiment
PMID:28427224,Ponatinib promotes a G1 cell-cycle arrest of merlin/NF2-deficient human schwann cells.,EXCLUDE,Pharmacological treatment study
PMID:28454108,Telomere erosion in NF1 tumorigenesis.,EXCLUDE,Telomere erosion analysis
PMID:28468780,Combined Inhibition of NEDD8-Activating Enzyme and mTOR Suppresses ,EXCLUDE,Molecular pathway investigation
PMID:28489286,Sustained activation of ERK1/2 MAPK in Schwann cells causes corneal neurofibroma.,EXCLUDE,Cellular signaling mechanism study
PMID:28502478,The Cellular Retinoic Acid Binding Protein 2 Promotes Survival of Malignant Peripheral Nerve Sheath Tumor Cells.,EXCLUDE,Molecular expression analysis
PMID:28525381,The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.,INCLUDE,Cell of origin computational analysis
PMID:28529006,Validation of a Next-Generation Sequencing Pipeline for the Molecular Diagnosis of Multiple Inherited Cancer Predisposing Syndromes.,INCLUDE,Next-generation sequencing pipeline
PMID:28542306,Gene signature associated with benign neurofibroma transformation to malignant peripheral nerve sheath tumors.,INCLUDE,Gene signature computational tool
PMID:28548933,KIR2DL5 mutation and loss underlies sporadic dermal neurofibroma pathogenesis and growth.,EXCLUDE,Genetic mutation analysis
PMID:28558025,Doxycycline potentiates antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy in malignant peripheral nerve sheath tumor cells.,EXCLUDE,Therapeutic treatment study
PMID:28566755,Merlin is required for coordinating proliferation of two stem cell lineages in the Drosophila testis.,EXCLUDE,Stem cell proliferation mechanism
PMID:28580399,Does pamidronate enhance the osteogenesis in mesenchymal stem cells derived from fibrous hamartoma in congenital pseudarthrosis of the tibia?,EXCLUDE,Stem cell osteogenesis experiment
PMID:28589254,Characterisation of malignant peripheral nerve sheath tumours in neurofibromatosis-1 using heterogeneity analysis of ,INCLUDE,PET imaging characterization tool
PMID:28595424,Animal models of meningiomas.,EXCLUDE,Animal model review
PMID:28608929,High-grade serous carcinomas arise in the mouse oviduct via defects linked to the human disease.,EXCLUDE,Cancer model development
PMID:28610844,Overexpression of eIF4F components in meningiomas and suppression of meningioma cell growth by inhibiting translation initiation.,EXCLUDE,Molecular expression study
PMID:28637487,The NF1 somatic mutational landscape in sporadic human cancers.,EXCLUDE,Mutational landscape analysis
PMID:28644838,"Characterization and utilization of an international neurofibromatosis web-based, patient-entered registry: An observational study.",INCLUDE,Web-based patient registry
PMID:28725547,Spatial working memory in neurofibromatosis 1: Altered neural activity and functional connectivity.,INCLUDE,Neuroimaging functional connectivity tool
PMID:28729415,An Essential Role for the Tumor-Suppressor Merlin in Regulating Fatty Acid Synthesis.,EXCLUDE,Molecular mechanism study
PMID:28735371,Identifying Symptoms of Distress in Youth Living with Neurofibromatosis Type 1 (NF1).,INCLUDE,Distress symptom identification tool
PMID:28753199,Erratum: Capturing the wide variety of impaired fracture healing phenotypes in Neurofibromatosis Type 1 with eight key factors: a computational study.,EXCLUDE,Erratum publication
PMID:28764788,Regulation of human glioma cell apoptosis and invasion by miR-152-3p through targeting DNMT1 and regulating NF2 : MiR-152-3p regulate glioma cell apoptosis and invasion.,EXCLUDE,MicroRNA regulation study
PMID:28776579,Significance of H3K27me3 loss in the diagnosis of malignant peripheral nerve sheath tumors.,EXCLUDE,Diagnostic marker investigation
PMID:28783719,Tumours with class 3 BRAF mutants are sensitive to the inhibition of activated RAS.,EXCLUDE,Molecular pathway study
PMID:28783725,A Braf kinase-inactive mutant induces lung adenocarcinoma.,EXCLUDE,Genetic mutation study
PMID:28789444,p53 performs an essential role in mediating the oncogenic stimulus triggered by loss of expression of neurofibromatosis type 2 during ,EXCLUDE,Molecular mechanism investigation
PMID:28813519,"Expression and inhibition of BRD4, EZH2 and TOP2A in neurofibromas and malignant peripheral nerve sheath tumors.",EXCLUDE,Molecular expression study
PMID:28831766,NMR resonance assignments of the EVH1 domain of neurofibromin's recruitment factor Spred1.,INCLUDE,NMR resonance assignment tool
PMID:28846462,Immunohistochemical Markers for Prospective Studies in Neurofibromatosis-1 Porcine Models.,INCLUDE,Immunohistochemical marker development
PMID:28848060,Genetic Severity Score predicts clinical phenotype in NF2.,INCLUDE,Genetic severity score tool
PMID:28923059,Osteoglycin promotes meningioma development through downregulation of NF2 and activation of mTOR signaling.,EXCLUDE,Molecular pathway study
PMID:28972170,1 integrin-dependent Rac/group I PAK signaling mediates YAP activation of Yes-associated protein 1 (YAP1) via NF2/merlin.,EXCLUDE,Molecular signaling mechanism
PMID:29032173,The reduced osteogenic potential of Nf1-deficient osteoprogenitors is EGFR-independent.,EXCLUDE,Cellular potential investigation
PMID:29131833,MEK inhibitors enhance therapeutic response towards ATRA in NF1 associated malignant peripheral nerve sheath tumors (MPNST) in-vitro.,EXCLUDE,Treatment response study
PMID:29137242,Immune profiling of NF1-associated tumors reveals histologic subtype distinctions and heterogeneity: implications for immunotherapy.,INCLUDE,Immune profiling tool
PMID:29179212,LukS-PV-Regulated MicroRNA-125a-3p Promotes THP-1 Macrophages Differentiation and Apoptosis by Down-Regulating NF1 and Bcl-2.,EXCLUDE,Molecular regulation study
PMID:29179472,"BCRP expression in schwannoma, plexiform neurofibroma and MPNST.",EXCLUDE,Protein expression analysis
PMID:29185159,"The effect of estradiol, testosterone, and human chorionic gonadotropin on the proliferation of Schwann cells with NF1 ",EXCLUDE,Cellular proliferation experiment
PMID:29206885,Does elevated glucose metabolism correlate with higher cell density in Neurofibromatosis type 1 associated peripheral nerve sheath tumors?,EXCLUDE,Metabolic correlation study
PMID:29249622,Differential Expression of NF2 in Neuroepithelial Compartments Is Necessary for Mammalian Eye Development.,EXCLUDE,Developmental biology mechanism
PMID:29331035,Noninvasive optical spectroscopy for identification of non-melanoma skin cancer: Pilot study.,EXCLUDE,No research tools mentioned
PMID:29351992,Involvement of Aryl hydrocarbon receptor in myelination and in human nerve sheath tumorigenesis.,INCLUDE,Potential cell/molecular biology research tool (Aryl hydrocarbon receptor investigation)
PMID:29354122,Neurofibromin 1 Impairs Natural Killer T-Cell-Dependent Antitumor Immunity against a T-Cell Lymphoma.,EXCLUDE,Immunology research without specific tools
PMID:29402968,Integrating Functional Analysis in the Next-Generation Sequencing Diagnostic Pipeline of RASopathies.,INCLUDE,Functional analysis in diagnostic pipeline (computational tool)
PMID:29408605,Nf2 Mutation in Schwann Cells Delays Functional Neural Recovery Following Injury.,INCLUDE,NF2 mutation mouse model
PMID:29409008,"Targeted next-generation sequencing for differential diagnosis of neurofibromatosis type 2, schwannomatosis, and meningiomatosis.",INCLUDE,Targeted next-generation sequencing tool
PMID:29409029,The characteristics of 76 atypical neurofibromas as precursors to neurofibromatosis 1 associated malignant peripheral nerve sheath tumors.,EXCLUDE,Clinical characterization study
PMID:29415745,Cutaneous neurofibromas in Neurofibromatosis type I: a quantitative natural history study.,EXCLUDE,Clinical natural history study
PMID:29423604,Autism Spectrum Disorder in an Unselected Cohort of Children with Neurofibromatosis Type 1 (NF1).,EXCLUDE,Clinical autism assessment study
PMID:29426343,Differences in MWCNT- and SWCNT-induced DNA methylation alterations in association with the nuclear deposition.,EXCLUDE,Toxicology research without specific tools
PMID:29440379,Targeting the cMET pathway augments radiation response without adverse effect on hearing in NF2 schwannoma models.,INCLUDE,NF2 schwannoma research model
PMID:29493886,Increased expression of miR-641 contributes to erlotinib resistance in non-small-cell lung cancer cells by targeting NF1.,EXCLUDE,Molecular biology mechanism study
PMID:29515781,CXCR4: A new player in vestibular schwannoma pathogenesis.,EXCLUDE,Pathogenesis investigation
PMID:29566645,"Oscillatory motor patterning is impaired in neurofibromatosis type 1: a behavioural, EEG and fMRI study.",INCLUDE,EEG and fMRI research tools
PMID:29570943,"The Relationship Between Heart Rate Variability, Psychological Flexibility, and Pain in Neurofibromatosis Type 1.",EXCLUDE,Clinical psychological study
PMID:29587439,NF2/Merlin Inactivation and Potential Therapeutic Targets in Mesothelioma.,EXCLUDE,Therapeutic targets review
PMID:29590612,A Conserved Circadian Function for the Neurofibromatosis 1 Gene.,INCLUDE,Drosophila genetic model
PMID:29596064,Contributions of inflammation and tumor microenvironment to neurofibroma tumorigenesis.,EXCLUDE,Tumor microenvironment study
PMID:29626191,Lipid binding promotes the open conformation and tumor-suppressive activity of neurofibromin 2.,EXCLUDE,Protein biochemistry research
PMID:29629523,Attention Deficit Hyperactivity Disorder in Neurofibromatosis Type 1: Evaluation with a Continuous Performance Test.,EXCLUDE,Clinical ADHD assessment
PMID:29662612,Exploiting mitochondrial and metabolic homeostasis as a vulnerability in NF1 deficient cells.,INCLUDE,Metabolic research tools
PMID:29666462,Tranilast inhibits the expression of genes related to epithelial-mesenchymal transition and angiogenesis in neurofibromin-deficient cells.,EXCLUDE,Gene expression study
PMID:29670214,Restoring functional neurofibromin by protein transduction.,INCLUDE,Protein transduction research tool
PMID:29704429,Insights into optic pathway glioma vision loss from mouse models of neurofibromatosis type 1.,INCLUDE,Mouse model of NF1
PMID:29712669,Proliferation-independent role of NF2 (merlin) in limiting biliary morphogenesis.,INCLUDE,Biliary morphogenesis model
PMID:29715273,Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation.,INCLUDE,Oligodendrocyte cell research model
PMID:29718344,Association of plexiform neurofibroma volume changes and development of clinical morbidities in neurofibromatosis 1.,EXCLUDE,Clinical volume change study
PMID:29731861,Analysis of YAP1 and TAZ expression by immunohistochemical staining in malignant mesothelioma and reactive mesothelial cells.,EXCLUDE,Immunohistochemical staining
PMID:29787563,Graph complexity analysis identifies an ETV5 tumor-specific network in human and murine low-grade glioma.,INCLUDE,Graph complexity computational tool
PMID:29796169,Aberrant ATRX protein expression is associated with poor overall survival in NF1-MPNST.,EXCLUDE,Survival analysis study
PMID:29847659,Neurofibromin Deficiency Induces Endothelial Cell Proliferation and Retinal Neovascularization.,INCLUDE,Endothelial cell and retinal research model
PMID:29897904,Traditional and systems biology based drug discovery for the rare tumor syndrome neurofibromatosis type 2.,INCLUDE,Systems biology drug discovery approach
PMID:29914349,Social skills in children with RASopathies: a comparison of Noonan syndrome and neurofibromatosis type 1.,EXCLUDE,Clinical social skills assessment
PMID:29925695,A porcine model of neurofibromatosis type 1 that mimics the human disease.,INCLUDE,Porcine NF1 research model
PMID:29941005,Increased extracellular matrix deposition during chondrogenic differentiation of dental pulp stem cells from individuals with neurofibromatosis type 1: an in vitro 2D and 3D study.,INCLUDE,Dental pulp stem cell research model
PMID:29958847,Radiomic biomarkers informative of cancerous transformation in neurofibromatosis-1 plexiform tumors.,INCLUDE,Radiomic biomarker computational tool
PMID:29982664,EPH receptor signaling as a novel therapeutic target in NF2-deficient meningioma.,INCLUDE,EPH receptor signaling research approach
PMID:29987129,Creating a comprehensive research strategy for cutaneous neurofibromas.,EXCLUDE,Research strategy discussion
PMID:29987131,The biology of cutaneous neurofibromas: Consensus recommendations for setting research priorities.,EXCLUDE,Research priority recommendations
PMID:29987133,Clinical trial design for cutaneous neurofibromas.,EXCLUDE,Clinical trial design discussion
PMID:30055648,Testing ATRA and MEK inhibitor PD0325901 effectiveness in a nude mouse model for human MPNST xenografts.,INCLUDE,Nude mouse xenograft model
PMID:30112810,Targeting of AKT/ERK/CTNNB1 by DAW22 as a potential therapeutic compound for malignant peripheral nerve sheath tumor.,EXCLUDE,Therapeutic compound investigation
PMID:30166301,Effects of methylphenidate on cognition and behaviour in children with neurofibromatosis type 1: a study protocol for a randomised placebo-controlled crossover trial.,EXCLUDE,Clinical trial protocol
PMID:30179114,Abnormal Morphology of Select Cortical and Subcortical Regions in Neurofibromatosis Type 1.,INCLUDE,Neuroimaging computational tool
PMID:30181519,Targeting Difficult Protein-Protein Interactions with Plain and General Computational Approaches.,EXCLUDE,Computational approach review
PMID:30192842,Use of machine learning to predict cognitive performance based on brain metabolism in Neurofibromatosis type 1.,INCLUDE,Machine learning cognitive performance prediction tool
PMID:30271432,Confocal Microscopy Predicts the Risk of Recurrence and Malignant Transformation of Mucocutaneous Neurofibromas in NF-1: An Observational Study.,INCLUDE,Confocal microscopy diagnostic tool
PMID:30274821,Synergistic effect of Nutlin-3 combined with MG-132 on schwannoma cells through restoration of merlin and p53 tumour suppressors.,INCLUDE,Schwannoma cell research model
PMID:30274822,Exhaustive non-synonymous variants functionality prediction enables high resolution characterization of the neurofibromin architecture.,INCLUDE,Computational variant prediction tool
PMID:30284154,"Treatment of Disfiguring Cutaneous Lesions in Neurofibromatosis-1 with Everolimus: A Phase II, Open-Label, Single-Arm Trial.",EXCLUDE,Clinical treatment trial
PMID:30290804,Genetic diagnosis of neurofibromatosis type 1: targeted next- generation sequencing with Multiple Ligation-Dependent Probe Amplification analysis.,INCLUDE,Genetic diagnostic tool (targeted next-generation sequencing)
PMID:30335132,A proteasome-resistant fragment of NIK mediates oncogenic NF-B signaling in schwannomas.,EXCLUDE,Molecular signaling study
PMID:30381327,Identification of a Specific Translational Machinery via TCTP-EF1A2 Interaction Regulating NF1-associated Tumor Growth by Affinity Purification and Data-independent Mass Spectrometry Acquisition (AP-DIA).,INCLUDE,Novel mass spectrometry technique for protein interaction
PMID:30470263,Tonic ATP-mediated growth suppression in peripheral nerve glia requires arrestin-PP2 and is evaded in NF1.,EXCLUDE,Physiological mechanism study
PMID:30478285,Usp9X Regulates Cell Death in Malignant Peripheral Nerve Sheath Tumors.,EXCLUDE,Molecular mechanism study
PMID:30479396,NF1 heterozygosity fosters de novo tumorigenesis but impairs malignant transformation.,EXCLUDE,Tumorigenesis mechanism study
PMID:30542122,STAT3 inhibition reduces macrophage number and tumor growth in neurofibroma.,EXCLUDE,Tumor microenvironment study
PMID:30571760,Neurofibromin haploinsufficiency results in altered spermatogenesis in a mouse model of neurofibromatosis type 1.,INCLUDE,Mouse model of NF1
PMID:30615146,Preclinical assessment of MEK1/2 inhibitors for neurofibromatosis type 2-associated schwannomas reveals differences in efficacy and drug resistance development.,INCLUDE,Preclinical assessment tool for schwannoma drug screening
PMID:30617350,"A cerebellopontine angle mouse model for the investigation of tumor biology, hearing, and neurological function in NF2-related vestibular schwannoma.",INCLUDE,Mouse model for NF2-related vestibular schwannoma
PMID:30710873,Reduced higher dimensional temporal dynamism in neurofibromatosis type 1.,EXCLUDE,Neurological dynamics study
PMID:30713041,Reprogramming Captures the Genetic and Tumorigenic Properties of Neurofibromatosis Type 1 Plexiform Neurofibromas.,INCLUDE,Cell reprogramming technique
PMID:30722027,"Low mutation burden and frequent loss of CDKN2A/B and SMARCA2, but not PRC2, define premalignant neurofibromatosis type 1-associated atypical neurofibromas.",EXCLUDE,Genomic mutation analysis
PMID:30728335,Cxcr3-expressing leukocytes are necessary for neurofibroma formation in mice.,EXCLUDE,Leukocyte interaction study
PMID:30737893,"Substantial pain burden in frequency, intensity, interference and chronicity among children and adults with neurofibromatosis Type 1.",EXCLUDE,Clinical pain assessment study
PMID:30744170,SYK Inhibition Potentiates the Effect of Chemotherapeutic Drugs on Neuroblastoma Cells in Vitro.,EXCLUDE,Drug interaction study
PMID:30796033,Overcoming BET Inhibitor Resistance in Malignant Peripheral Nerve Sheath Tumors.,EXCLUDE,Drug resistance mechanism study
PMID:30800298,A qualitative study of the impact of plexiform neurofibromas on need fulfilment in adults with neurofibromatosis type 1.,EXCLUDE,Qualitative patient experience study
PMID:30820037,Educational delay and attainment in persons with neurofibromatosis 1 in Denmark.,EXCLUDE,Educational attainment study
PMID:30850948,Neddylation inhibitor MLN4924 suppresses cilia formation by modulating AKT1.,EXCLUDE,Cellular mechanism study
PMID:30859021,Neurofibromatosis Type 1: Review of Cutaneous and Subcutaneous Tumor Treatment on Quality of Life.,EXCLUDE,Treatment review
PMID:30867289,EZH1/2 function mostly within canonical PRC2 and exhibit proliferation-dependent redundancy that shapes mutational signatures in cancer.,EXCLUDE,Epigenetic mechanism study
PMID:30915713,Dysregulation of CRMP2 Post-Translational Modifications Drive Its Pathological Functions.,EXCLUDE,Protein modification study
PMID:30971890,Schwann Cell Precursors; Multipotent Glial Cells in Embryonic Nerves.,EXCLUDE,Developmental biology review
PMID:30984524,Next Generation Sequencing Identified a Novel Multi Exon Deletion of the ,INCLUDE,Next-generation sequencing genetic diagnostic tool
PMID:31009417,Towards a neurobiological understanding of pain in neurofibromatosis type 1: mechanisms and implications for treatment.,EXCLUDE,Pain mechanism review
PMID:31015291,Proximity biotinylation identifies a set of conformation-specific interactions between Merlin and cell junction proteins.,INCLUDE,Proximity biotinylation technique
PMID:31023785,Malignant Peripheral Nerve Sheath Tumors: From Epigenome to Bedside.,EXCLUDE,Review article
PMID:3102622,A computed image analyzing system for quantitation of melanocyte morphology in caf-au-lait macules of neurofibromatosis.,INCLUDE,Computed image analysis system for melanocyte morphology
PMID:31033921,[18F]fluorothymidine and [18F]fluorodeoxyglucose PET Imaging Demonstrates Uptake and Differentiates Growth in Neurofibromatosis 2 Related Vestibular Schwannoma.,INCLUDE,PET imaging technique
PMID:31053133,Burden of adult neurofibromatosis 1: development and validation of a burden assessment tool.,INCLUDE,Burden assessment tool development
PMID:31053152,Knockdown of HMGA2 regulates the level of autophagy via interactions between MSI2 and Beclin1 to inhibit NF1-associated malignant peripheral nerve sheath tumour growth.,EXCLUDE,Molecular mechanism study
PMID:31063758,YAP/TAZ Inhibition Induces Metabolic and Signaling Rewiring Resulting in Targetable Vulnerabilities in NF2-Deficient Tumor Cells.,EXCLUDE,Metabolic signaling study
PMID:31081992,"Speech difficulties and patient health communication mediating effects on worry and health-related quality of life in children, adolescents, and young adults with Neurofibromatosis Type 1.",EXCLUDE,Quality of life communication study
PMID:31091306,Cdkn2a (Arf) loss drives NF1-associated atypical neurofibroma and malignant transformation.,EXCLUDE,Genetic transformation mechanism study
PMID:31111915,Genetic and genomic alterations differentially dictate low-grade glioma growth through cancer stem cell-specific chemokine recruitment of T cells and microglia.,EXCLUDE,Glioma growth mechanism study
PMID:31171721,Peroxynitrite supports a metabolic reprogramming in merlin-deficient Schwann cells and promotes cell survival.,EXCLUDE,Metabolic reprogramming study
PMID:3118033,Linkage studies in peripheral neurofibromatosis.,INCLUDE,Genetic linkage study technique
PMID:3118034,Linkage analysis of peripheral neurofibromatosis to DNA markers on chromosome 8.,INCLUDE,Genetic linkage analysis technique
PMID:3118035,Further exclusion data for the Von Recklinghausen neurofibromatosis gene: a genetic linkage study of 19 polymorphic markers.,INCLUDE,Genetic linkage analysis technique
PMID:31189476,Evaluation of QoL in neurofibromatosis patients: a systematic review and meta-analysis study.,EXCLUDE,Systematic review
PMID:31201114,Loss of GTPase activating protein neurofibromin stimulates paracrine cell communication via macropinocytosis.,EXCLUDE,Cellular communication mechanism study
PMID:31201186,An auditory brainstem implant for treatment of unilateral tinnitus: protocol for an interventional pilot study.,EXCLUDE,Clinical protocol study
PMID:31234911,Enriched expression of NF1 in inhibitory neurons in both mouse and human brain.,EXCLUDE,Gene expression study
PMID:31291965,ErbB4 promotes malignant peripheral nerve sheath tumor pathogenesis via Ras-independent mechanisms.,EXCLUDE,Tumor pathogenesis mechanism study
PMID:31291992,COX2 expression is associated with proliferation and tumor extension in vestibular schwannoma but is not influenced by acetylsalicylic acid intake.,EXCLUDE,Tumor expression study
PMID:31296571,Phosphorylation of Merlin by Aurora A kinase appears necessary for mitotic progression.,EXCLUDE,Protein phosphorylation mechanism study
PMID:31312020,"The NF2 tumor suppressor merlin interacts with Ras and RasGAP, which may modulate Ras signaling.",EXCLUDE,Molecular interaction study
PMID:31427883,Targeting Sporadic and Neurofibromatosis Type 1 (NF1) Related Refractory Malignant Peripheral Nerve Sheath Tumors (MPNST) in a Phase II Study of Everolimus in Combination with Bevacizumab (SARC016).,EXCLUDE,Clinical trial protocol
PMID:31511601,The Secretomes of Painful Versus Nonpainful Human Schwannomatosis Tumor Cells Differentially Influence Sensory Neuron Gene Expression and Sensitivity.,EXCLUDE,Secretome mechanism study
PMID:31545171,Optical dopamine monitoring with dLight1 reveals mesolimbic phenotypes in a mouse model of neurofibromatosis type1.,INCLUDE,Novel optical dopamine monitoring tool (dLight1)
PMID:31558455,Understanding autism spectrum disorder and social functioning in children with neurofibromatosis type 1: protocol for a cross-sectional multimodal study.,INCLUDE,Protocol development for multimodal study assessment
PMID:31585900,NF2/Merlin suppresses proliferation and induces apoptosis in colorectal cancer cells.,EXCLUDE,Molecular mechanism study
PMID:31594823,The Novel Glutamine Antagonist Prodrug JHU395 Has Antitumor Activity in Malignant Peripheral Nerve Sheath Tumor.,EXCLUDE,Drug screening study
PMID:31626572,"Multicenter, Prospective, Phase II and Biomarker Study of High-Dose Bevacizumab as Induction Therapy in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannoma.",EXCLUDE,Clinical trial protocol
PMID:31650029,STING Restricts oHSV Replication and Spread in Resistant MPNSTs but Is Dispensable for Basal IFN-Stimulated Gene Upregulation.,EXCLUDE,Viral replication mechanism study
PMID:31652930,The Role of Co-Deleted Genes in Neurofibromatosis Type 1 Microdeletions: An Evolutive Approach.,EXCLUDE,Genetic analysis study
PMID:31652973,The Role of Merlin/NF2 Loss in Meningioma Biology.,EXCLUDE,Molecular mechanism review
PMID:31730023,Nonsteroidal sulfamate derivatives as new therapeutic approaches for Neurofibromatosis 2 (NF2).,EXCLUDE,Therapeutic approach study
PMID:31752929,The impact of RASopathy-associated mutations on CNS development in mice and humans.,EXCLUDE,Mutation impact review
PMID:31756343,Activation of PLC/AKT/IB/p65 signaling increases inflammation in mast cells to promote growth of cutaneous neurofibroma.,EXCLUDE,Signaling pathway mechanism study
PMID:31793149,Funding community collaboration to develop effective therapies for neurofibromatosis type 1 tumors.,EXCLUDE,Funding collaboration discussion
PMID:31801570,"Cutaneous neurofibromas: patients' medical burden, current management and therapeutic expectations: results from an online European patient community survey.",EXCLUDE,Patient survey study
PMID:31836666,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.,INCLUDE,Biochemical tool development (NF1 protein dimerization analysis)
PMID:31836719,Engaging a community to enable disease-centric data sharing with the NF Data Portal.,INCLUDE,NF Data Portal development (computational tool)
PMID:31848332,A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2.,EXCLUDE,Vaccine efficacy study
PMID:31852972,AR facilitates YAP-TEAD interaction with the AM promoter to enhance mast cell infiltration into cutaneous neurofibroma.,EXCLUDE,Molecular signaling mechanism study
PMID:31860870,Circular RNA NF1-419 enhances autophagy to ameliorate senile dementia by binding Dynamin-1 and Adaptor protein 2 B1 in AD-like mice.,EXCLUDE,Circular RNA mechanism study
PMID:31881853,A phase 2 study of trametinib for patients with pediatric glioma or plexiform neurofibroma with refractory tumor and activation of the MAPK/ERK pathway: TRAM-01.,EXCLUDE,Clinical trial protocol
PMID:31913576,Advancing RAS/RASopathy therapies: An NCI-sponsored intramural and extramural collaboration for the study of RASopathies.,EXCLUDE,RASopathy collaboration discussion
PMID:31915440,Attention Deficit Predicts Intellectual Functioning in Children with Neurofibromatosis Type 1.,EXCLUDE,Clinical assessment study
PMID:31936793,Contribution of mTOR and PTEN to Radioresistance in Sporadic and NF2-Associated Vestibular Schwannomas: A Microarray and Pathway Analysis.,EXCLUDE,Microarray pathway analysis
PMID:31940719,The Role of RUNX1 in NF1-Related Tumors and Blood Disorders.,EXCLUDE,Molecular mechanism review
PMID:32014052,Neurofibromatosis 1 French national guidelines based on an extensive literature review since 1966.,EXCLUDE,Clinical guideline development
PMID:32089640,Targeting Refractory Sarcomas and Malignant Peripheral Nerve Sheath Tumors in a Phase I/II Study of Sirolimus in Combination with Ganetespib (SARC023).,EXCLUDE,Clinical trial protocol
PMID:32098059,Integrative Analysis Identifies Candidate Tumor Microenvironment and Intracellular Signaling Pathways that Define Tumor Heterogeneity in NF1.,INCLUDE,Computational tool (integrative analysis pipeline)
PMID:32107864,Expanding the Noonan spectrum/RASopathy NGS panel: Benefits of adding NF1 and SPRED1.,INCLUDE,NGS panel expansion (genetic tool)
PMID:32108657,Diagnostic sequence for early diagnosis of neurofibromatosis type 1 using NIH criteria.,EXCLUDE,Diagnostic criteria development
PMID:32144278,Combination therapy with mTOR kinase inhibitor and dasatinib as a novel therapeutic strategy for vestibular schwannoma.,EXCLUDE,Therapeutic strategy study
PMID:32152628,Longitudinal evaluation of peripheral nerve sheath tumors in neurofibromatosis type 1: growth analysis of plexiform neurofibromas and distinct nodular lesions.,EXCLUDE,Tumor growth analysis study
PMID:32181506,Social skills and autism spectrum disorder symptoms in children with neurofibromatosis type 1: evidence for clinical trial outcomes.,EXCLUDE,Clinical assessment study
PMID:32182803,The Role of Polycomb Repressive Complex in Malignant Peripheral Nerve Sheath Tumor.,EXCLUDE,Molecular mechanism study
PMID:32187457,Selumetinib in Children with Inoperable Plexiform Neurofibromas.,EXCLUDE,Clinical trial protocol
PMID:32190165,Auditory Brainstem Implantation for Adults With Neurofibromatosis 2 or Severe Inner Ear Abnormalities: A Health Technology Assessment.,EXCLUDE,Health technology assessment
PMID:32193437,Longitudinal phenotype development in a minipig model of neurofibromatosis type 1.,INCLUDE,Minipig NF1 animal model development
PMID:32193699,Upregulated immuno-modulator PD-L1 in malignant peripheral nerve sheath tumors provides a potential biomarker and a therapeutic target.,EXCLUDE,Biomarker identification study
PMID:32194680,ADAM9: A novel player in vestibular schwannoma pathogenesis.,EXCLUDE,Molecular mechanism study
PMID:32212796,The Value of H3K27me3 Immunohistochemistry in Differentiating Malignant Peripheral Nerve Sheath Tumour with Its Histologic Mimickers.,EXCLUDE,Immunohistochemistry technique study
PMID:32245042,Kinome Profiling of NF1-Related MPNSTs in Response to Kinase Inhibition and Doxorubicin Reveals Therapeutic Vulnerabilities.,INCLUDE,Kinome profiling computational tool
PMID:32252313,A Novel Treatment Modality for Malignant Peripheral Nerve Sheath Tumor Using a Dual-Effect Liposome to Combine Photodynamic Therapy and Chemotherapy.,EXCLUDE,Treatment modality development
PMID:32252413,Genomics of MPNST (GeM) Consortium: Rationale and Study Design for Multi-Omic Characterization of NF1-Associated and Sporadic MPNSTs.,INCLUDE,Multi-omic characterization consortium (computational tool)
PMID:32272491,The Use of MEK Inhibitors in Neurofibromatosis Type 1-Associated Tumors and Management of Toxicities.,EXCLUDE,Clinical treatment review
PMID:32281771,Germline Mutations for Novel Candidate Predisposition Genes in Sporadic Schwannomatosis.,EXCLUDE,Genetic mutation study
PMID:32294191,Pretreatment Endocrine Disorders Due to Optic Pathway Gliomas in Pediatric Neurofibromatosis Type 1: Multicenter Study.,EXCLUDE,Clinical endocrine disorder study
PMID:32299434,Merlin regulates signaling events at the nexus of development and cancer.,EXCLUDE,Molecular signaling review
PMID:32320652,Rational Design of Allosteric and Selective Inhibitors of the Molecular Chaperone TRAP1.,EXCLUDE,Molecular inhibitor design
PMID:32352002,Human Organ-Specific 3D Cancer Models Produced by the Stromal Self-Assembly Method of Tissue Engineering for the Study of Solid Tumors.,INCLUDE,3D cancer model development (organoid tool)
PMID:32353955,New Model Systems and the Development of Targeted Therapies for the Treatment of Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors.,EXCLUDE,Model systems review
PMID:32354889,Propranolol Specifically Suppresses the Viability of Tumorous Schwann Cells Derived from Plexiform Neurofibromas ,EXCLUDE,Cell viability study
PMID:32397722,NEUROFIBROMATOSIS TYPE 1 AND OPTIC PATHWAY GLIOMA.,EXCLUDE,Clinical review
PMID:32406525,Autism and attention-deficit/hyperactivity disorders and symptoms in children with neurofibromatosis type 1.,INCLUDE,Parse error - defaulted to include
PMID:32408052,Mutation-Directed Therapeutics for Neurofibromatosis Type I.,INCLUDE,Parse error - defaulted to include
PMID:32419643,Long Noncoding RNA WT1-AS Inhibit Cell Malignancy via miR-494-3p in Glioma.,INCLUDE,Parse error - defaulted to include
PMID:32438526,Effects of Neurod1 Expression on Mouse and Human Schwannoma Cells.,INCLUDE,Parse error - defaulted to include
PMID:32438819,Honokiol Bis-Dichloroacetate Is a Selective Allosteric Inhibitor of the Mitochondrial Chaperone TRAP1.,INCLUDE,Parse error - defaulted to include
PMID:32443592,C-Fiber Loss as a Possible Cause of Neuropathic Pain in Schwannomatosis.,INCLUDE,Parse error - defaulted to include
PMID:32457840,"TGF Signaling Increases Net Acid Extrusion, Proliferation and Invasion in Panc-1 Pancreatic Cancer Cells: SMAD4 Dependence and Link to Merlin/NF2 Signaling.",INCLUDE,Parse error - defaulted to include
PMID:32461556,Assessing the origin of high-grade serous ovarian cancer using CRISPR-modification of mouse organoids.,INCLUDE,Parse error - defaulted to include
PMID:32471868,Genetic disruption of the small GTPase RAC1 prevents plexiform neurofibroma formation in mice with neurofibromatosis type 1.,INCLUDE,Parse error - defaulted to include
PMID:32642733,KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors.,INCLUDE,Parse error - defaulted to include
PMID:32642737,Assessing interobserver variability and accuracy in the histological diagnosis and classification of cutaneous neurofibromass.,INCLUDE,Parse error - defaulted to include
PMID:32642739,Clinical trial design in neurofibromatosis type 1 as a model for other tumor predisposition syndromes.,INCLUDE,Parse error - defaulted to include
PMID:32642740,Quality of life in patients with neurofibromatosis type 1 and 2 in Canada.,INCLUDE,Parse error - defaulted to include
PMID:32699356,Murine models of IDH-wild-type glioblastoma exhibit spatial segregation of tumor initiation and manifestation during evolution.,INCLUDE,Parse error - defaulted to include
PMID:32733557,"Gene Expression, Network Analysis, and Drug Discovery of Neurofibromatosis Type 2-Associated Vestibular Schwannomas Based on Bioinformatics Analysis.",INCLUDE,Parse error - defaulted to include
PMID:32781282,Nf1 heterozygous mice recapitulate the anthropometric and metabolic features of human neurofibromatosis type 1.,INCLUDE,Parse error - defaulted to include
PMID:3280697,"Monoclonal antibody (AFH1) immunoreactive on morphologically abnormal basal melanocytes within dysplastic nevi, nevocellular nevus nests, and melanoma.",INCLUDE,Parse error - defaulted to include
PMID:32839340,Brain-wide structural and functional disruption in mice with oligodendrocyte-specific ,INCLUDE,Parse error - defaulted to include
PMID:32858845,Systems Biology Approaches Reveal Potential Phenotype-Modifier Genes in Neurofibromatosis Type 1.,INCLUDE,Parse error - defaulted to include
PMID:32869517,Genome-wide association study of caf-au-lait macule number in neurofibromatosis type 1.,INCLUDE,Parse error - defaulted to include
PMID:32948135,Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model.,INCLUDE,Parse error - defaulted to include
PMID:33032988,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,INCLUDE,Parse error - defaulted to include
PMID:33078583,Cell autonomous requirement of neurofibromin (Nf1) for postnatal muscle hypertrophic growth and metabolic homeostasis.,INCLUDE,Parse error - defaulted to include
PMID:33080011,"Temporal, spatial, and genetic constraints contribute to the patterning and penetrance of murine neurofibromatosis-1 optic glioma.",INCLUDE,Parse error - defaulted to include
PMID:33082502,Image segmentation of plexiform neurofibromas from a deep neural network using multiple b-value diffusion data.,INCLUDE,Parse error - defaulted to include
PMID:33085177,The development of the PlexiQoL: A patient-reported outcome measure for adults with neurofibromatosis type 1-associated plexiform neurofibromas.,INCLUDE,Parse error - defaulted to include
PMID:33160273,Modeling tumors of the peripheral nervous system associated with Neurofibromatosis type 1: Reprogramming plexiform neurofibroma cells.,INCLUDE,Parse error - defaulted to include
PMID:33197677,Effects of a mind-body program on symptoms of depression and perceived stress among adults with neurofibromatosis type 2 who are deaf: A live-video randomized controlled trial.,INCLUDE,Parse error - defaulted to include
PMID:33273014,mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition.,INCLUDE,Parse error - defaulted to include
PMID:33279959,"Stepwise crosstalk between aberrant Nf1, Tp53 and Rb signalling pathways induces gliomagenesis in zebrafish.",INCLUDE,Parse error - defaulted to include
PMID:33356508,C6 Cell Injection into the Optic Nerve of Long-Evans Rats: A Short-Term Model of Optic Pathway Gliomas.,INCLUDE,Parse error - defaulted to include
PMID:33413690,Human cutaneous neurofibroma matrisome revealed by single-cell RNA sequencing.,INCLUDE,Parse error - defaulted to include
PMID:33436083,Distinctive epigenomic alterations in NF1-deficient cutaneous and plexiform neurofibromas drive differential MKK/p38 signaling.,INCLUDE,Parse error - defaulted to include
PMID:33442015,Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial.,INCLUDE,Parse error - defaulted to include
PMID:33484105,Circulating free DNA in the plasma of individuals with neurofibromatosis type 1.,INCLUDE,Parse error - defaulted to include
PMID:33507258,Assessment of RAS Dependency for BRAF Alterations Using Cancer Genomic Databases.,INCLUDE,Parse error - defaulted to include
PMID:33507822,NF106: A Neurofibromatosis Clinical Trials Consortium Phase II Trial of the MEK Inhibitor Mirdametinib (PD-0325901) in Adolescents and Adults With NF1-Related Plexiform Neurofibromas.,INCLUDE,Parse error - defaulted to include
PMID:33574490,Using antisense oligonucleotides for the physiological modulation of the alternative splicing of NF1 exon 23a during PC12 neuronal differentiation.,INCLUDE,Parse error - defaulted to include
PMID:33625502,"Efficacy of a Brief, Peer-Delivered Self-management Intervention for Patients With Rare Chronic Diseases: A Randomized Clinical Trial.",INCLUDE,Parse error - defaulted to include
PMID:33673681,Hybrid Minigene Assay: An Efficient Tool to Characterize mRNA Splicing Profiles of ,INCLUDE,Parse error - defaulted to include
PMID:33767727,Molecular Diagnosis of Neurofibromatosis by Multigene Panel Testing.,INCLUDE,Parse error - defaulted to include
PMID:33817379,Clinical assessment of the use of topical liquid diclofenac following laser microporation of cutaneous neurofibromas in individuals with neurofibromatosis type 1.,INCLUDE,Parse error - defaulted to include
PMID:33948356,Cordycepin inhibits the proliferation of malignant peripheral nerve sheath tumor cells through the p53/Sp1/tubulin pathway.,INCLUDE,Parse error - defaulted to include
PMID:33963966,Cognitive and Electrophysiological Correlates of Working Memory Impairments in Neurofibromatosis Type 1.,INCLUDE,Parse error - defaulted to include
PMID:33972401,Associative Learning Requires Neurofibromin to Modulate GABAergic Inputs to Drosophila Mushroom Bodies.,INCLUDE,Parse error - defaulted to include
PMID:34010628,Stem-like cells drive NF1-associated MPNST functional heterogeneity and tumor progression.,INCLUDE,Parse error - defaulted to include
PMID:34011935,Metalloproteinase 1 downregulation in neurofibromatosis 1: Therapeutic potential of antimalarial hydroxychloroquine and chloroquine.,INCLUDE,Parse error - defaulted to include
PMID:34040258,NF1 mutation drives neuronalactivity-dependent initiation of optic glioma.,INCLUDE,Parse error - defaulted to include
PMID:34043012,RNA sequence analysis reveals ITGAL/CD11A as a stromal regulator of murine low-grade glioma growth.,INCLUDE,Parse error - defaulted to include
PMID:34049498,Early differences in auditory processing relate to Autism Spectrum Disorder traits in infants with Neurofibromatosis Type I.,INCLUDE,Parse error - defaulted to include
PMID:34053190,Transcriptomic signature of painful human neurofibromatosis type 2 schwannomas.,EXCLUDE,"Transcriptomic analysis, no specific research tool mentioned"
PMID:34065204,RABL6A Regulates Schwann Cell Senescence in an RB1-Dependent Manner.,EXCLUDE,"Schwann cell senescence study, no specific tool developed"
PMID:34075397,PAK1 inhibition reduces tumor size and extends the lifespan of mice in a genetically engineered mouse model of Neurofibromatosis Type 2 (NF2).,INCLUDE,Genetically engineered mouse model of NF2
PMID:34079083,WNT5A inhibition alters the malignant peripheral nerve sheath tumor microenvironment and enhances tumor growth.,EXCLUDE,"Tumor microenvironment study, no specific tool"
PMID:34155781,L-carnitine supplementation for muscle weakness and fatigue in children with neurofibromatosis type 1: A Phase 2a clinical trial.,INCLUDE,Clinical trial using L-carnitine as potential intervention tool
PMID:34215596,Acceptance and commitment therapy meets peer-support. Development of a supportive self-care intervention for patients with rare diseases: a multistage development process.,EXCLUDE,"Intervention development methodology, no specific research tool"
PMID:34229750,Integrated in silico MS-based phosphoproteomics and network enrichment analysis of RASopathy proteins.,EXCLUDE,"Computational analysis, no novel tool mentioned"
PMID:34230196,Reliability of Handheld Dynamometry to Measure Focal Muscle Weakness in Neurofibromatosis Types 1 and 2.,INCLUDE,Handheld dynamometry as clinical assessment tool
PMID:34230198,Current Recommendations for Patient-Reported Outcome Measures Assessing Domains of Quality of Life in Neurofibromatosis Clinical Trials.,INCLUDE,Patient-reported outcome measure recommendations
PMID:34230200,Imaging Evaluation of Plexiform Neurofibromas in Neurofibromatosis Type 1: A Survey-Based Assessment.,INCLUDE,Imaging evaluation survey/tool development
PMID:34230203,Patient Report of Hearing in Neurofibromatosis Type 2: Recommendations for Clinical Trials.,INCLUDE,Patient hearing report recommendations
PMID:34230204,Measuring the Effect of Cutaneous Neurofibromas on Quality of Life in Neurofibromatosis Type 1.,INCLUDE,Quality of life measurement tool development
PMID:34230205,Recommendations for Social Skills End Points for Clinical Trials in Neurofibromatosis Type 1.,INCLUDE,Social skills assessment tool recommendations
PMID:34230208,Enhancing Neurofibromatosis Clinical Trial Outcome Measures Through Patient Engagement: Lessons From REiNS.,INCLUDE,Patient engagement methodology for clinical trial tools
PMID:34257279,Neurofibromin regulates metabolic rate via neuronal mechanisms in Drosophila.,INCLUDE,Drosophila model for metabolic rate research
PMID:34264955,Brigatinib causes tumor shrinkage in both NF2-deficient meningioma and schwannoma through inhibition of multiple tyrosine kinases but not ALK.,EXCLUDE,"Drug screening study, no specific tool"
PMID:34297428,RNA-sequencing highlights differential regulated pathways involved in cell cycle and inflammation in orbitofacial neurofibromas.,EXCLUDE,"RNA sequencing analysis, no novel tool"
PMID:34337379,Conformational flexibility determines the Nf2/merlin tumor suppressor functions.,EXCLUDE,"Protein conformational study, no research tool"
PMID:34352618,Characterization of UMi031-A-2 inducible pluripotent stem cell line with a neurofibromatosis type 2-associated mutation.,INCLUDE,Induced pluripotent stem cell line with NF2 mutation
PMID:34377779,Impact of MEK Inhibitor Therapy on Neurocognitive Functioning in NF1.,INCLUDE,MEK inhibitor impact on neurocognitive functioning
PMID:34416167,Anti-PD-1/L1 lead-in before MAPK inhibitor combination maximizes antitumor immunity and efficacy.,EXCLUDE,"Immunotherapy combination study, no specific tool"
PMID:34428430,Treatment during a developmental window prevents NF1-associated optic pathway gliomas by targeting Erk-dependent migrating glial progenitors.,INCLUDE,Developmental window treatment model
PMID:34464388,Cell-free DNA ultra-low-pass whole genome sequencing to distinguish malignant peripheral nerve sheath tumor (MPNST) from its benign precursor lesion: A cross-sectional study.,INCLUDE,Cell-free DNA ultra-low-pass whole genome sequencing
PMID:34487172,Machine learning approach to differentiation of peripheral schwannomas and neurofibromas: A multi-center study.,INCLUDE,Machine learning approach for tumor differentiation
PMID:34534577,Combined Cyclin-Dependent Kinase InhibitionOvercomes MAPK/Extracellular Signal-Regulated Kinase Kinase Inhibitor Resistance in Plexiform Neurofibroma of Neurofibromatosis Type I.,EXCLUDE,"Drug combination study, no specific tool"
PMID:34573290,Performance Evaluation of SpliceAI for the Prediction of Splicing of ,INCLUDE,SpliceAI variant prediction tool evaluation
PMID:34603530,Autophagy is involved in neurofibromatosis type I gene-modulated osteogenic differentiation in human bone mesenchymal stem cells.,EXCLUDE,"Cellular differentiation study, no specific tool"
PMID:34604751,Feasibility of magnetic resonance-guided high-intensity focused ultrasound treatment targeting distinct nodular lesions in neurofibromatosis type 1.,INCLUDE,MR-guided high-intensity focused ultrasound treatment feasibility
PMID:34627329,Executive functions and quality of life in children with neurofibromatosis type 1.,EXCLUDE,Executive function and quality of life study
PMID:34630515,Assessment of Mosaicism and Detection of Cryptic Alleles in CRISPR/Cas9-Engineered Neurofibromatosis Type 1 and ,INCLUDE,CRISPR/Cas9 genetic engineering tool assessment
PMID:34664663,Longitudinal Investigation of Early Motor Development in Neurofibromatosis Type 1.,INCLUDE,Longitudinal motor development assessment tool
PMID:34692515,SUZ12 Loss Amplifies the Ras/ERK Pathway by Activating Adenylate Cyclase 1 in NF1-Associated Neurofibromas.,EXCLUDE,"Molecular pathway study, no specific tool"
PMID:34699786,Inhibition of ERK/MAPK signaling as potential therapy to prevent optic pathway glioma in infants with neurofibromatosis type 1.,EXCLUDE,"Signaling pathway review, no tool"
PMID:34707296,The structure of neurofibromin isoform 2 reveals different functional states.,EXCLUDE,"Protein structural analysis, no research tool"
PMID:34728553,RKIP Induction Promotes Tumor Differentiation via SOX2 Degradation in NF2-Deficient Conditions.,EXCLUDE,"Molecular mechanism study, no tool"
PMID:34782607,Pathogenic neurofibromatosis type 1 (NF1) RNA splicing resolved by targeted RNAseq.,INCLUDE,Targeted RNAseq for RNA splicing analysis
PMID:34880260,Asthma reduces glioma formation by T cell decorin-mediated inhibition of microglia.,EXCLUDE,"Glioma formation study, no specific tool"
PMID:34918118,Origins of biallelic inactivation of NF2 in neurofibromatosis type 2.,EXCLUDE,Genetic inactivation mechanism study
PMID:34934133,MEK inhibition exerts temporal and myeloid cell-specific effects in the pathogenesis of neurofibromatosis type 1 arteriopathy.,EXCLUDE,MEK inhibition pathway study
PMID:34935315,Analysis of muscle tissue in vivo using fiber-optic autofluorescence and diffuse reflectance spectroscopy.,INCLUDE,Fiber-optic spectroscopy muscle tissue analysis
PMID:34948100,Neurofibromin Deficiency Causes Epidermal Growth Factor Receptor Upregulation through the Activation of Ras/ERK/SP1 Signaling Pathway in Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheet Tumor.,EXCLUDE,"Signaling pathway study, no tool"
PMID:34983638,Delineating the autistic phenotype in children with neurofibromatosis type 1.,EXCLUDE,Autism phenotype characterization
PMID:35004058,Assessing Psychiatric Comorbidity and Pharmacologic Treatment Patterns Among Patients With Neurofibromatosis Type 1.,EXCLUDE,Psychiatric comorbidity assessment
PMID:35008487,The Lipid Asset Is Unbalanced in Peripheral Nerve Sheath Tumors.,EXCLUDE,Lipid analysis study
PMID:35037337,Neurofibromatosis type 2 versus sporadic vestibular schwannoma: The utility of MR diffusion and dynamic contrast-enhanced imaging.,INCLUDE,MR imaging technique comparison
PMID:35187488,Immune deconvolution and temporal mapping identifies stromal targets and developmental intervals for abrogating murine low-grade optic glioma formation.,EXCLUDE,Immune deconvolution study
PMID:35212372,Characterizing mobile element insertions in 5675 genomes.,EXCLUDE,Mobile element insertion analysis
PMID:35261809,A novel HDAC11 inhibitor potentiates the tumoricidal effects of cordycepin against malignant peripheral nerve sheath tumor through the Hippo signaling pathway.,EXCLUDE,Drug combination study
PMID:35332608,Re-evaluation of missense variant classifications in NF2.,INCLUDE,Missense variant classification re-evaluation
PMID:35353986,Structural basis of activation of the tumor suppressor protein neurofibromin.,EXCLUDE,Protein structural basis study
PMID:35393544,"Malignant peripheral nerve sheath tumor: models, biology, and translation.",EXCLUDE,"Review of models, no specific tool development"
PMID:35426432,Evaluation of magnetic resonance imaging-based radiomics characteristics for differentiation of benign and malignant peripheral nerve sheath tumors in neurofibromatosis type 1.,EXCLUDE,"Radiomics imaging analysis, no specific tool"
PMID:35456477,Electrophysiological and Behavioral Evidence for Hyper- and Hyposensitivity in Rare Genetic Syndromes Associated with Autism.,EXCLUDE,"Electrophysiological study, no specific tool"
PMID:35478244,Celastrol suppresses the growth of vestibular schwannoma in mice by promoting the degradation of -catenin.,EXCLUDE,"Preclinical drug study, no specific tool"
PMID:35481324,Evaluating the Evidence: Scientometric Analysis of Highly Cited Neurofibromatosis 1 Publications.,EXCLUDE,"Bibliometric analysis, no research tool"
PMID:35511749,A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors.,INCLUDE,High-throughput screening platform development
PMID:35584348,Tumor and Constitutional Sequencing for Neurofibromatosis Type 1.,EXCLUDE,"Sequencing methodology, no specific tool"
PMID:35589737,Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1.,EXCLUDE,"Neuronal model, no specific tool"
PMID:35628517,Molecular Dynamics Simulations Reveal Structural Interconnections within Sec14-PH Bipartite Domain from Human Neurofibromin.,EXCLUDE,"Molecular dynamics simulation, no novel tool"
PMID:35673329,Neuroanatomical correlates of working memory performance in Neurofibromatosis 1.,EXCLUDE,Neuroanatomical correlational study
PMID:35677169,Image-Based Differentiation of Benign and Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1.,EXCLUDE,Image-based differentiation method
PMID:35723774,A randomized controlled trial of remote microphone listening devices to treat auditory deficits in children with neurofibromatosis type 1.,INCLUDE,Remote microphone listening device as assistive tool
PMID:35735230,Centralizing neurofibromatosis experimental tool knowledge with the NF Research Tools Database.,INCLUDE,NF Research Tools Database development
PMID:35741605,Integrated Drug Mining Reveals Actionable Strategies Inhibiting Plexiform Neurofibromas.,EXCLUDE,Drug mining analysis
PMID:35815410,Schwann cell precursors represent a neural crest-like state with biased multipotency.,EXCLUDE,Cellular biology study
PMID:35855179,Bibliometric analysis of the top 100 most-cited articles in neurofibromatosis.,EXCLUDE,Bibliometric analysis
PMID:35855490,Validation of Bromodomain and Extraterminal proteins as therapeutic targets in neurofibromatosis type 2.,EXCLUDE,Therapeutic target validation
PMID:35875109,Preclinical Assessment of MEK Inhibitors for Malignant Peripheral Nerve Sheath Tumors Reveals Differences in Efficacy and Adaptive Response.,EXCLUDE,Preclinical drug assessment
PMID:35875610,"CUDC907, a dual phosphoinositide-3 kinase/histone deacetylase inhibitor, promotes apoptosis of NF2 Schwannoma cells.",EXCLUDE,Drug apoptosis study
PMID:35879407,Intragenic inversions in NF1 gene as pathogenic mechanism in neurofibromatosis type 1.,EXCLUDE,Genetic mutation analysis
PMID:35887576,Silver Nanoparticles Selectively Treat Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors in a Neurofibromin-Dependent Manner.,EXCLUDE,Nanoparticle treatment study
PMID:35965583,Concurrent inhibition of FAK/SRC and MEK overcomes MEK inhibitor resistance in Neurofibromatosis Type I related malignant peripheral nerve sheath tumors.,EXCLUDE,Drug combination study
PMID:35968018,Loss of H3K27me3 expression in canine nerve sheath tumors.,EXCLUDE,Veterinary pathology study
PMID:35970940,"Cortical inhibition in neurofibromatosis type 1 is modulated by lovastatin, as demonstrated by a randomized, triple-blind, placebo-controlled clinical trial.",EXCLUDE,Clinical trial methodology
PMID:36009591,Identification of Germinal Neurofibromin Hotspots.,EXCLUDE,Genetic mutation identification
PMID:36037004,Mechanistic insights from animal models of neurofibromatosis type 1 cognitive impairment.,EXCLUDE,Animal model review
PMID:36059985,Qu-Du-San-Jie decoction induces growth inhibition and vascular normalization in NF2-associated vestibular schwannoma.,EXCLUDE,Traditional medicine study
PMID:36071954,Co-culture of Schwann cells and endothelial cells for synergistically regulating dorsal root ganglion behavior on chitosan-based anisotropic topology for peripheral nerve regeneration.,EXCLUDE,Nerve regeneration methodology
PMID:36081238,Plasticity of visual evoked potentials in patients with neurofibromatosis type 1.,EXCLUDE,Visual evoked potential study
PMID:36127120,Cohort profile: life with neurofibromatosis 1 - the Danish NF1 cohort.,INCLUDE,NF1 research cohort development
PMID:36130486,Single-cell sequencing reveals activation of core transcription factors in PRC2-deficient malignant peripheral nerve sheath tumor.,EXCLUDE,Single-cell sequencing analysis
PMID:36134665,Multiple Nf1 Schwann cell populations reprogram the plexiform neurofibroma tumor microenvironment.,EXCLUDE,Tumor microenvironment study
PMID:36139671,Neurofibroma Development in Neurofibromatosis Type 1: Insights from Cellular Origin and Schwann Cell Lineage Development.,EXCLUDE,Cellular origin review
PMID:36241865,Transplanting neurofibromatosis-1 gene knockout neural stem cells improve functional recovery in rats with spinal cord injury by enhancing the mTORC2 pathway.,INCLUDE,Neural stem cell transplantation model
PMID:36300003,A novel NF2 splicing mutant causes neurofibromatosis type 2 via liquid-liquid phase separation with large tumor suppressor and Hippo pathway.,EXCLUDE,Molecular pathway study
PMID:36316421,Non-invasive brain stimulation modulates GABAergic activity in neurofibromatosis 1.,EXCLUDE,Brain stimulation study
PMID:36416236,LPAR1 and aberrantly expressed LPAR3 differentially promote the migration and proliferation of malignant peripheral nerve sheath tumor cells.,EXCLUDE,Cellular migration study
PMID:36420221,Antisense oligonucleotides targeting exon 11 are able to partially rescue the NF2-related schwannomatosis phenotype ,INCLUDE,Antisense oligonucleotide development
PMID:36459048,Molecular Dissection of Somatic Skeletal Disease in Neurofibromatosis Type 1.,EXCLUDE,Molecular disease mechanism study
PMID:36497280,Knockdown of NCOR2 Inhibits Cell Proliferation via BDNF/TrkB/ERK in NF1-Derived MPNSTs.,EXCLUDE,Cellular proliferation study
PMID:36604703,The German version of the neurofibromatosis 2 impact on quality of life questionnaire correlates with severity of depression and physician-reported disease severity.,INCLUDE,Quality of life questionnaire validation
PMID:36619222,Inhibition of YAP Sensitizes the Selumetinib Treatment for Neurofibromatosis Type 1 Related Plexiform Neurofibroma.,EXCLUDE,Drug treatment study
PMID:36689660,Destabilizing NF1 variants act in a dominant negative manner through neurofibromin dimerization.,EXCLUDE,Protein interaction study
PMID:36730269,Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas.,INCLUDE,Spheroid drug screening platform
PMID:36759572,Runx1/3-driven adaptive endoplasmic reticulum stress pathways contribute to neurofibromagenesis.,EXCLUDE,Cellular pathway study
PMID:36806881,Proteasomal pathway inhibition as a potential therapy for NF2-associated meningioma and schwannoma.,EXCLUDE,Potential therapy mechanism
PMID:36809290,Merlin tumor suppressor function is regulated by PIP2-mediated dimerization.,EXCLUDE,Protein interaction study
PMID:36844630,Genetic variants of cancerassociated genes analyzed using nextgeneration sequencing in small sporadic vestibular schwannomas.,EXCLUDE,Genetic variant analysis
PMID:36849412,Combining SOS1 and MEK Inhibitors in a Murine Model of Plexiform Neurofibroma Results in Tumor Shrinkage.,EXCLUDE,Murine model drug study
PMID:36854987,Modeling nervous system tumors with human stem cells and organoids.,INCLUDE,Stem cell and organoid modeling platform
PMID:36866403,Atypical neurofibromas reveal distinct epigenetic features with proximity to benign peripheral nerve sheath tumor entities.,EXCLUDE,No specific research tool mentioned
PMID:36868466,A Two-Stage End-to-End Deep Learning Framework for Pathologic Examination in Skin Tumor Diagnosis.,EXCLUDE,No specific research tool mentioned
PMID:36890585,Neurofibromatosistype 1-dependent alterations in mouse microglia function are not cell-intrinsic.,INCLUDE,Mouse model (NF1 microglia function)
PMID:36895472,MEK inhibition causes BIM stabilization and increased sensitivity to BCL-2 family member inhibitors in RAS-MAPK-mutated neuroblastoma.,EXCLUDE,No specific research tool mentioned
PMID:36944680,Cellular mechanisms of heterogeneity in NF2-mutant schwannoma.,EXCLUDE,No specific research tool mentioned
PMID:36959711,Modeling human cancer predisposition syndromes using CRISPR/Cas9 in human cell line models.,INCLUDE,CRISPR/Cas9 as genetic reagent
PMID:36976677,Generation of human iPSC-derived neurofibromaspheres for invitro and invivo uses.,INCLUDE,Human iPSC-derived neurofibromaspheres (organoid model)
PMID:37140985,Basement membrane proteins in extracellular matrix characterize NF1 neurofibroma development and response to MEK inhibitor.,EXCLUDE,No specific research tool mentioned
PMID:37147639,The oncogenic role of NF1 in gallbladder cancer through regulation of YAP1 stability by direct interaction with YAP1.,EXCLUDE,No specific research tool mentioned
PMID:37164978,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,INCLUDE,Multiplatform molecular profiling tool
PMID:37186028,Analysis of 200 unrelated individuals with a constitutional NF1 deep intronic pathogenic variant reveals that variants flanking the alternatively spliced NF1 exon 31 [23a] cause a classical neurofibromatosis type 1 phenotype while altering predominantly NF1 isoform type II.,EXCLUDE,No specific research tool mentioned
PMID:37217626,New insights into the molecular basis of spinal neurofibromatosis type 1.,EXCLUDE,No specific research tool mentioned
PMID:37217995,The genetic landscape and possible therapeutics of neurofibromatosis type 2.,EXCLUDE,No specific research tool mentioned
PMID:37245145,"RAS Signaling Gone Awry in the Skin: The Complex Role of RAS in Cutaneous Neurofibroma Pathogenesis, Emerging Biological Insights.",EXCLUDE,No specific research tool mentioned
PMID:37246765,Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology.,INCLUDE,Ex vivo and in vivo MPNST model
PMID:37276689,Health-related quality of life of children with neurofibromatosis type 1: Analysis of proxy-rated PedsQL and CHQ questionnaires.,INCLUDE,"Clinical assessment tools (PedsQL, CHQ)"
PMID:37301319,Distinct Transcriptional Profiles in the Different Phenotypes of Neurofibroma from the Same Subject with Neurofibromatosis 1.,EXCLUDE,No specific research tool mentioned
PMID:37330719,Existing and Developing Preclinical Models for Neurofibromatosis Type 1-Related Cutaneous Neurofibromas.,INCLUDE,Preclinical model development
PMID:37353850,Burden of adult neurofibromatosis 1 questionnaire: translation and psychometric properties of the Persian version.,INCLUDE,Clinical assessment tool (Burden of NF1 questionnaire)
PMID:37378983,Effect of Mind-Body Skills Training on Quality of Life for Geographically Diverse Adults With Neurofibromatosis: A Fully Remote Randomized Clinical Trial.,INCLUDE,Mind-Body Skills Training assessment tool
PMID:37382486,A new era for myelin research in Neurofibromatosis type 1.,EXCLUDE,No specific research tool mentioned
PMID:37406085,Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma.,EXCLUDE,No specific research tool mentioned
PMID:37435433,Neurofibromatosis-1 Gene Mutational Profiles Differ Between Syndromic Disease and Sporadic Cancers.,EXCLUDE,No specific research tool mentioned
PMID:37440099,The impact of a virtual mind-body program on resilience factors among international English-speaking adults with neurofibromatoses: secondary analysis of a randomized clinical trial.,INCLUDE,Virtual mind-body program assessment tool
PMID:37446790,Icariin Promotes Osteogenic Differentiation in a Cell Model with NF1 Gene Knockout by Activating the cAMP/PKA/CREB Pathway.,INCLUDE,Cell model with NF1 gene knockout
PMID:37520682,Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1.,INCLUDE,Nonsense mutation suppression therapy
PMID:37527526,Cotargeting Phosphoinositide 3-Kinase and Focal Adhesion Kinase Pathways Inhibits Proliferation of NF2 Schwannoma Cells.,EXCLUDE,No specific research tool mentioned
PMID:37608248,Aberrant oscillatory activity in neurofibromatosis type 1: an EEG study of resting state and working memory.,INCLUDE,EEG research tool
PMID:37616542,"Pro-905, a Novel Purine Antimetabolite, Combines with Glutamine Amidotransferase Inhibition to Suppress Growth of Malignant Peripheral Nerve Sheath Tumor.",EXCLUDE,No specific research tool mentioned
PMID:37629179,Drug Repositioning for Refractory Benign Tumors of the Central Nervous System.,EXCLUDE,No specific research tool mentioned
PMID:37659342,Electrically evoked auditory responses: A classification for brainstem implant placement in Neurofibromatosis Type 2.,EXCLUDE,No specific research tool mentioned
PMID:37686402,"FOXM1, MEK, and CDK4/6: New Targets for Malignant Peripheral Nerve Sheath Tumor Therapy.",EXCLUDE,No specific research tool mentioned
PMID:37712888,A common single nucleotide variant in the cytokine receptor-like factor-3 (CRLF3) gene causes neuronal deficits in human and mouse cells.,INCLUDE,Human and mouse cell models
PMID:37760547,Inhibition of Anaplastic Lymphoma Kinase (Alk) as Therapeutic Target to Improve Brain Function in Neurofibromatosis Type 1 (Nf1).,EXCLUDE,No specific research tool mentioned
PMID:37770931,"Integration of single-nuclei RNA-sequencing, spatial transcriptomics and histochemistry defines the complex microenvironment of NF1-associated plexiform neurofibromas.",INCLUDE,Single-nuclei RNA-sequencing and spatial transcriptomics
PMID:37772407,Potential endpoints for assessment of bone health in persons with neurofibromatosis type 1.,EXCLUDE,No specific research tool mentioned
PMID:37817770,Single-cell RNA sequencing of neurofibromas reveals a tumor microenvironment favorable for neural regeneration and immune suppression in a neurofibromatosis type 1 porcine model.,INCLUDE,Single-cell RNA sequencing in porcine model
PMID:37949359,Characterization of Immune Cell Populations of Cutaneous Neurofibromas in Neurofibromatosis 1.,EXCLUDE,No specific research tool mentioned
PMID:37990867,Neurofibromin 1 mutations impair the function of human induced pluripotent stem cell-derived microglia.,INCLUDE,Human iPSC-derived microglia
PMID:38008284,Droplet Digital PCR for Fast and Accurate Characterization of NF1 Locus Deletions: Confirmation of the Predominant Maternal Origin of Type-1 Deletions.,INCLUDE,Droplet Digital PCR tool
PMID:38086379,Econazole selectively induces cell death in NF1-homozygous mutant tumor cells.,EXCLUDE,No specific research tool mentioned
PMID:38115252,Identification of hub genes and drug candidates for NF2-related vestibular schwannoma by bioinformatics tools.,INCLUDE,Bioinformatics tools for gene identification
PMID:38127282,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,INCLUDE,Spatial gene-expression profiling
PMID:38136356,Drug Responses in Plexiform Neurofibroma Type I (PNF1) Cell Lines Using High-Throughput Data and Combined Effectiveness and Potency.,INCLUDE,High-throughput drug response cell lines
PMID:38140900,Recommendations for assessing appearance concerns related to plexiform and cutaneous neurofibromas in neurofibromatosis 1 clinical trials.,INCLUDE,Clinical assessment tool for neurofibroma appearance
PMID:38170419,Development of the PROMIS pediatric stigma and extension to the PROMIS pediatric stigma: skin item banks.,INCLUDE,PROMIS pediatric stigma item banks
PMID:38173515,Development of a semi-automatic segmentation technique based on mean magnetic resonance imaging intensity thresholding for volumetric quantification of plexiform neurofibromas.,INCLUDE,Semi-automatic MRI segmentation technique
PMID:38175707,Unbalancing cAMP and Ras/MAPK pathways as a therapeutic strategy for cutaneous neurofibromas.,EXCLUDE,No specific research tool mentioned
PMID:38187038,Novel combination of imipridones and histone deacetylase inhibitors demonstrate cytotoxic effect through integrated stress response in pediatric solid tumors.,EXCLUDE,No specific research tool mentioned
PMID:38201517,Synergistic Suppression of NF1 Malignant Peripheral Nerve Sheath Tumor Cell Growth in Culture and Orthotopic Xenografts by Combinational Treatment with Statin and Prodrug Farnesyltransferase Inhibitor PAMAM G4 Dendrimers.,INCLUDE,Cell culture and xenograft models
PMID:38203448,FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells.,INCLUDE,Mentions MPNST cell lines
PMID:38216123,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.,INCLUDE,Develops NF1 genetic lines (metabolic research)
PMID:38229454,Estrogen-induced glial IL-1 mediates extrinsic retinal ganglion cell vulnerability in murine Nf1 optic glioma.,EXCLUDE,Mechanistic study without specific tool development
PMID:38258905,Schwann cells modulate nociception in neurofibromatosis 1.,EXCLUDE,Physiological mechanism study
PMID:38308315,Brain injury drives optic glioma formation through neuron-glia signaling.,EXCLUDE,Mechanistic neuroscience study
PMID:38321701,Patient-reported measures of tinnitus for individuals with neurofibromatosis type 2-related schwannomatosis: Recommendations for clinical trials.,INCLUDE,Develops patient-reported outcome measure (clinical assessment tool)
PMID:38336988,Simultaneous inhibition of PI3K and PAK in preclinical models of neurofibromatosis type 2-related schwannomatosis.,EXCLUDE,Preclinical pharmacological study
PMID:38339230,Gender-Specific Fine Motor Skill Learning Is Impaired by Myelin-Targeted Neurofibromatosis Type 1 Gene Mutation.,EXCLUDE,Motor skill learning study
PMID:38360927,Neurofibromin 1 controls metabolic balance and Notch-dependent quiescence of murine juvenile myogenic progenitors.,EXCLUDE,Metabolic mechanism study
PMID:38372904,Imaging as an early biomarker to predict sensitivity to everolimus for progressive NF2-related vestibular schwannoma.,EXCLUDE,Imaging biomarker study
PMID:38387803,Development of a vestibular schwannoma tumor slice model for pharmacological testing.,INCLUDE,Develops vestibular schwannoma tumor slice model
PMID:38458648,C5aR plus MEK inhibition durably targets the tumor milieu and reveals tumor cell phagocytosis.,EXCLUDE,Immunological mechanism study
PMID:38463630,Interactions between Ras and Rap signaling pathways during neurodevelopment in health and disease.,EXCLUDE,Signaling pathway review
PMID:38480916,p53 modulates kinase inhibitor resistance and lineage plasticity in NF1-related MPNSTs.,EXCLUDE,Molecular mechanism study
PMID:38481529,Generation of heterozygous and homozygous NF1 lines from human-induced pluripotent stem cells using CRISPR/Cas9 to investigate bone defects associated with neurofibromatosis type 1.,INCLUDE,Generates NF1 human induced pluripotent stem cell lines (genetic reagent)
PMID:38499890,"The PlexiQoL, a patient-reported outcome measure on quality of life in neurofibromatosis type 1-associated plexiform neurofibroma: translation, cultural adaptation and validation into the Dutch language for the Netherlands.",INCLUDE,Develops patient-reported quality of life tool (clinical assessment tool)
PMID:38502231,STING activation reprograms the microenvironment to sensitize NF1-related malignant peripheral nerve sheath tumors for immunotherapy.,EXCLUDE,Immunotherapy mechanism study
PMID:38595983,Conditionally replicative adenovirus as a therapy for malignant peripheral nerve sheath tumors.,EXCLUDE,Viral therapy study
PMID:38603731,Raman difference spectroscopy and U-Net convolutional neural network for molecular analysis of cutaneous neurofibroma.,INCLUDE,Develops Raman spectroscopy and U-Net neural network tool
PMID:38607967,NF1 mutation-driven neuronal hyperexcitability sets a threshold for tumorigenesis and therapeutic targeting of murine optic glioma.,EXCLUDE,Neurological mechanism study
PMID:38691597,Effect of NFX-179 MEK inhibitor on cutaneous neurofibromas in persons with neurofibromatosis type 1.,EXCLUDE,Drug effect study
PMID:38714355,MEK Inhibition Enhances the Antitumor Effect of Radiotherapy in NF1-Deficient Glioblastoma.,EXCLUDE,Radiotherapy mechanism study
PMID:38722890,NF-B1 deficiency promotes macrophage-derived adrenal tumors but decreases neurofibromas in HTLV-I LTR-Tax transgenic mice.,EXCLUDE,Tumor mechanism study
PMID:38783059,Deep learning for dual detection of microsatellite instability and POLE mutations in colorectal cancer histopathology.,EXCLUDE,Deep learning method study
PMID:38811427,Quality of life in individuals with neurofibromatosis type 1 associated cutaneous neurofibromas: validation of the Dutch cNF-Skindex.,INCLUDE,Validates patient quality of life tool (clinical assessment tool)
PMID:38816530,Nf1 mutation disrupts activity-dependent oligodendroglial plasticity and motor learning in mice.,EXCLUDE,Neurological mechanism study
PMID:38828669,PD-L1 regulates tumor proliferation and T-cell function in NF2-associated meningiomas.,EXCLUDE,Immunological mechanism study
PMID:38874808,"Genetic/epigenetic effects in NF1 microdeletion syndrome: beyond the haploinsufficiency, looking at the contribution of not deleted genes.",EXCLUDE,Genetic mechanism study
PMID:38879607,G6PD and ACSL3 are synthetic lethal partners of NF2 in Schwann cells.,EXCLUDE,Metabolic mechanism study
PMID:38895115,Enhanced IL-12 transgene expression improves oncolytic viroimmunotherapy.,EXCLUDE,Viral immunotherapy study
PMID:38900740,Revisiting the NPcis mouse model: A new tool to model plexiform neurofibroma.,INCLUDE,Develops NPcis mouse model (animal model)
PMID:38913608,Dietary intervention rescues a bone porosity phenotype in a murine model of Neurofibromatosis Type 1 (NF1).,EXCLUDE,Dietary intervention study
PMID:38924432,MEK-SHP2 inhibition prevents tibial pseudarthrosis caused by ,EXCLUDE,Cellular mechanism study
PMID:38931352,PET Imaging of Neurofibromatosis Type 1 with a Fluorine-18 Labeled Tryptophan Radiotracer.,INCLUDE,Develops PET imaging radiotracer (computational tool)
PMID:38945076,Selective nitration of Hsp90 acts as a metabolic switch promoting tumor cell proliferation.,EXCLUDE,Metabolic mechanism study
PMID:38990917,Optical coherence tomography of the macular ganglion cell layer in children with neurofibromatosis type 1 is a useful tool in the assessment for optic pathway gliomas.,INCLUDE,Develops optical coherence tomography assessment tool
PMID:38995012,The Use of Hexokinase 2-Displacing Peptides as an Anti-Neoplastic Approach for Malignant Peripheral Nerve Sheath Tumors.,EXCLUDE,Peptide therapeutic approach
PMID:39001468,Genotype-Phenotype Correlation in Neurofibromatosis Type 1: Evidence for a Mild Phenotype Associated with Splicing Variants Leading to In-Frame Skipping of ,EXCLUDE,Genetic correlation study
PMID:39016685,Chemical genetic screens reveal defective lysosomal trafficking as synthetic lethal with NF1 loss.,INCLUDE,Develops chemical genetic screening method
PMID:39022906,Expanding the phenotype of neurofibromatosis type 1 microdeletion syndrome.,EXCLUDE,Genetic syndrome characterization
PMID:39023130,Maternal obesogenic diet operates at the tumor cell of origin to increase incidence and decrease latency of neurofibromatosis type 1 optic pathway glioma.,EXCLUDE,Maternal diet mechanism study
PMID:39059735,Longitudinal changes in retinal ganglion cell function in optic pathway glioma evaluated by photopic negative response.,EXCLUDE,Retinal function study
PMID:39061138,A Fibroblast-Derived Secretome Stimulates the Growth and Invasiveness of 3D Plexiform Neurofibroma Spheroids.,INCLUDE,Develops 3D plexiform neurofibroma spheroid model
PMID:39083549,Synergistic effect of PAK and Hippo pathway inhibitor combination in NF2-deficient Schwannoma.,EXCLUDE,Pharmacological mechanism study
PMID:39094827,Reduced PTPRS expression promotes epithelial-mesenchymal transition of Schwann cells in NF1-related plexiform neurofibromas.,EXCLUDE,Cellular mechanism study
PMID:39100928,NF1-dependent disruption of the blood-nerve-barrier is improved by blockade of P2RY14.,EXCLUDE,Cellular mechanism study
PMID:39106942,Investigating therapeutic nonsense suppression in a neurofibromatosis mouse model.,INCLUDE,Develops mouse model for nonsense suppression
PMID:39110684,Electrical stimulation of Schwann cells on electrospun hyaluronic acid carbon nanotube fibers.,INCLUDE,Develops Schwann cell electrical stimulation model
PMID:39129390,Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors.,EXCLUDE,Autophagy mechanism study
PMID:39140257,Heterozygosity for loss-of-function variants in LZTR1 is associated with isolated multiple caf-au-lait macules.,EXCLUDE,Genetic variant study
PMID:39179860,Targeting MERTK on tumour cells and macrophages: a potential intervention for sporadic and NF2-related meningioma and schwannoma tumours.,EXCLUDE,No specific research tool mentioned
PMID:39193326,Efficient analysis of adverse drug events and toxicological mechanisms of newly marketed drugs by integrating pharmacovigilance and network toxicology: selumetinib as an example.,EXCLUDE,Drug analysis without specific research tool
PMID:39196570,Cutaneous Neurofibromas and Quality of Life in Adults With Neurofibromatosis Type 1.,EXCLUDE,Quality of life study without research tools
PMID:39198186,Quality of life and neurological symptoms in patients with neurofibromatosis type 2: a national database study in Japan.,EXCLUDE,Quality of life database study
PMID:39201967,"Quality of Life in Children with Neurofibromatosis Type 1: Agreement between Parents and Patients, and the Role of Disease Severity and Visibility.",EXCLUDE,Quality of life comparison study
PMID:39210910,Impact of pathogenic variants of the Ras-mitogen-activated protein kinase pathway on major white matter tracts in the human brain.,EXCLUDE,Neuroimaging analysis without novel tool
PMID:39216515,An Atypical Mechanism of SUMOylation of Neurofibromin SecPH Domain Provides New Insights into SUMOylation Site Selection.,EXCLUDE,Protein modification study
PMID:39217323,Unraveling neuronal and metabolic alterations in neurofibromatosis type 1.,EXCLUDE,Neurological review without tools
PMID:39225289,Comparing 3D imaging devices for the measurement of cutaneous neurofibromas in patients with Neurofibromatosis Type 1.,INCLUDE,3D imaging device comparison
PMID:39234078,"Long-term distress throughout one's life: health-related quality of life, economic and caregiver burden of patients with neurofibromatosis type 1 in China.",EXCLUDE,Quality of life survey
PMID:39258154,LZTR1 loss-of-function variants associated with caf au lait macules with or without freckling.,EXCLUDE,Genetic variant analysis
PMID:39273214,Interferon-Induced Transmembrane Protein 1 (IFITM1) Is Downregulated in Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors.,EXCLUDE,Molecular biology study
PMID:39321200,Multidimensional Immunotyping of Human NF1-Associated Peripheral Nerve Sheath Tumors Uncovers Tumor-Associated Macrophages as Key Drivers of Immune Evasion in the Tumor Microenvironment.,EXCLUDE,Immunotyping study
PMID:39335500,Cold Atmospheric Plasma Induces Growth Arrest and Apoptosis in Neurofibromatosis Type 1-Associated Peripheral Nerve Sheath Tumor Cells.,EXCLUDE,Experimental treatment study
PMID:39355740,Pigment epithelium derived factor drives melanocyte proliferation and migration in neurofibromatosis caf au lait macules.,EXCLUDE,Molecular biology mechanism study
PMID:39373898,Identification of Pathogenic Missense Mutations of NF1 Using Computational Approaches.,INCLUDE,Computational mutation identification approach
PMID:39409151,Proof of Concept for Genome Profiling of the Neurofibroma/Sarcoma Sequence in Neurofibromatosis Type 1.,INCLUDE,Genome profiling technique
PMID:39413183,Stimulator of interferon gene facilitates recruitment of effector CD8 T cells that drive neurofibromatosis type 1 nerve tumor initiation and maintenance.,EXCLUDE,Immunological mechanism study
PMID:39415595,Generation of a zebrafish neurofibromatosis model via inducible knockout of nf2a/b.,INCLUDE,Zebrafish NF model development
PMID:39482412,TSPO deficiency promotes the progression of malignant peripheral sheath tumors by regulating the G2/M phase of the cell cycle via CDK1.,EXCLUDE,Molecular mechanism study
PMID:39488637,TGF- superfamily-induced transcriptional activation pathways establish the RAD52-dependent ALT machinery during malignant transformation of MPNSTs.,EXCLUDE,Molecular pathway study
PMID:39514826,"ReNeu: A Pivotal, Phase IIb Trial of Mirdametinib in Adults and Children With Symptomatic Neurofibromatosis Type 1-Associated Plexiform Neurofibroma.",EXCLUDE,Clinical trial description
PMID:39518076,Leveraging Neural Crest-Derived Tumors to Identify NF1 Cancer Stem Cell Signatures.,EXCLUDE,Cancer stem cell signature study
PMID:39521772,Automatic construction of Petri net models for computational simulations of molecular interaction network.,EXCLUDE,Generic computational modeling
PMID:39539654,Quality of life of patients with neurofibromatosis 1-Physical disability does not necessarily result in poor mental health.,EXCLUDE,Quality of life study
PMID:39596296,Integrated Transcriptome Profiling and Pan-Cancer Analyses Reveal Oncogenic Networks and Tumor-Immune Modulatory Roles for FABP7 in Brain Cancers.,EXCLUDE,Transcriptome profiling study
PMID:39601046,Role of long non-coding RNAs in neurofibromatosis and Schwannomatosis: pathogenesis and therapeutic potential.,EXCLUDE,Literature review
PMID:39609892,Neurocognitive functioning in adults with neurofibromatosis type 1- a nationwide population-based study.,EXCLUDE,Neurocognitive population study
PMID:39620202,Multiomic analyses reveal new targets of polycomb repressor complex 2 in Schwann lineage cells and malignant peripheral nerve sheath tumors.,INCLUDE,Multiomic analysis tool
PMID:39669605,Next-generation variant exon screening: Moving forward in routine genetic disease investigations.,INCLUDE,Next-generation variant screening technique
PMID:39731295,"Therapeutic effect of novel drug candidate, PRG-N-01, on NF2 syndrome-related tumor.",EXCLUDE,Drug candidate study
PMID:39749698,SUCLG1 promotes aerobic respiration and progression in plexiform neurofibroma.,EXCLUDE,Molecular mechanism study
PMID:39762421,Selumetinib in adults with NF1 and inoperable plexiform neurofibroma: a phase 2 trial.,EXCLUDE,Clinical trial description
PMID:39786423,"Triple Combination of MEK, BET, and CDK Inhibitors Significantly Reduces Human Malignant Peripheral Nerve Sheath Tumors in Mouse Models.",EXCLUDE,Experimental treatment study
PMID:39793045,Hydroxychloroquine prevents resistance and potentiates the antitumor effect of SHP2 inhibition in NF1-associated malignant peripheral nerve sheath tumors.,EXCLUDE,Experimental treatment study
PMID:39804140,"Loss of NF1 Accelerates Uveal and Intradermal Melanoma Tumorigenesis, and Oncogenic GNAQ Transforms Schwann Cells.",EXCLUDE,Genetic mechanism study
PMID:39824854,Comparison of 1D and 3D volume measurement techniques in NF2-associated vestibular schwannoma monitoring.,INCLUDE,1D and 3D volume measurement technique
PMID:39835668,"Selumetinib for children with neurofibromatosis type 1 and plexiform neurofibromas that can't be removed by surgery, and impact on how the condition affects caregivers: a plain language summary.",EXCLUDE,Plain language summary
PMID:39840093,Disproportionate adverse event signals of selumetinib in neurofibromatosis type I: insights from FAERS.,EXCLUDE,Adverse event analysis
PMID:39840811,Allosteric modulation of NF1 GAP: Differential distributions of catalytically competent populations in loss-of-function and gain-of-function mutants.,EXCLUDE,Molecular modeling study
PMID:39841844,WWC proteins-mediated compensatory mechanism restricts schwannomatosis driven by ,EXCLUDE,Molecular mechanism study
PMID:39844170,Internalizing and externalizing symptoms in individuals with neurofibromatosis type 1: a systematic review and meta-analysis.,EXCLUDE,Systematic review
PMID:39845289,Evaluating dimensionality reduction of comorbidities for predictive modeling in individuals with neurofibromatosis type 1.,INCLUDE,Predictive modeling approach
PMID:39857943,UBR5 in Tumor Biology: Exploring Mechanisms of Immune Regulation and Possible Therapeutic Implications in MPNST.,EXCLUDE,Tumor biology study
PMID:39863790,A multicenter study of neurofibromatosis type 1 utilizing deep learning for whole body tumor identification.,INCLUDE,Deep learning whole body tumor identification tool
PMID:39868555,Intestinal Bacteroides drives glioma progression by regulating CD8+ T cell tumor infiltration.,EXCLUDE,Microbiome mechanism study
PMID:39881370,"Spectrophotometric and computational characterization of charge transfer complex of selumetinib with 2,3-dichloro-5,6-dicyano-1,4-benzoquinone and its utilization in developing an innovative green and high throughput microwell assay for analysis of bulk form and pharmaceutical formulation.",INCLUDE,Spectrophotometric and computational characterization technique
PMID:39890807,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,INCLUDE,Global proteomics and mass spectrometry analysis technique
PMID:39921490,NF2 is Essential for Human Endoderm Development.,EXCLUDE,Developmental biology study
PMID:39948669,How does a preference-based generic health-related quality of life measure perform in patients with a rare disease? Measurement properties of the EQ-5D-Y proxy version among underage patients with neurofibromatosis type 1.,EXCLUDE,Quality of life measurement study
PMID:39952425,Sex-dependent variations of retinal function and architecture in a neurofibromatosis type I mouse model with normal vision.,INCLUDE,Sex-dependent mouse model of NF1
PMID:39965929,Neurofibromin Deficiency Alters the Patterning and Prioritization of Motor Behaviors in a State-Dependent Manner.,INCLUDE,NF1 mouse behavioral model
PMID:39966622,The development of an artificial intelligence auto-segmentation tool for 3D volumetric analysis of vestibular schwannomas.,INCLUDE,AI auto-segmentation tool development
PMID:39996452,Cas9 Mouse Model of Skull Base Meningioma Driven by Combinational Gene Inactivation in Meningeal Cells.,INCLUDE,Cas9 mouse model development
PMID:40025578,Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment.,INCLUDE,CAR-T cell therapy tool development
PMID:40191916,"The draft genome of the Wisconsin Miniature SwineTM, a valuable biomedical research tool.",INCLUDE,Genome of research animal model
PMID:40217315,A single-cell atlas of Schwannoma across genetic backgrounds and anatomic locations.,INCLUDE,Single-cell atlas computational tool
PMID:40225167,Functional Assays Combined with Pre-mRNA-Splicing Analysis Improve Variant Classification and Diagnostics for Individuals with Neurofibromatosis Type 1 and Legius Syndrome.,INCLUDE,Functional assay and splicing analysis tool
PMID:40299482,Sleep Disorders in Pediatric Patients Affected by Neurofibromatosis Type 1: Reports of a Questionnaire and an Apple Watch Sleep Assessment.,INCLUDE,Apple Watch sleep assessment tool
PMID:40304934,Development of patient reported outcome measures assessing tumor pain intensity and tumor pain interference for individuals with neurofibromatosis type 1 and plexiform neurofibromas: qualitative findings.,INCLUDE,Patient reported outcome measure development
PMID:40352015,Development of a Machine Learning Algorithm for the Prediction of WHO Grade 1 Meningioma Recurrence.,INCLUDE,Machine learning algorithm development
PMID:40394150,Mass spectrometric insights into the protein composition of human cutaneous neurofibromas: comparison of neurofibromas with the overlying skin.,INCLUDE,Mass spectrometry protein analysis tool
PMID:40437318,Quantitative MRI of dorsal root ganglion alterations in neurofibromatosis type 1 patients with or without pain.,INCLUDE,Quantitative MRI analysis tool
PMID:40460210,Development of two different eco-friendly label-free platforms for analysis of selumetinib.,INCLUDE,Label-free analytical platform development
PMID:40507334,Development of a Novel Biomarker Platform for Profiling Key Protein-Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs.,INCLUDE,Biomarker platform development
PMID:40529476,Using Durometers to Quantify Stiffness as an Outcome Measure for Cutaneous Neurofibroma in Neurofibromatosis Type 1.,INCLUDE,Durometer stiffness measurement tool
PMID:40563570,The RXR Agonist MSU-42011 Reduces Tumor Burden in a Murine Preclinical NF1-Deficient Model.,EXCLUDE,Pharmacological intervention study
PMID:40587782,"A transcriptomic, proteomic, and functional genetic atlas dissects neurofibromin function in the peripheral nervous system.",INCLUDE,Transcriptomic/proteomic functional atlas
PMID:40590220,A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice.,INCLUDE,Haploinsufficiency restoration strategy
PMID:40737523,Clinician Perspectives of a Magnetic Resonance Imaging-Based 3D Volumetric Analysis Tool for Neurofibromatosis Type 2-Related Schwannomatosis: Qualitative Pilot Study.,INCLUDE,3D volumetric MRI analysis tool
PMID:40769067,Serum miRNAs as biomarkers in Neurofibromatosis 1: New promising findings.,INCLUDE,Serum miRNA biomarker development
PMID:40842873,Evaluating the effect of voxel size on the accuracy of 3D volumetric analysis measurements of brain tumors.,INCLUDE,3D volumetric measurement tool
PMID:40862755,Fibroblasts Attenuate Anti-Tumor Drug Efficacy in Tumor Cells via Paracrine Interactions with Tumor Cells in 3D Plexiform Neurofibroma Cultures.,INCLUDE,3D plexiform neurofibroma culture model
PMID:40887659,RENOVO-NF1 accurately predicts NF1 missense variant pathogenicity.,INCLUDE,RENOVO-NF1 variant prediction tool
PMID:40896930,High resolution nerve ultrasound in neurofibromatosis type 1: a prospective and descriptive study.,INCLUDE,High resolution nerve ultrasound tool
PMID:40977920,Cell-free DNA fragmentomics: a universal framework for early cancer detection and monitoring.,EXCLUDE,Cell-free DNA fragmentomics method
PMID:41001135,"Schwann cells in the inner ear: development, disease, and regeneration.",EXCLUDE,Schwann cell review
PMID:41001593,Loss of Schwann cell's normal rhythmic core clock gene expression and gain of rhythmic expression of oncogenic driver genes in malignant NF1-associated peripheral nerve sheath tumor.,INCLUDE,Gene expression analysis tool
PMID:41022755,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors.,INCLUDE,AAV vector gene therapy development
PMID:41023593,Selective inhibition of BRAF and CRAF sensitizes NF1-deficient malignant peripheral nerve sheath tumors to MEK inhibitors.,INCLUDE,Pharmacogenomic screening tool
PMID:41036607,Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors.,INCLUDE,Pharmacogenomic synthetic lethal screening
PMID:41149489,Small Extracellular Vesicles Derived from NF2-Associated Schwannoma Cells Modulate Tumor Progression and Immunity via HSP90.,INCLUDE,Extracellular vesicle analysis tool
PMID:41168866,Artificial intelligence-based tools for precision diagnosis and treatment of neurofibromatosis type 1 associated peripheral and central glial tumors.,INCLUDE,AI diagnostic/treatment tool development
PMID:41210219,Radiation sensitivity in genetic tumour syndromes and how to test for them.,EXCLUDE,Radiation sensitivity review
PMID:41211508,Ambient ionization mass spectrometry in brain cancer diagnosis.,EXCLUDE,Mass spectrometry diagnostic method
PMID:41223283,Glial-to-mesenchymal transition of tumor Schwann cells drives the genetic burden in MPNSTs from neurofibromatosis type 1 mouse model.,EXCLUDE,Mouse model mechanistic study
PMID:41294711,Neurofibromatosis Type 1 and the Search for Effective Tumor Therapies Using High-Throughput Drug Screening.,INCLUDE,High-throughput drug screening approach
PMID:41397954,Pharmacological inhibition of RAS pathway alleviates spine deformity in a mouse model of neurofibromatosis type 1.,EXCLUDE,Pharmacological intervention study
PMID:41411243,PERADIGM: Phenotype embedding similarity-based rare disease gene mapping.,INCLUDE,PERADIGM rare disease gene mapping tool
PMID:41444363,Focused ultrasound-mediated drug delivery of bevacizumab in treating NF2-related schwannomatosis in an animal model.,INCLUDE,Focused ultrasound drug delivery method
PMID:41468561,NF1-Specific Growth Charts for Head Circumference Over the First 3 Years of Life.,INCLUDE,NF1-specific growth chart development
PMID:41480763,NF2 loss malignantly transforms human pancreatic acinar cells and enhances cell fitness under environmental stress.,EXCLUDE,Cellular transformation mechanism study
PMID:41496278,Simultaneous reprogramming and gene correction to generate six iPSC lines and isogenic controls from individuals with neurofibromatosis type 1.,INCLUDE,iPSC line generation tool
PMID:41545416,Asthma-mediated control of optic glioma growth via T cell-microglia interactions: A mathematical model.,INCLUDE,Mathematical modeling tool
PMID:41564118,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,INCLUDE,Schwann cell line immortalization
PMID:41582719,Inhibition of Cxcr4 chemokine receptor signaling improves habituation learning in a zebrafish model of Neurofibromatosis.,INCLUDE,Zebrafish NF behavioral model
PMID:41591566,FAP expression as a marker of malignant transformation enabling in vivo characterization in peripheral nerve sheath tumors: a multimodal and translational study.,INCLUDE,FAP expression characterization tool
PMID:41598414,Dermoscopy-Guided High-Frequency Ultrasound Imaging of Subcentimeter Cutaneous and Subcutaneous Neurofibromas in Patients with Neurofibromatosis Type 1.,INCLUDE,Dermoscopy-ultrasound imaging tool
PMID:41602242,Perspectives of Patients and Providers on Chronic Pain Assessment in Neurofibromatosis Type 1 (NF1): A Qualitative Study.,INCLUDE,Chronic pain assessment tool
PMID:41616055,Inhibition of focal adhesion kinase impairs tumor formation and preserves hearing in a murine model of NF2-related schwannomatosis.,INCLUDE,Murine NF2 schwannomatosis model
PMID:41680443,Proof-of-principle of NF1 gene therapy in plexiform neurofibroma xenograft mouse models.,INCLUDE,Parse error - defaulted to include
PMID:4327710,Complications of mediastinal neural tumours.,INCLUDE,Parse error - defaulted to include
PMID:4371739,Tumours of the nervous system.,INCLUDE,Parse error - defaulted to include
PMID:4604946,Primary mediastinal tumours.,INCLUDE,Parse error - defaulted to include
PMID:4622580,Recent advances in neuroblastoma.,INCLUDE,Parse error - defaulted to include
PMID:5003511,Neurofibromatosis and leprosy.,INCLUDE,Parse error - defaulted to include
PMID:5282620,Electron microscopic observations on structures resembling myxovirus in human sarcomas.,INCLUDE,Parse error - defaulted to include
PMID:6093111,Characterization of nerve growth factor receptor in neural crest tumors using monoclonal antibodies.,INCLUDE,Parse error - defaulted to include
PMID:6139138,Multiple endocrine neoplasia associated with von Recklinghausen's disease.,INCLUDE,Parse error - defaulted to include
PMID:6168641,Effect of interferon in therapy of skin and head and neck tumors.,INCLUDE,Parse error - defaulted to include
PMID:6203987,Neurofibromatosis of von Recklinghausen: a quantitative study of the epidermal keratinocyte and melanocyte populations.,INCLUDE,Parse error - defaulted to include
PMID:6278936,S-100 protein in soft-tissue tumors derived from Schwann cells and melanocytes.,INCLUDE,Parse error - defaulted to include
PMID:6413007,Tumors of the peripheral nervous system.,INCLUDE,Parse error - defaulted to include
PMID:6417334,Linkage analysis of neurofibromatosis (von Recklinghausen disease).,INCLUDE,Parse error - defaulted to include
PMID:6432917,The nature and origin of the melanin macroglobule.,INCLUDE,Parse error - defaulted to include
PMID:6451216,An enzyme activity in normal and ataxia telangiectasia cell lines which is involved in the repair of gamma-irradiation-induced DNA damage.,INCLUDE,Parse error - defaulted to include
PMID:6490532,The effects of mesencephalic neural crest cell extirpation on the development of chicken embryos.,INCLUDE,Parse error - defaulted to include
PMID:6523094,An evaluation of reports of dioxin exposure and soft tissue sarcoma pathology among chemical workers in the United States.,INCLUDE,Parse error - defaulted to include
PMID:666085,Scanning electron microscopy of nerve sheath neoplasms.,INCLUDE,Parse error - defaulted to include
PMID:6810767,Caf-au-lait spots in schoolchildren.,INCLUDE,Parse error - defaulted to include
PMID:7426572,Primary optic nerve meningioma.,INCLUDE,Parse error - defaulted to include
PMID:7474134,Frequent disruption of the Nf1 gene by a novel murine AIDS virus-related provirus in BXH-2 murine myeloid lymphomas.,INCLUDE,Parse error - defaulted to include
PMID:7485397,Neurofibromatosis type 2 protein co-localizes with elements of the cytoskeleton.,INCLUDE,Parse error - defaulted to include
PMID:7485407,NF2 gene analysis distinguishes hemangiopericytoma from meningioma.,INCLUDE,Parse error - defaulted to include
PMID:7493911,Low incidence of a nucleotide sequence alteration of the neurofibromatosis 2 gene in human breast cancers.,INCLUDE,Parse error - defaulted to include
PMID:7499408,"Inhibition of Ras/Raf interaction by anti-oncogenic mutants of neurofibromin, the neurofibromatosis type 1 (NF1) gene product, in cell-free systems.",INCLUDE,Parse error - defaulted to include
PMID:7505343,"Modulation of the neurofibromatosis type 1 gene product, neurofibromin, during Schwann cell differentiation.",INCLUDE,Parse error - defaulted to include
PMID:7570581,"Evidence for the presence of two amino-terminal isoforms of neurofibromin, a gene product responsible for neurofibromatosis type 1.",INCLUDE,Parse error - defaulted to include
PMID:7609078,Retroviral integration at the Evi-2 locus in BXH-2 myeloid leukemia cell lines disrupts Nf1 expression without changes in steady-state Ras-GTP levels.,INCLUDE,Parse error - defaulted to include
PMID:7671302,Loss of neurofibromin results in neurotrophin-independent survival of embryonic sensory and sympathetic neurons.,INCLUDE,Parse error - defaulted to include
PMID:7686513,An exon-trapping system with a newly constructed trapping vector pEXT2; its application to the proximal region of the human chromosome 21 long arm.,INCLUDE,Parse error - defaulted to include
PMID:7686619,Multiple dispersed loci produce small cytoplasmic Alu RNA.,INCLUDE,Parse error - defaulted to include
PMID:7706208,An exon 8-spliced out transcript of neurofibromatosis 2 gene is constitutively expressed in various human tissues.,INCLUDE,Parse error - defaulted to include
PMID:7717450,Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma.,INCLUDE,Parse error - defaulted to include
PMID:7818486,Activation of Ito cells involves regulation of AP-1 binding proteins and induction of type I collagen gene expression.,INCLUDE,Parse error - defaulted to include
PMID:7903272,An EcoRI RFLP in the 5' region of the human NF1 gene.,INCLUDE,Parse error - defaulted to include
PMID:7911002,Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas.,INCLUDE,Parse error - defaulted to include
PMID:7947085,"Frequency of allele loss of DCC, p53, RBI, WT1, NF1, NM23 and APC/MCC in colorectal cancer assayed by fluorescent multiplex polymerase chain reaction.",INCLUDE,Parse error - defaulted to include
PMID:7947096,Loss of heterozygosity on chromosome 22 in ovarian carcinoma is distal to and is not accompanied by mutations in NF2 at 22q12.,INCLUDE,Parse error - defaulted to include
PMID:7949098,Genetic analysis is consistent with the hypothesis that NF1 limits myeloid cell growth through p21ras.,INCLUDE,Parse error - defaulted to include
PMID:7959746,DNA sequences in the promoter region of the NF1 gene are highly conserved between human and mouse.,INCLUDE,Parse error - defaulted to include
PMID:7977647,Characterization of naturally occurring cutaneous neurofibromatosis in Holstein cattle. A disorder resembling neurofibromatosis type 1 in humans.,INCLUDE,Parse error - defaulted to include
PMID:7985572,Neurofibromatosis type 1: the evolution of deep gray and white matter MR abnormalities.,INCLUDE,Parse error - defaulted to include
PMID:7996175,Hepatocyte growth factor is a mitogen for Schwann cells and is present in neurofibromas.,INCLUDE,Parse error - defaulted to include
PMID:803743,Vascular manifestations of von Recklinghausen's disease.,INCLUDE,Parse error - defaulted to include
PMID:8051082,Cloning and characterization of a novel epidermal cell surface antigen (ESA).,INCLUDE,Parse error - defaulted to include
PMID:8089100,An anti-Ras function of neurofibromatosis type 2 gene product (NF2/Merlin).,INCLUDE,Parse error - defaulted to include
PMID:8105688,Linkage disequilibrium in the neurofibromatosis 1 (NF1) region: implications for gene mapping.,INCLUDE,Parse error - defaulted to include
PMID:8176268,Localization of neurofibromin to keratinocytes and melanocytes in developing rat and human skin.,INCLUDE,Parse error - defaulted to include
PMID:8176761,Modulation of neurofibromatosis type 1 gene expression during in vitro myoblast differentiation.,INCLUDE,Parse error - defaulted to include
PMID:8226742,The GTPase-activating NF1 fragment of 91 amino acids reverses v-Ha-Ras-induced malignant phenotype.,EXCLUDE,"Biochemical mechanism study, no specific research tool"
PMID:8226805,Purification of a novel ras GTPase-activating protein from rat brain.,EXCLUDE,"Protein purification technique, no specific research tool"
PMID:8246952,Effector domain mutations dissociate p21ras effector function and GTPase-activating protein interaction.,EXCLUDE,"Molecular mechanism study, no specific research tool"
PMID:8264632,Neurofibromin can inhibit Ras-dependent growth by a mechanism independent of its GTPase-accelerating function.,EXCLUDE,"Molecular mechanism study, no specific research tool"
PMID:8320697,A genetic study of neurofibromatosis type 1 (NF1) in south-western Ontario. II. A PCR based approach to molecular and prenatal diagnosis using linkage.,INCLUDE,PCR-based molecular diagnostic approach
PMID:8328449,An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1): evidence for modifying genes.,EXCLUDE,"Genetic variation analysis, no specific research tool"
PMID:8332934,Neurofibromatosis type 1 gene product (neurofibromin) associates with microtubules.,EXCLUDE,"Protein localization study, no specific research tool"
PMID:8335107,Differential contribution of M(r) 120 kDa rasGTPase-activating protein and neurofibromatosis type 1 gene product during the transition from growth phase to arrested state in human fibroblasts accompanied by a unique rasGTPase-activating activity.,EXCLUDE,"Cellular biochemistry study, no specific research tool"
PMID:8341688,Suppression of oncogenic Ras by mutant neurofibromatosis type 1 genes with single amino acid substitutions.,EXCLUDE,"Molecular mechanism study, no specific research tool"
PMID:8417346,"A conserved alternative splice in the von Recklinghausen neurofibromatosis (NF1) gene produces two neurofibromin isoforms, both of which have GTPase-activating protein activity.",INCLUDE,Alternative splice variant analysis using PCR
PMID:8455625,Differential regulation of cellular activities by GTPase-activating protein and NF1.,EXCLUDE,"Cellular signaling mechanism study, no specific research tool"
PMID:8544190,Characterisation of germline mutations in the neurofibromatosis type 1 (NF1) gene.,INCLUDE,Mutation characterization using genetic techniques
PMID:8582272,Neurofibromin-deficient fibroblasts fail to form perineurium in vitro.,INCLUDE,Cell culture model development
PMID:8602361,The neurofibromatosis type I messenger RNA undergoes base-modification RNA editing.,EXCLUDE,"mRNA editing mechanism study, no specific research tool"
PMID:8612763,Phosphorylation of neurofibromatosis type 1 gene product (neurofibromin) by cAMP-dependent protein kinase.,EXCLUDE,"Protein phosphorylation study, no specific research tool"
PMID:8621451,A naturally occurring T14A11 tract blocks nucleosome formation over the human neurofibromatosis type 1 (NF1)-Alu element.,EXCLUDE,"Chromatin organization study, no specific research tool"
PMID:8627811,Repression of the NF1 gene by Tax may expain the development of neurofibromas in human T-lymphotropic virus type 1 transgenic mice.,EXCLUDE,"Transgenic mouse model observation, no tool development"
PMID:8659521,Genotyping of PCR-based polymorphisms and linkage-disequilibrium analysis at the NF1 locus.,INCLUDE,PCR-based polymorphism genotyping
PMID:8666669,"Distinct cellular and subcellular patterns of expression imply distinct functions for the Drosophila homologues of moesin and the neurofibromatosis 2 tumor suppressor, merlin.",EXCLUDE,"Protein expression study, no specific research tool"
PMID:8751853,Germ-line mutations in the neurofibromatosis 2 gene: correlations with disease severity and retinal abnormalities.,EXCLUDE,"Genetic mutation correlation study, no specific research tool"
PMID:8892969,NF1 mRNA isoform expression in PC12 cells: modulation by extrinsic factors.,EXCLUDE,"mRNA isoform expression study, no specific research tool"
PMID:8982875,Differential tissue-specific expression of neurofibromin isoform mRNAs in rat.,EXCLUDE,"mRNA isoform expression study, no specific research tool"
PMID:9001241,Nf1-deficient mouse Schwann cells are angiogenic and invasive and can be induced to hyperproliferate: reversion of some phenotypes by an inhibitor of farnesyl protein transferase.,INCLUDE,Mouse Schwann cell model development
PMID:9036924,Post-transcriptional regulation of neurofibromin level in cultured human melanocytes in response to growth factors.,EXCLUDE,"Cellular protein regulation study, no specific research tool"
PMID:9078372,Neurocristopathy resembling neurofibromatosis type 1 in an NGF-SV40 transgenic line.,EXCLUDE,"Transgenic mouse model observation, no tool development"
PMID:9136014,Isolation of mutations in the Drosophila homologues of the human Neurofibromatosis 2 and yeast CDC42 genes using a simple and efficient reverse-genetic method.,INCLUDE,Reverse-genetic mutation isolation method
PMID:9222967,Four frameshift mutations in neurofibromatosis type 1 caused by small insertions.,INCLUDE,Mutation detection using heteroduplex analysis
PMID:9399891,Molecular analysis of the NF2 tumor-suppressor gene in schwannomatosis.,EXCLUDE,"Molecular genetic analysis, no specific research tool"
PMID:9430655,"NHE-RF, a regulatory cofactor for Na(+)-H+ exchange, is a common interactor for merlin and ERM (MERM) proteins.",EXCLUDE,"Protein interaction study, no specific research tool"
PMID:9458162,A rapid and sensitive protocol for competitive reverse transcriptase (cRT) PCR analysis of cellular genes.,INCLUDE,Competitive RT-PCR protocol development
PMID:9516485,"Regulation of the neurofibromatosis type 2 tumor suppressor protein, merlin, by adhesion and growth arrest stimuli.",EXCLUDE,"Protein regulation study, no specific research tool"
PMID:9560242,A role for Pak protein kinases in Schwann cell transformation.,EXCLUDE,"Cellular signaling mechanism study, no specific research tool"
PMID:9607929,Nf1 regulates hematopoietic progenitor cell growth and ras signaling in response to multiple cytokines.,EXCLUDE,"Hematopoietic cell signaling study, no specific research tool"
PMID:9687500,Structural analysis of the GAP-related domain from neurofibromin and its implications.,EXCLUDE,"Protein structural analysis, no specific research tool"
PMID:9703963,Merlin differs from moesin in binding to F-actin and in its intra- and intermolecular interactions.,EXCLUDE,"Protein interaction study, no specific research tool"
PMID:9878702,Region-specific astrogliosis in brains of mice heterozygous for mutations in the neurofibromatosis type 1 (Nf1) tumor suppressor.,EXCLUDE,"Brain pathology study, no specific research tool"
